## Page 1

fnins-15-650785 April13,2021 Time:14:5 #1
REVIEW
published:15April2021
doi:10.3389/fnins.2021.650785
Neuroimmune Mechanisms as Novel
Treatment Targets for Substance Use
Disorders and Associated
Comorbidities
MarkD.Namba1*,JonnaM.Leyrer-Jackson2,ErinK.Nagy2,M.FosterOlive2and
JanetL.Neisewander1*
1SchoolofLifeSciences,ArizonaStateUniversity,Tempe,AZ,UnitedStates,2DepartmentofPsychology,ArizonaState
University,Tempe,AZ,UnitedStates
Recent studies examining the neurobiology of substance abuse have revealed a
Editedby: significant role of neuroimmune signaling as a mechanism through which drugs of
FlaviaEugeniaSaravia, abuse induce aberrant changes in synaptic plasticity and contribute to substance
UniversidaddeBuenosAires,
abuse-related behaviors. Immune signaling within the brain and the periphery critically
Argentina
regulates homeostasis of the nervous system. Perturbations in immune signaling can
Reviewedby:
MarcelloSolinas, induce neuroinflammation or immunosuppression, which dysregulate nervous system
InstitutNationaldelaSantéetdela
function including neural processes associated with substance use disorders (SUDs).
RechercheMédicale(INSERM),
France In this review, we discuss the literature that demonstrates a role of neuroimmune
KarenK.Szumlinski, signaling in regulating learning, memory, and synaptic plasticity, emphasizing specific
UniversityofCalifornia,
cytokinesignalingwithinthecentralnervoussystem.Wethenhighlightrecentpreclinical
SantaBarbara,UnitedStates
studies,withinthelast5yearswhenpossible,thathaveidentifiedimmunemechanisms
*Correspondence:
JanetL.Neisewander withinthebrainandtheperipheryassociatedwithaddiction-relatedbehaviors.Findings
janet.neisewander@asu.edu
thus far underscore the need for future investigations into the clinical potential of
MarkD.Namba
mnamba@asu.edu immunopharmacology as a novel approach toward treating SUDs. Considering the
high prevalence rate of comorbidities among those with SUDs, we also discuss
Specialtysection:
neuroimmune mechanisms of common comorbidities associated with SUDs and
Thisarticlewassubmittedto
Neuropharmacology, highlight potentially novel treatment targets for these comorbid conditions. We argue
asectionofthejournal that immunopharmacology represents a novel frontier in the development of new
FrontiersinNeuroscience
pharmacotherapiesthatpromotelong-termabstinencefromdruguseandminimizethe
Received:08January2021
detrimentalimpactofSUDcomorbiditiesonpatienthealthandtreatmentoutcomes.
Accepted:24March2021
Published:15April2021
Keywords:neuroinflammation,addiction,PTSD,MDD,chronicpain,HIV
Citation:
NambaMD,Leyrer-JacksonJM,
NagyEK,OliveMFand INTRODUCTION
NeisewanderJL(2021)Neuroimmune
MechanismsasNovelTreatment
Substance Use Disorders (SUDs) are a significant public health concern and remain a leading
TargetsforSubstanceUseDisorders
cause of preventable death in the United States (US) and worldwide. Moreover, the economic
andAssociatedComorbidities.
Front.Neurosci.15:650785. burden of SUDs is substantial, amounting to more than $740 billion annually within the US in
doi:10.3389/fnins.2021.650785 healthcarecosts,lostproductivity,andcrime(NationalInstituteonDrugAbuse[NIDA],2020d).
FrontiersinNeuroscience|www.frontiersin.org 1 April2021|Volume15|Article650785

## Page 2

fnins-15-650785 April13,2021 Time:14:5 #2
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
Current FDA-approved pharmacotherapies used to treat describe neuroimmune mechanisms underlying SUDs and
SUDs primarily function to reduce withdrawal symptoms via associatedcomorbidities.
partial receptor stimulation or to prevent drug reinforcement
through receptor inhibition. Such strategies can reduce
CYTOKINES CRITICALLY REGULATE
drug cravings and promote abstinence, yet relapse rates
SYNAPTIC PLASTICITY, LEARNING,
remain high even for individuals receiving such treatments
(NationalInstituteonDrugAbuse[NIDA],2020b).Impediments AND MEMORY
tosuccessfultreatmentincludecomorbiditiessuchasdepression,
anxiety, and other physical ailments that are not adequately Glia play diverse roles in dynamically modulating synaptic
addressed by current treatment strategies (Swendsen et al., plasticity, learning, and memory beyond their “traditional”
2010). Thus, new and effective treatments that target shared roles in supporting tissue homeostasis (Temburni and Jacob,
mechanisms underlying these comorbidities may enhance 2001; Ben Achour and Pascual, 2010; Perea et al., 2014). For
treatmentoutcomes. example, neurochemical signaling molecules such as glutamate
Decadesofresearchhaverevealeddistinctneuralmechanisms mediate neuron-glia crosstalk that can alter downstream
involved in various phases of SUD development. Early work immunomodulatory signaling. As illustrated in Figure 1,
utilizinganimalmodelsfocusedontheeffectsofdrugexposure microglia, which continuously survey their environment with
on mesolimbic dopamine transmission originating from the ramified processes, express both ionotropic and metabotropic
ventral tegmental area (VTA) and terminating in corticolimbic glutamate receptors and can release proinflammatory factors
structuressuchasthenucleusaccumbens(seeKoobandVolkow, in response to rapid changes in extracellular glutamate levels
2010 for review). More recent studies have expounded the (Hagino et al., 2004; Murugan et al., 2011; Liu H. et al., 2016).
role of other molecular pathways and cellular circuitries that Similarly, astrocytes express such receptors and dynamically
are involved in the cycle of addiction (Koob and Volkow, respond to rapid changes in synaptic glutamate levels through
2016). For example, the role of glial cells in modulating drug- modulationofglutamateuptake(Duanetal.,1999)andthrough
induced neural plasticity and behavior has emerged as an gliotransmission via adenosine triphosphate (ATP) and other
important topic in the study of the pathophysiology of SUDs transmitters(Haradaetal.,2016).Aswell,astrocytesarehighly
(Miguel-Hidalgo, 2009). Specifically, glia within the CNS and sensitive to immunomodulatory signals and this has indirect
immune cells within the periphery are capable of modulating consequences on astrocytic regulation of synaptic transmission
brain plasticity and behavior through complex interactions, (Cekanaviciute and Buckwalter, 2016). Together, microglia and
and mounting evidence suggests that these interactions may astrocytes can orchestrate potent modulatory control over
underlie substance abuse and relapse vulnerability (Crews synapticplasticitythroughglialcell-derivedimmunomodulatory
and Vetreno, 2011; Crews et al., 2011; Clark et al., 2013; factorssuchascytokines.
Cuietal.,2014). Cytokines have been extensively studied for their role in
There are several recent and thorough reviews on learning,memory,andsynapticplasticity(LevinandGodukhin,
neuroimmune mechanisms of SUDs (Cui et al., 2014; 2017),andtheoutcomeoftheseprocessesdependonthespecific
Bachtell et al., 2015; Jacobsen et al., 2016; Crews et al., 2017; cytokine, its concentration within the brain, receptors available
Hofford et al., 2019) and other neuropsychiatric disorders for cytokine binding and activation of signal transduction
(Hodes et al., 2015; Wohleb et al., 2016; Bekhbat and Neigh, pathways, and the conditions underlying cytokine release
2018; Brenhouse et al., 2019). Here, we focus on literature (Goshen and Yirmiya, 2007). For example, Beattie et al.
from within the last 5 years when possible to highlight (2002) and Stellwagen et al. (2005) have demonstrated that
the most recent advances in neuroimmune mechanisms of glial tumor necrosis factor alpha (TNFα) facilitates membrane
SUDs across several common drugs of abuse. As well, we insertion of calcium-permeable α-amino-3-hydroxy-5-methyl-
highlight recent studies on neuroimmune mechanisms of 4-isoxazolepropionic acid (AMPA) glutamate receptors (CP-
psychiatric and non-psychiatric comorbidities and discuss AMPARs) and internalization of γ-aminobutyric acid type
how these studies reveal intersections with the SUD literature. A (GABA ) receptors within the hippocampus, leading to
A
Specifically, we discuss the neuroimmune mechanisms that enhanced excitatory synaptic transmission. In contrast, Lewitus
are associated with addiction-related processes, first focusing et al. (2014) found that TNFα exerts an opposite effect at
on neuron-glia interactions and how they underlie synaptic striatal synapses, where TNFα internalizes CP-AMPARs and
plasticity, learning, and memory with cytokine signaling as reduces corticostriatal synaptic strength. These investigators
a case in point. Next, we highlight recent preclinical studies demonstrated that microglia-induced TNFα release depresses
that have identified immune processes that are associated excitatory synaptic activity within the ventral striatum through
with drug-induced neural plasticity and behavior. We then internalization of AMPARs and that this process is associated
discuss how recent studies have implicated neuroimmune with cocaine-induced locomotor sensitization (Lewitus et al.,
mechanisms in the comorbidity of SUDs with other diseases 2016).Anotherexampleofregion-specificregulationofsynaptic
and disorders, and we describe how targeting these underlying plasticityshowedthatTNFαsecretioninresponsetoperipheral
neuroimmune mechanisms may represent a novel approach nerve injury enhances excitatory synaptic connectivity within
toward improving treatment outcomes. Lastly, we provide the spinal cord but impairs this connectivity within the
recommendations for future studies that aim to identify and hippocampus (Liu et al., 2017). These studies provide clear
FrontiersinNeuroscience|www.frontiersin.org 2 April2021|Volume15|Article650785

## Page 3

fnins-15-650785 April13,2021 Time:14:5 #3
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
FIGURE1|Immunomodulationofstriatalglutamatergicsynapticplasticity.GABAergicmediumspinyneurons(MSNs)withinthenucleusaccumbens(NAc)receive
glutamatergicinputsfromvariouscorticolimbicstructuresthatdrivedrug-seekingbehavior,whichincludestheprelimbiccortex(PrL),theamygdala(AMY),andthe
hippocampus(HPC).GlutamatergicplasticityatdendriticspinesonMSNsisregulatedbygliaandextracellularmatrixsignaling.Glialcell-derivedneuroimmune
signalssuchascytokinesplayasignificantroleinmodulatingthisplasticity.Additionally,glutamatetransporterssuchasGLT-1andthecystine-glutamateexchanger,
systemxc-(Sxc−),whicharefoundonbothastrocytesandmicroglia,tightlyregulateextracellularlevelsofglutamate.Microgliaandastrocytesexpressionotropic
andmetabotropicglutamatereceptors(e.g.,mGlu5)andcanreleaseneuroimmunefactorsinresponsetoglutamatergicstimulation.Withintheextracellularmatrix
(ECM),enzymessuchasmatrixmetalloproteinases(MMPs),whicharepredominantlyproducedbymicrogliaandastrocytes,canremodeltheECMtofacilitate
dendriticspineplasticity.CytokinescanpromotetheexpressionandactivationofMMPs,whichareassociatedwithlearning,memory,andsynapticplasticity.
Cytokinesalsobinddirectlytoreceptorslocatedonbothneuronsandglia,whichcandirectlyinfluencedownstreamgeneexpressionandsynapticplasticity.This
canresultinchangesinglutamatetransporterexpression,glutamatereceptorsurfaceexpression,intracellularsignaling,geneexpression,dendriticspine
morphology,andpost-synapticexcitability.
evidencethatimmunomodulatorysignalssuchasTNFαcrucially expressionduringtheinductionofhippocampalLTPshowthat
regulate synaptic plasticity in a brain region-specific manner, LTP induces an upregulation of IL-6 mRNA that is localized
which may have important implications for understanding the to non-neuronal cells such as astrocytes (Jankowsky et al.,
pathophysiologyofSUDs. 2000; Balschun et al., 2004) and inhibition of IL-6 signaling
LikeTNFα,microgliaandastrocytesalsoreleaseinterleukin- results in improved performance in hippocampus-dependent
6 (IL-6) within the CNS, a cytokine involved in modulating memory tasks (del Rey et al., 2013). Consistent with this
learning and memory (Ye and Johnson, 1999; Dong and finding, IL-6 knockout mice exhibit enhanced performance in
Benveniste,2001;Choietal.,2014).Earlystudiesdemonstrated a radial arm maze task compared to wild type mice, which is
that acute IL-6 exposure inhibits long-term potentiation (LTP) correlated with hippocampal choline acetyltransferase activity
within the hippocampus likely through inhibition of mitogen- (Braidaetal.,2004).
activated protein kinase/extracellular signal-regulated kinase Interleukin-1β (IL-1β) is also critically involved in
(MAPK/ERK) signaling (Li et al., 1997; Tancredi et al., 2002). hippocampal-dependent learning and synaptic plasticity.
In addition, overexpression of IL-6 in astrocytes of mice Withinthehippocampus,fearconditioningandLTPupregulate
results in reduced LTP in the dentate gyrus (Bellinger et al., IL-1β and systemic administration of small concentrations of
1995). However, in vitro and in vivo studies examining IL-6 IL-1βcanenhancelearningandmemory(Schneideretal.,1998;
FrontiersinNeuroscience|www.frontiersin.org 3 April2021|Volume15|Article650785

## Page 4

fnins-15-650785 April13,2021 Time:14:5 #4
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
Balschun et al., 2003; Goshen et al., 2007; del Rey et al., 2013). geared to inform future investigations into the neuroimmune
Additionally, acute intra-hippocampal administration and mechanismsofSUDs.
chronic overexpression of IL-1β can impair fear conditioning
Cocaine
andspatiallearningaswellashippocampalLTPsimilartoIL-6
(Vereker et al., 2000; Loscher et al., 2003; Ross et al., 2003; Since2015,cocaineoverdosedeaths,particularlythoseinvolving
Gonzalez et al., 2009; Moore et al., 2009; Hein et al., 2010; synthetic opioids, have risen sharply to over 15,000 as of
MacHado et al., 2010). Despite these seemingly convergent 2019 in the United States (National Institute on Drug Abuse
and consistent findings, studies examining learning (e.g., fear [NIDA], 2021), highlighting a resurgence of psychostimulant
conditioning) and hippocampal plasticity using IL-1 receptor abuse in the wake of the opioid epidemic. Importantly, no
(IL-1R)knockoutmicehavedemonstratedmixedeffects(Avital effective medications exist that successfully treat cocaine use
et al., 2003; Koo and Duman, 2009; Murray et al., 2013). This disorders (CUDs). Studies in humans have demonstrated that
is likely the result of complex interactions with other cytokines CUDsareassociatedwithalteredserumlevelsofpro-andanti-
within the IL-1 family, which is a very broad family of closely inflammatory cytokines (Moreira et al., 2016; Zaparte et al.,
relatedcytokines(Dinarello,2018). 2019). As well, serum cytokine levels may be useful indicators
Thesestudiesprovideclearevidencethatcytokinescanexert for assessing the severity for CUDs and identifying effective
a dynamic modulatory role within the nervous system over treatment strategies, although sex differences and psychiatric
synaptic plasticity, learning, and memory. They also highlight comorbidity are important factors to consider (Araos et al.,
thatthespecificcytokineandconditionsinwhichneuralcircuits 2015; Pedraz et al., 2015; Maza-Quiroga et al., 2017; Pianca
are exposed to them are paramount when interpreting these et al., 2017). Thus, preclinical investigation into the impact
findings. This complexity is a primary reason why elucidating of cocaine on immune function may reveal novel targets for
the role of immunomodulation and neuron-glia crosstalk in pharmacotherapy development. In a recent study by Calipari
facilitating the formation and persistence of addiction-related etal.(2018),bothnon-contingentcocaineexposureandcocaine
behaviors remains challenging. Below we highlight recent self-administration in mice were found to upregulate serum
preclinical studies, within the last 5 years when possible, levels of granulocyte-colony stimulating factor (G-CSF), a
that demonstrate the diverse nature of immunomodulation in knowngrowthfactorregulatorofgranulocytes,whichpositively
regulating addiction-related behaviors and underscore some of correlated with cocaine-induced locomotor sensitization. This
theremaininggapsinourunderstandingoftheseprocesses. study also found that both acute and sub-chronic cocaine
exposureincreasedG-CSFmRNAexpressionwithinthenucleus
accumbens (NAc) and medial prefrontal cortex (mPFC) and
that G-CSF potentiates cocaine self-administration. This effect
is likely not specific to cocaine, as this same group also
RECENT PRECLINICAL STUDIES
demonstrated that G-CSF enhances sucrose motivation and
EXAMINING IMMUNOMODULATION OF
cognitive flexibility, which they hypothesize may be through
ADDICTION-RELATED BEHAVIORS AND
indirect modulation of mesolimbic dopamine transmission via
ASSOCIATED NEUROPLASTICITY other immunomodulators such as TNFα (Kutlu et al., 2018).
As well, the role of G-CSF in cocaine-induced dopaminergic
Since2015,hundredsofarticlesrelatedtoimmunemechanisms plasticity was also shown to be dependent on estrous cycle
involvedinSUDshavebeenpublished,rangingfromcellularand phase in female mice (Brady et al., 2019), suggesting important
molecular studies exploring novel neuroimmune mechanisms sexdifferencesunderlyingimmunomodulationofdrug-induced
of addiction-related behaviors to clinical studies examining the neuralandbehavioralplasticity.
efficacy of immunopharmacology in the treatment of SUDs Asmentionedabove,TNFαisacriticalmodulatorofsynaptic
and associated comorbidities. For example, a PubMed search plasticity and specifically cocaine-induced neuroadaptations.
conducted at the time of preparation of this manuscript for A recent study demonstrated that non-contingent cocaine
all articles within the last 5 years containing the keywords exposure in mice activated microglia and increased TNFα in
“addiction” and “immune” yielded over 900 results, showing the NAc, leading to depressed excitatory synaptic strength at
the exponential growth of research in this area. Of relevance striatal synapses (Lewitus et al., 2016). Interestingly, this study
to the current review, preclinical animal models of SUDs have showedthattreatmentwithaweakagonistoftoll-likereceptor4
proveninvaluableinadvancingourunderstandingofthesocial, (TLR4)resultedinmicrogliaactivation,reducedcocaine-induced
psychological,andbiologicaletiologyofSUDs(Lynchetal.,2010; locomotorsensitization,anddecreasedexcitatoryactivitywithin
Kuhnetal.,2019),andrecentstudiesutilizingthesemodelshave the NAc. This study suggests that TNFα plays an adaptive
revealedvaluableinsightsintothesignificantroleneuroimmune role in suppressing cocaine-induced neurobehavioral plasticity.
mechanisms play in regulating drug reward and motivation. Nevertheless, the effects of TNFα on downstream cell signaling
Here, we highlight key preclinical research developments in and subsequent changes in gene expression and cellular
this area, focusing on cocaine, methamphetamine, nicotine, physiology are sensitive to the concentration and duration of
alcohol, and opioids. This review is by no means intended to exposure to these immunomodulators. For example, nuclear
be exhaustive, but rather serves to highlight recent advances, factor kappa B (NF-κB), which is a DNA-binding protein
common themes, and lingering gaps within the literature complex that is induced by TNFα, exhibits autoregulatory
FrontiersinNeuroscience|www.frontiersin.org 4 April2021|Volume15|Article650785

## Page 5

fnins-15-650785 April13,2021 Time:14:5 #5
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
feedback and oscillatory nuclear translocation with prolonged how neuroimmune mechanisms may underly the intersection
upstreamreceptorstimulation.Thisallowscellstodiscriminate between SUDs and other comorbidities, including non-
against multiple levels of cytokine input and subsequently psychiatric comorbidities such as HIV. As discussed below,
fine-tune downstream gene transcription (Inoue et al., 2016; other psychostimulants such as methamphetamine also exhibit
Zambrano et al., 2016; Zhang Q. et al., 2017). Moreover, the similarqualities.
effects of immunomodulators such as TNFα are likely drug-
Methamphetamine
specificanddependentonthepreclinicalbehavioralmodel(e.g.,
see Araos et al., 2015 for comparison to nicotine). Indeed, Over the last decade, methamphetamine (METH) use has
attentiontotheseconsiderationsisimportantforunderstanding risen sharply, particularly among individuals that also use
the role of neuroimmune signaling in the pathophysiology opioids. Specifically, the number of psychostimulant overdoses
of SUDs. Recent studies examining mesolimbic neuroimmune (consistingprimarilyofMETH),bothwithandwithoutopioids,
signaling implicate proinflammatory signaling mechanisms as has been sharply rising within the United States over the last
an important regulator of cocaine-induced neurobehavioral decade in the wake of the opioid epidemic (Mattson et al.,
plasticity. For example, Brown et al. (2018) demonstrated that 2021). This highlights an important need for novel therapeutic
antagonism of TLR4 within the ventral tegmental area (VTA), strategiestotreatpsychostimulantusedisorders,whichcurrently
whichsendsdopaminergicprojectionstocorticolimbicstructures havenoFDA-approvedpharmacologicaltreatments.METHhasa
such as the striatum to drive drug-seeking, reduces cocaine- profoundimpactonimmunesystemfunctionthroughdisruption
primedreinstatementofdrugseekingwithnoeffectonsucrose of the blood–brain barrier, dysregulation of both central and
seeking.Aswell,stimulationoftheVTAwithlipopolysaccharide peripheral immune signaling, epigenetic modifications, and
(LPS),whichactivatesTLR4,modestlyreinstatescocaineseeking, perturbation to the gut microbiome (for a recent review,
andinhibitionofcocaine-inducedelevationsinIL-1βwithinthe see Prakash et al., 2017). For instance, METH alters the
VTA reduces cocaine seeking (Brown et al., 2018). This study expression of microRNAs (miRNAs) that regulate immune-
corroboratesapreviousstudydemonstratingthatcocainebinds and addiction-related genes (Zhu et al., 2015, 2016). A recent
uniquely with the TLR4 receptor complex within the VTA to studydemonstratedthatMETHexposureinmicedownregulates
modulatedopamineinputintotheNAcandsubsequentcocaine- miR-29b and miR-124 within the NAc, which is consistent
seeking behavior (Northcutt et al., 2015). TLR4 knockout mice with previous observations in animals treated with cocaine
exhibit attenuated cocaine conditioned place preference (CPP), (ChandrasekarandDreyer,2009;Eipper-Mainsetal.,2011;Zhu
whichmaybeduetoimpairmentsinexcitatorysynapticplasticity et al., 2016). These miRNAs are crucial regulators of immune
withintheNAccore(KashimaandGrueter,2017).Thesefindings systemfunction(Listonetal.,2012;Qinetal.,2016),suggesting
are consistent with the hypothesis that dopamine input into thatMETH(andpossiblypsychostimulantsingeneral)mayexert
the NAc and cocaine-mediated activation of TLR4 stimulate aberrant immunomodulatory effects over mesocorticolimbic
microglial activation, resulting in TNFα release that serves as reward pathway signaling through dysregulation of miRNA
a feedback mechanism to scale down drug-induced increases expression.Inadditiontoindirectimmunomodulationofdrug-
insynapticstrength.Nevertheless,whethertheseneuroimmune induced plasticity via miRNA regulation, METH interacts
mechanisms play a significant role in abstinence-dependent directly with immune cells to promote neuroinflammation
changes in mesocorticolimbic plasticity and subsequent relapse and alter reward learning. Indeed, a recent report examining
remainsunclear. METH’s effects on TLR4 signaling and VTA-NAc dopamine
Like cytokines, chemokines are immunomodulators that transmission provides convincing evidence of this fact. In this
are influenced by cocaine and may be important regulators study, Wang X. et al. (2019) report that METH can bind to
of cocaine-induced neurobehavioral plasticity. Traditionally, lymphocyte antigen 96 (i.e., MD-2), which interacts directly
chemokines promote cellular chemotaxis and are important with TLR4 to confer receptor responsiveness to LPS, and that
for directing both homeostatic and inflammatory immune inhibitionofTLR4attenuatedMETH-inducedNF-κBactivation
responses.Kimetal.(2017)recentlydemonstratedthatinhibiting in microglia. In addition, this study also showed that METH
the chemokine receptor CXCR4 with the antagonist AMD3100 upregulatesIL-6withintheVTAandthatthisisassociatedwith
reduces cocaine CPP and cocaine-induced locomotion. enhancedextracellulardopaminewithintheNAc,andtreatment
Similar effects are also observed with the synthetic cathinone with the TLR4 inhibitor (+) naloxone or an intra-VTA IL-6
methylenedioxypyrovalerone (MDPV) (Oliver et al., 2018), antibody reduces METH-induced increases in NAc dopamine
whichmimicscocaineinitsphysiologicalandbehavioraleffects. (Wang X. et al., 2019). This study parallels findings described
Interestingly, this same group has recently provided the first above by Brown et al. (2018), which demonstrated reduced
evidence that the chemokine receptor CCR5, which is highly cocaine-primed reinstatement following intra-VTA treatment
implicatedinthepathophysiologyofhumanimmunodeficiency with a TLR4 antagonist. These findings collectively suggest
virus (HIV), is upregulated by cocaine and regulates the that psychostimulants such as METH and cocaine may alter
formation of cocaine CPP (Nayak et al., 2020). Cocaine is dopamine transmission and reward processing through similar
known to facilitate HIV invasion and viral replication within immunomodulatorymechanismssuchasTLR4signaling.
the brain (Zhang et al., 1998; Sahu et al., 2015; Tyagi et al., Another recent study examining the potential role of
2016) and HIV may also potentiate the reinforcing properties dopamine D1 receptors (D1Rs) in mediating METH’s
ofcocaine(McIntoshetal.,2015).Thus,thesestudieshighlight immunomodulatory effects found that acute METH exposure
FrontiersinNeuroscience|www.frontiersin.org 5 April2021|Volume15|Article650785

## Page 6

fnins-15-650785 April13,2021 Time:14:5 #6
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
increases LPS-induced IL-6 and TNFα release within the mediators such as TNFα, IL-1β, and matrix metalloproteinase-
NAc, hippocampus (HPC), and caudate-putamen (CPu), 9 (MMP-9) (Gonçalves et al., 2017). While this study did
and that systemic inhibition of D1Rs suppresses this effect not examine whether these METH-induced neuroadaptations
(Wang B. et al., 2019). This study suggests that METH primes are directly involved in METH-seeking behaviors, many other
neuroimmune responses to inflammatory stimuli within studies discussed previously have implicated TNFα and IL-
the mesocorticolimbic reward circuitry and that METH- 1β in regulating learning, memory, and synaptic plasticity,
induced dopamine transmission may be involved in this and MMP-9 in particular has also been implicated in these
process. Nevertheless, whether these processes confer increased processes as well as in cue-motivated drug seeking specifically
susceptibility to METH relapse remains unclear. An intriguing (Mizoguchi et al., 2007; Knapska and Kaczmarek, 2015; Smith
pair of studies has attempted to address this gap within the et al., 2015). METH-induced impairments on the BBB are well
literature, where investigators used a CPP paradigm to probe documented, and the consequences of these proinflammatory
whether cannabidiol (CBD) reduces reinstatement of METH effects of METH on the BBB can exacerbate invasion of
seeking in animals that experienced sleep deprivation and viruses as well as peripheral immune cells into the brain (see
if CBD modulates cytokine expression within the prefrontal NorthropandYamamoto, 2015forreview). Indeed,individuals
cortex(PFC)andHPC(Karimi-HaghighiandHaghparast,2018; who use METH are significantly more vulnerable to HIV
Karimi-Haghighietal.,2020).Thesestudiescollectivelyshowed and the neurocognitive dysfunctions associated with chronic
thatMETH-inducedreinstatementisaccompaniedbyincreased HIV infection (Borgmann and Ghorpade, 2015; Kesby et al.,
expression of TNFα and the anti-inflammatory cytokine IL-10 2015a).RecentpreclinicalanimalstudiesdemonstratethatHIV
within the PFC and HPC, and CBD treatment significantly and its proteins exacerbate METH-induced deficits in learning
reducesreinstatementaswellasproinflammatorycytokinelevels and memory (Hoefer et al., 2015; Kesby et al., 2015a,b) as
within thesebrain regions. Interestingly, CBDtreatment before well as METH reward sensitivity and behavioral sensitization
sleep deprivation elevated TNFα, IL-1β, IL-6, and IL-10 levels (Liu et al., 2009; Kesby et al., 2014). Taken together, METH
withintheHPCbutreducedIL-10levelswithinthePFC.These producessignificantperturbationstocellularsystemswithinthe
resultsindicatethatCBDmayattenuateMETH-seekingbehavior mesocorticolimbic reward system through immunomodulation
through immunomodulatory mechanisms. However, the clear and, akin to cocaine, these immunomodulatory mechanisms
heterogeneity of cytokine expression profiles across the brain may underlie the co-morbidity of chronic METH use and both
raiseimportantquestionsregardingthefunctionalroleofthese psychiatricandnon-psychiatricdiseases.
cytokines within specific neural circuits. Thus, further studies
Nicotine
that attempt to dissect possible circuit-specific mechanisms of
immunomodulationarewarranted. Unlike other drugs of abuse such as alcohol, cocaine, and
One limitation of the studies above is that METH was methamphetamine, relatively little preclinical research exists
experimenter-delivered to the animals, as opposed to self- on the role of immunomodulation in nicotine addiction-
administered. Previous studies demonstrate that the magnitude related behaviors. Previous work demonstrates that nicotine
ofMETHeffectsontheCNS,suchasondopaminetransporter produces predominantly anti-inflammatory and pro-cognitive
(DAT) expression, is larger in experimenter-delivered METH effects, which has been largely attributed to nicotine’s full-
exposure models as compared to human clinical and post- agonistactivityatα7-containingnicotinicacetylcholinereceptors
mortem studies (Wilson et al., 1996; Volkow et al., 2001a,b; (Kalra et al., 2004; Shytle et al., 2004; Foucault-Fruchard
Sekine et al., 2003). Indeed, self-administration models better and Antier, 2017) (nAChRs; although see Thomsen and
recapitulate the effects of METH on striatal DAT function and Mikkelsen, 2012). For example, recent studies suggest that
expressionobservedinhumans(McFaddenetal.,2012).Aswell, nicotine’s acute anti-inflammatory effects via α7-containing
experimenter-deliveredMETHmodelsdonotallowinvestigators nAChR signaling may improve learning and memory and
to correlate drug-induced neuroplasticity with behavioral reduce the severity of neurocognitive symptoms associated
measures such as escalation of drug intake and cue-motivated with neurodegenerative diseases such as Alzheimer’s disease.
drug seeking. Thus, self-administration models examining the Specifically,arecentstudydemonstratedthatnicotineattenuates
neuroimmune consequences of chronic METH use provide LPS-inducedneuroinflammationwithintheHPCandassociated
a clearer understanding of how these immune mechanisms cognitive deficits in spatial learning (Wei et al., 2015). As
facilitateMETHabuseandrelapsevulnerabilityinhumans. well, another study showed that inhibition of α7-containing
Recent investigations using self-administration paradigms nAChRs with an α7-specific antibody is sufficient to produce
implicate neuroinflammation and disruption of blood-brain neuroinflammation, accumulation of β-amyloid, and memory
barrier (BBB) integrity as a consequences of chronic METH impairmentsinmice(Lykhmusetal.,2015).Whilethesestudies
use. For example, Gonçalves et al. (2017) examined the impact suggest that nicotine may be therapeutic within certain clinical
of extended-access METH self-administration and abstinence contexts(e.g.,Alzheimer’sdisease),thereareanumberofcaveats
on BBB integrity and neuroinflammation within the HPC to consider. Firstly, individuals who are dependent on nicotine
and striatum. This study found that METH self-administration largely smoke tobacco, which can produce profoundly different
and abstinence downregulated tight junction proteins and effects on cognition and neuroinflammation when compared
collagen IV, indicating reduced BBB integrity, as well as to nicotine alone (Swan and Lessov-Schlaggar, 2007). This
astrogliosis, microgliosis, and upregulated proinflammatory complicates the interpretations one can make from preclinical
FrontiersinNeuroscience|www.frontiersin.org 6 April2021|Volume15|Article650785

## Page 7

fnins-15-650785 April13,2021 Time:14:5 #7
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
nicotinestudiesregardingtheneuroimmuneandneurocognitive NACsignificantlyattenuatesoralnicotineself-administrationas
effects of smoking in humans. Additionally, acute versus well as consumption of nicotine following a period of nicotine
chronic nicotine, as well as varying withdrawal periods, are deprivation(Quintanillaetal.,2021).
all associated with significant differences in whether they are Taken together, the above findings highlight the need
associated with neuroinflammation and cognitive deficits. For for future studies to evaluate multiple timepoints when
example, a recent study revealed cognitive impairment and attempting to describe neuroimmune mechanisms of
neuroinflammation within the PFC and HPC of mice 4 days addiction-related behaviors. As well, these data underscore
aftermecamylamine-precipitatednicotinewithdrawal,whichwas the need for investigators to exhibit caution when describing
reversed by cannabidiol (Saravia et al., 2019). This contrasts their findings related to the neuroimmune consequences of
the studies described above demonstrating anti-inflammatory nicotine exposure. While it can be tempting to ascribe labels
andcognition-enhancingeffectsofacuteorsub-chronicnicotine such as “neuroinflammation” to processes that upregulate
treatment in inflammatory disease models. Furthermore, these proinflammatory cytokines such as TNFα, the studies above
disparate findings in the literature may be attributed to the illustratethattheseimmunomodulatorsexhibitdiversefunctions
heterogenousdistributionofnAChRsthroughouttheCNS(Gotti that serve to fine-tune neuronal plasticity and behavior, and
et al., 2009). Given the significant role of nAChRs in immune dysregulation of a specific cytokine may not be indicative
system function [particularly the α7-containing nAChR (Fujii of a net “inflammatory” or “anti-inflammatory” process per
etal.,2017)],theheterogeneityofnAChRdistributionwithinthe se. Significant gaps remain in the understanding of whether
CNScouldhavesignificantimplicationsforimmunomodulation nicotine alters neuroimmune signaling within the brain’s
ofnicotineaddiction-relatedbehaviors. mesocorticolimbic reward circuitry and whether such changes
Several recent studies have attempted to address these are relevant to the reinforcing and incentive motivational
significant gaps in the literature by investigating whether properties of nicotine. However, α7-containing nAChRs are
neuroimmune mechanisms within mesocorticolimbic reward critically involved in nicotine addiction-related behaviors, and
circuitryareinvolvedinnicotineaddiction-relatedbehaviors.In it is possible that neuroimmune mechanisms downstream of
ourrecentstudy,weattemptedtoinvestigatewhetherchangesin α7-containing nAChRs mediate the modulatory role of this
NAccoreneuroimmunesignalingwereassociatedwithnicotine receptortypeovernicotinerewardandreinforcement.
self-administration, extinction, and cue-induced reinstatement The α7 nAChR subunit plays a critical yet complex role
as well as the therapeutic efficacy of the antioxidant compound in mediating the effects of nicotine on immune system
N-acetylcysteine(NAC).NAC,whichhasbeenusedtraditionally function. For example, a recent study demonstrated that an
asamucolyticandasatreatmentforacetaminophenoverdose, α7-containing nAChR agonist inhibits LPS-induced astroglial
isknowntoreversedrug-inducedperturbationsinglutamatergic release of proinflammatory cytokines and NF-κB activation
homeostasis within the NAc and to inhibit cue-motivated drug in vitro (Patel et al., 2017). Moreover, another recent study
seeking (Baker et al., 2003; Moran et al., 2005; Moussawi et al., showed that α7-containing nAChR agonist treatment improves
2009;Deepmalaetal.,2015;Reissneretal.,2015;ElbiniDhouib neuronal survival and reduces microglial activation in rats
etal.,2016;Powelletal.,2019).Wedemonstratedthat2weeks treatedwithanexcitotoxiclesionwithinthestriatum(Foucault-
ofextinctiontrainingfollowingnicotineself-administrationwas Fruchard et al., 2017). While many studies demonstrate an
associatedwithenhancedTNFαexpressionwithintheNAccore anti-inflammatory and protective role ofα7-containing nAChR
and concomitant downregulation of the astrocytic glutamate stimulation in a variety of disease models, other studies offer
transporter GLT-1. As well, we showed that NAC ameliorated conflicting conclusions (Thomsen and Mikkelsen, 2012). In
thesedeficitsandblockedcue-inducedreinstatementofnicotine addition to its role in regulating neuroimmune signaling, the
seeking through GLT-1- and NF-κB-dependent mechanisms α7 nAChR subunit has also been implicated in the reinforcing
withintheNAccore(Nambaetal.,2019).UnlikeTNFα,IL-6was properties of nicotine (Levin et al., 2009; Besson et al., 2012;
notupregulatedafteraperiodofextinctionandcuereinstatement Brunzell and McIntosh, 2012). In a recent study examining
testing,althoughglialfibrillaryacidicprotein(GFAP)expression nicotine-induced changes in α7 expression within the striatum
was downregulated at these timepoints. No changes in TNFα and frontal cortex of mice, experimenter-delivered, nicotine-
and GFAP expression were observed immediately following containing electronic cigarette vapor exposure upregulated
nicotine self-administration when compared to yoked saline α7 expression within these brain regions (Alasmari et al.,
controls. This is consistent with a previous report showing 2017). In contrast, another recent study demonstrated that
downregulated NAc GFAP expression following 2 weeks of nicotine consumption in rats is negatively correlated with α7
cocaine extinction (Scofield et al., 2016). Our findings were expressionwithintheHPC,whichismostprominentinfemales
also corroborated by another recent study demonstrating that (Gozen et al., 2016). Indeed, the heterogeneity of nAChR
withdrawal from experimenter-delivered nicotine exposure in expression throughout the brain as well as the differential
mice upregulates TNFα and IL-1β mRNA within the NAc and neurobehavioralimpactofexperimenter-delivereddrugexposure
increases anxiety-like behavior, both of which are prevented versus self-administration likely contributed to these seemingly
by pharmacological depletion of microglia with a colony- discrepant findings (Gotti et al., 2009; Namba et al., 2018).
stimulating factor 1 receptor inhibitor (Adeluyi et al., 2019). Additionally, such differences may suggest that nicotine alters
Moreover,anotherrecentstudyshowedthatco-administrationof α7-containing nAChR expression differentially throughout the
thenon-steroidalanti-inflammatorydrugacetylsalicylicacidwith brain, which could produce brain region-specific differences
FrontiersinNeuroscience|www.frontiersin.org 7 April2021|Volume15|Article650785

## Page 8

fnins-15-650785 April13,2021 Time:14:5 #8
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
in downstream neuroimmune signaling. Varenicline, which is Specifically, chronic alcohol intake increases TNFα and MCP1
a popular smoking-cessation medication, has been reported expressionwithinthecerebellum,aneffectmediatedbyalcohol-
to be a full agonist at α7-containing nAChRs in addition to induced activation of miR-155 (Lippai et al., 2013). This effect
a partial agonist at α4β2∗ nAChRs (Mihalak et al., 2006). was further validated in this study using miR-155 knockout
Interestingly, a recent study demonstrated that combination mice, where alcohol-induced TNFα and MCP1 elevations were
therapy of varenicline with the weak monoamine reuptake prevented in these animals following alcohol treatment. Also
inhibitor bupropion reduced nicotine self-administration in known for its role in alcohol-induced liver diseases (for review
rats (Hall et al., 2015), and bupropion has been shown to see Hartmann and Tacke, 2016), miR-155 has been shown
exhibit anti-inflammatory properties in mice (Hajhashemi and to promote cytokine release through TLR4 activation (Lippai
Khanjani,2014).However,anotherrecentstudyconcludedthat et al., 2013). TLR4, which is a potent mediator of alcohol-
discontinuation of varenicline treatment may increase relapse induced neuroinflammation (Alfonso-Loeches et al., 2010),
vulnerability. Specifically, this study showed that rats receiving participates in alcohol-induced, long-term synaptic remodeling
varenicline treatment exhibited impaired extinction learning, duringadolescence(Montesinosetal.,2016),promotesleukocyte
which was particularly evident in varenicline-treated rats that infiltrationacrosstheblood–brainbarrier(BBB)inthepresence
underwent a second cycle of nicotine self-administration and of alcohol (Alfonso-Loeches et al., 2016), and participates in
extinction training without continued varenicline treatment alcohol-induced autophagy and synaptic dysfunction during
(Macnamara et al., 2016). Perturbations to α7-containing development (Montesinos et al., 2018). Furthermore, alcohol
nAChRs and subsequent α7-mediated neuroimmune responses increases the release of TLR4 and cytokines from astrocytes by
mayalsocomefromflavoradditivesintobaccoproductssuchas mediating the release of astrocyte-derived extracellular vesicles
menthol,whichhasbeenshowntoinhibitα7-containingnAChR (EVs) containing these inflammation-related proteins (Ibáñez
receptor function (Ashoor et al., 2013) and facilitate nicotine et al., 2019). Such mechanisms are capable of altering the
self-administration (Biswas et al., 2016). Ultimately, it remains physiological state of neurons and has the ability to enhance
unclearwhetherimmunomodulatorymechanisms,suchasthose alcohol-induced neuroinflammation. Interestingly, alcohol does
elicitedbyα7-containingnAChRs,arerelevanttotheformation not induce EV release in TLR4-deficient astrocytes, further
andpersistenceofnicotineaddiction-relatedbehaviors.Aswell, implicatingTLR4asanimportantcomponentofalcohol-induced
it is unclear if such mechanisms would be effective targets neuroinflammation (Ibáñez et al., 2019). Additionally, genetic
for medications development. While recent preclinical studies elimination of TLR4 prevents damage to myelin and synapses
have attempted to shed light on this gap in the literature withinthePFCaswellasneuroinflammatoryprocessesinduced
(Adeluyi et al., 2019; Namba et al., 2019), future research that by intermittent alcohol treatment (Montesinos et al., 2015),
utilizespreclinicalmodelsofvolitionaldrugself-administration, and inhibition of TLR4 using the opioid antagonist nalmefene
withdrawal, and cue-motivated nicotine seeking is needed to hasbeenshowntopreventalcohol-inducedneuroinflammation
better understand whether neuroimmune mechanisms underly (Montesinosetal.,2017).Takentogether,TLR4playsanessential
thepathophysiologyofnicotineaddiction-relatedbehaviors. role inmediating alcohol-induced neuroinflammationand may
serveasapromisingtargetfortreatmentinpatientswithAUDs.
Alcohol
Similartootherdrugsofabuse,alcoholconsumptionincreases
Similar to cocaine and methamphetamine, alcohol (ethanol) LPS-induced inflammation, which has known interactions with
promotes inflammation and immune system dysfunction. TLR4 located within the hepatic system as well as on microglia
Alcohol and its metabolites induce oxidative stress, increase and astrocytes (Monnig, 2017). Interestingly, while alcohol
systemic endotoxin levels, and promote the release of increases proinflammatory cytokine release within the mouse
inflammatory peptides. Together, these effects contribute hippocampus,includingTNFα,IL-1βandMCP-1,co-treatment
to liver disease, bone and muscle disease, cardiovascular with LPS (alcohol + LPS) further increases MCP-1 and IL-
disease, reproductive disorders, and neuroinflammation 1β (Qin et al., 2008). Additionally, alcohol + LPS significantly
(González-Reimers et al., 2014). Many studies have revealed decreasesthenumberofcellswithinthedentategyrusrelativeto
alcohol-induced changes in immunoregulatory miRNAs, controls, an effect not observed with alcohol or LPS treatment
cytokines, and other signaling pathways associated with alone (Qin et al., 2008). The ionized calcium binding adapter
neuroinflammation, and increasing evidence suggests that molecule 1 (Iba-1) protein is expressed within microglia and
alcohol-induced neuroinflammation contributes to brain is elevated in post-mortem brains of patients with AUD (He
damage and neurodegeneration that is observed in individuals and Crews, 2008). Iba-1 expression is increased in a TLR4-
with severe alcohol use disorders (AUDs) (Vallés et al., 2006; dependent manner in response to ethanol, where 35 days of
Tajuddinetal.,2014;Orioetal.,2019). chronic intermittent ethanol (CIE) exposure enhanced Iba-
NF-κBregulatesalcohol-inducedchangesinimmune-related 1 expression within the PFC (Sanchez-Alavez et al., 2019).
gene expression, either through direct interactions with NF- Conversely,arecentstudyshowedthat15daysofCIEexposure
κB-specific binding sites on many immune-related genes (e.g., plus10hofwithdrawaldecreasesIba-1immunoreactivitywithin
IL-1β,TNFα,andMCP1)orwithmiRNAstoindirectlyregulate the prelimbic cortex (PrL), whereas no changes are observed
immune-related gene expression. For example, the miRNA in the NAc. This study also demonstrated that LPS exposure
miR-155 is induced by NF-κB activation and plays a role in produces an enlargement of soma volume in Iba-1-expressing
alcohol-induced dysregulation of TNFα and MCP1 expression. microglia within the PrL and NAc and a decrease in microglial
FrontiersinNeuroscience|www.frontiersin.org 8 April2021|Volume15|Article650785

## Page 9

fnins-15-650785 April13,2021 Time:14:5 #9
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
density within the NAc (Siemsen et al., 2020). Taken together, agonists,whichgenerallypromoteanti-inflammatoryresponses.
these studies suggest that chronic alcohol exposure may prime Specifically,PPARαactivationwithfenofibratedecreasesalcohol
both central and peripheral immune mechanisms to exhibit consumptionduringthe2BCandDIDtasksinbothUChBmale
exacerbated immune responses to inflammatory insults such as rats and C57/BL6 male mice (Karahanian et al., 2014; Blednov
LPS.Aswell,thesestudiessuggestthatalcoholexposureproduces et al., 2016). PPARα activation with gemfibrozil also decreases
a unique profile of neuroimmune effects that are distinct from 2BCalcoholconsumptioninmaleSprague-Dawleyrats(Barson
classicproinflammatorystimulisuchasLPSandthattheduration et al., 2009). Lastly, treatment with ceftriaxone [a beta-lactam
ofalcoholexposureandwithdrawalareimportantfactorswhen antibiotic with immunomodulatory mechanisms (Wei et al.,
consideringalcohol-inducedchangesinneuroimmunefunction. 2012; Kaur and Prakash, 2017; Ochoa-Aguilar et al., 2018)] or
In addition to processes described above, alcohol activates the antioxidant N-acetylcysteine reduces relapse-like drinking
nicotinamideadeninedinucleotidephosphate(NADHP)oxidase, in alcohol preferring P rats (Qrunfleh et al., 2013; Alhaddad
an enzyme known to produce reactive oxygen species, thus et al., 2014) as well as alcohol seeking and alcohol-reinforced
contributing to oxidative stress, alcohol-induced cell damage, responding in Long-Evans rats (Lebourgeois et al., 2018).
and neuroinflammation (Qin and Crews, 2012). As a common Altogether,thesefindingsprovideacriticalfoundationforfuture
activator of glial cells within the brain, oxidative stress is investigations into anti-inflammatory compounds that may
promoted by inducible nitric oxide synthase (iNOS), a gene reduce alcohol motivation and consumption. However, most
activatedbypro-inflammatorycytokinesinducedbyalcohol(Sun of the studies discussed here were conducted in male subjects
andSun,2001).Further,iNOScatalyzestheoxidationofalcohol only,makingitdifficulttodeterminewhethertheseeffectswould
into acetaldehyde and α-hydroxyethyl radicals (Porasuphatana also be observed in females. Thus, further characterization of
et al., 2006), and acetyladehyde production promotes reactive potentialsexdifferencesinbothalcohol-inducedneuroimmune
oxygenspecies(ROS)formationthatcontributestounbalanced responses as well as the effects of pharmacological and genetic
cellularoxidativestress(Hernándezetal.,2016;Yanetal.,2016). manipulationsontheseresponsesarewarranted.
Through its activation of p38 mitogen-activated protein kinase While much preclinical evidence exists demonstrating
(MAPK)andinhibitionofextracellularsignal-regulatedkinases, alcohol-induced neuroinflammation and cellular toxicity as
acetaldehyde induces cytotoxicity by promoting apoptotic well as the effects of anti-inflammatory agents in reducing
signaling and inhibiting cell survival pathways (Yan et al., alcohol consumption, studies examining pharmacotherapies
2016). Interestingly, inhibition of the phosphoinositide 3- for treating alcohol-induced neuroinflammation in humans are
kinase/proteinkinaseB(PI3K/Akt)pathwaywithglycineinhibits lacking. N-acetylcysteine (NAC) prevents alcohol-induced
ROS production in young rats and reduces alcohol-induced neuroinflammation in rats (Schneider et al., 2017) and
neuroinflammation(Aminetal.,2016).Altogether,thesestudies human studies suggest that NAC may be useful for treating
highlightthecomplexitiesofROSandoxidativestressinducedby AUDs. Preclinically, NAC prevents alcohol withdrawal-
alcohol,andmorestudiesinvestigatingtheroleoftheseprocesses induced increases in TNFα, IL-1β, IL-6, and IL-18 within the
inalcoholaddiction-relatedbehaviorsarewarranted. hippocampus and medial prefrontal cortex of rats (Schneider
Preclinical models of alcohol consumption are largely etal.,2017).Aswell,co-treatmentwithaspirinandNACrestores
reliant on three forms of self-administration paradigms, alcohol-induced impairments in glial glutamate transporter
which include drinking-in-the-dark (DID), two-bottle expression within the prefrontal cortex and prevents microglial
choice (2BC), and operant conditioning for oral alcohol activation (as measured through morphological alterations)
consumption. Each paradigm allows rodents to self-administer within the hippocampus of rats (Israel et al., 2019). Parallel
alcohol-containing solutions and have varying degrees of to these preclinical findings, NAC has also shown efficacy
translational value. Pharmacological and genetic manipulations within humans with AUDs for reducing alcohol intake and
of neuroinflammatory targets have yielded promising results in withdrawal symptoms (Back et al., 2016; Squeglia et al., 2016,
reducingalcoholconsumptionacrossthesedifferentparadigms. 2018); however, studies have not examined whether NAC
For example, inhibition of microglia activation reduces alcohol reducesinflammationinhumans.NAC’spoorbioavailabilityisa
consumption during the DID task in C57/BL6 male mice significant clinical limitation that may impair its efficacy. Thus,
(Lainiola and Linden, 2017) and prevents relapse-like drinking improvingitsbioavailabilitywithnoveldeliveryvectorssuchas
in the 2BC task in male rats (Gajbhiye et al., 2018). Further, nanoparticlesmayenhanceitsanti-inflammatorypropertiesand,
inhibition of microglial P2X7 receptor signaling also reduces consequently,itstherapeuticefficacy(MarkoutsaandXu,2017).
alcohol consumption in C57/BL6 male mice during the DID SimilartoNAC,thelipidtransmitteroleoylethanolamide(OEA),
paradigm (Lainiola and Linden, 2017). Dual knockout of IL-1 which is primarily generated by phospholipid cleavage, reduces
and TNFα receptors reduces social stress-induced increases in alcohol-mediated neuroinflammation. By modulating oxidative
alcoholconsumptionduringthe2BCtaskinmalemice(Karlsson stress, neuroinflammation, glial cell activation, as well as
etal.,2017),andIL-6knockoutmicealsoshowsimilarreductions neurotransmission,OEAhasneuroprotectiveproperties,suchas
(Blednovetal.,2012).Likewise,antagonismoftheIL-1receptor blockingalcohol-inducedupregulationofTLR4andsubsequent
within the basolateral amygdala reduces alcohol consumption proinflammatory signaling (Orio et al., 2019; Orio, 2020). OEA
duringDIDinmaleC57/BL6mice(Marshalletal.,2016).Similar providesneuroprotectionofthefrontalcortexinalcohol-exposed
reductions in alcohol consumption have also been observed rats by inhibiting NF-κB and TLR4 signaling pathways (Antón
using peroxisome proliferator activated receptor (PPAR) et al., 2017). Interestingly, systemic OEA treatment reduces
FrontiersinNeuroscience|www.frontiersin.org 9 April2021|Volume15|Article650785

## Page 10

fnins-15-650785 April13,2021 Time:14:5 #10
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
operant responding for alcohol and prevents alcohol-induced has been used as a medication to treat both OUDs and
withdrawalsymptomsinrodents(Bilbaoetal.,2016). AUDs,attenuatesinflammationandpainassociatedwithchronic
Another novel treatment target that is being investigated autoimmune disorders and cancer (Li et al., 2018; Patten et al.,
both clinically and preclinically for its use in treating AUDs is 2018).Severalgroupshaverecentlyprovidedthorough,in-depth
phosphodiesterases (PDEs). PDEs are upstream modulators of reviews of the many neuroimmune mechanisms involved in
intracellularcyclicnucleotides,suchascyclicAMP(cAMP)and OUDs (Plein and Rittner, 2018; Eidson and Murphy, 2019;
cyclicGMP(cGMP),aswellasimmunomodulatorsthatunderly Hoffordetal.,2019;Zhangetal.,2020).Thus,forthepurposesof
alcoholrewardandtoxicity(Wenetal.,2018).Specifically,PDEs thisreview,wewillsummarizekeyfindingswithinthelast5years,
catalyze the hydrolysis of cAMP and cGMP, decreasing their andemphasizerecentadvancementswithinthelast2yearswhere
intracellular levels and thus downstream signal transduction. possible, to highlight current trends in the field and offer our
As well, PDEs (e.g., PDE4) are involved in ethanol-mediated perspectivesonfuturedirectionsregardingnovelneuroimmune
inflammatory responses (Gobejishvili et al., 2008; Avila et al., mechanismsofOUDs.
2017). Evidence suggests that ethanol exposure alters cAMP TLR4 is known to play a critical role in the rewarding
signaltransductionbymodulatingadenylatecyclase(Yangetal., and reinforcing effects of opioids, and TLR4 antagonists may
1996; Asher et al., 2002; Asyyed et al., 2006). This modulatory be efficacious pharmacotherapies to treat OUDs (Hutchinson
effect may depend on the amount of ethanol exposure as etal.,2012;Wangetal.,2012;Bachtelletal.,2015).Specifically,
acute ethanol promotes cAMP signal transduction whereas a study by Hutchinson et al. (2012) showed that inhibition
chronicethanolattenuatesthissignaling(Saitoetal.,1987;Yang of TLR4 and its downstream myeloid differentiation primary
et al., 1996, 1998; Pandey, 2004). Preclinical studies show that response 88 (MyD88)-dependent signaling suppresses opioid-
reductionsincAMPandcGMPlevels,causedbyhyperactivityof conditioned place preference and self-administration as well
PDEs,promoteexcessiveethanoluse.Giventheirlinktoalcohol as morphine-induced increases in NAc extracellular dopamine.
seeking, several studies have attempted to pharmacologically This study was paralleled by another study demonstrating
identify which PDEs modulate alcohol consumption (Hu et al., that morphine induces neuroinflammation through activation
2011; Wen et al., 2012; Blednov et al., 2014; Bell et al., of TLR4 signaling and that inhibition of TLR4 signaling can
2015; Logrip, 2015). Other studies have attempted to describe enhance the analgesic properties of morphine (Wang et al.,
geneticdifferencesinPDEsbetweenalcohol-preferringandnon- 2012).TLR4isalsoinvolvedinopioidreinforcement,tolerance,
preferring mouse lines (Mulligan et al., 2006). Importantly, and withdrawal. For example, knockdown of TLR4 within the
pharmacologicalinhibitionofPDE4(Huetal.,2011;Wenetal., ventrolateralperiaqueductalgray(vlPAG)increasesglutamicacid
2012;Blednovetal.,2014)andPDE10(Belletal.,2015;Logrip, decarboxylasemRNAwithinthePAGanddecreaseswithdrawal
2015)reduceethanolintakeinrodents.Giventheresultsofthese symptoms in morphine-exposed rats (Liu Q.F. et al., 2016). As
preclinical findings, two PDEinhibitors are undergoing clinical well, chronic morphine exposure stimulates TLR4 and recruits
trialsfortheirtherapeuticefficacyintreatingAUDs.Specifically, TNFαsignalingwithinthePAGtoenhanceneuroinflammation,
the PDE inhibitor Ibudilast, a non-specific PDE inhibitor that downregulate glutamate transporters, and increase morphine
targets PDE3, PDE4, PDE10, and PDE11, is currently within tolerance(Eidsonetal.,2017).WithintheVTA,TLR4signaling
Phase I (ClinicalTrials.gov, 2021a), while the PDE4 inhibitor also facilitates the acquisition and maintenance opioid CPP,
Apremilast is currently within Phase II (ClinicalTrials.gov, which may depend on downstream signal transducer and
2021b).ForadditionalinformationregardingPDEsandalcohol, activator of transcription 3 (STAT3) signaling (Chen et al.,
see the in-depth review by Wen et al. (2018). Taken together, 2017). Interestingly, genetic deletion of Myd88, in microglia of
targetingneuroinflammationandreducingoxidativestressmay miceimpairsextinctionlearningandenhancesreinstatementof
beapromisingtherapeuticstrategyforindividualswithAUDsby morphineCPP(Riveraetal.,2019).Thesefindingsareseemingly
reducingtheunderlyingeffectsofalcoholonneuroinflammation. conflictingwiththoseofHutchinsonetal.(2012)ashighlighted
above which used a Myd88 knockout mouse model that lacked
Opioids
cell-type specificity. Nevertheless, it is likely that neuroimmune
Opioids are a class of drugs that possess a very high abuse influences over addiction-related behaviors, such as those
liabilityandhavebeenatthecenterofanongoingpublichealth mediated by TLR4-Myd88 signaling, are cell type-specific and
crisis.Betweentheyears2000and2017,yearlyopioidoverdose- brain region-dependent. Moreover, there are likely sex-specific
relateddeathsrosetomorethan47,000withintheUnitedStates, neuroimmunemechanismsthatmayinfluenceopioidaddiction-
and 21–29 percent of individuals who are prescribed opioids relatedbehaviorsandopioidtreatmentoutcomesforchronicpain
to manage chronic pain misuse them (Vowles et al., 2015; (Posillicoetal.,2015;Doyleetal.,2017).Whilethereisstillsome
National Institute on Drug Abuse [NIDA], 2020c). In response conflicting evidence regarding the efficacy of TLR4 antagonists
to this crisis, considerable preclinical research has revealed forreducingopioidcravingandrelapse(Yueetal.,2020),future
many neuronal and non-neuronal mechanisms underlying research should explore the efficacy of TLR4 antagonists as
opioid reward and reinforcement, including neuroimmune medications that supplement other treatment approaches for
mechanisms. This research has advanced our understanding of OUDsandcomorbidchronicpain.
the pathophysiology of opioid use disorders (OUDs) as well Several recent investigations have identified many cytokines
as other comorbid chronic pain and inflammatory conditions. and other immune-related signaling mechanisms that may
For example, the opioid receptor antagonist naltrexone, which regulate opioid reinforcement and motivation. For example, a
FrontiersinNeuroscience|www.frontiersin.org 10 April2021|Volume15|Article650785

## Page 11

fnins-15-650785 April13,2021 Time:14:5 #11
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
recentstudyusingarodentmodeloffentanylself-administration abstinence from chronic opioid self-administration and the
showed that the NAc and HPC are particularly vulnerable to functional role of such changes on opioid craving and relapse
changes in the expression of a number of immune markers, are not well understood. As well, sex differences within these
such as increased IL-1β, TNFα, and IFN-γ within the NAc and processes are poorly understood. Future studies are needed to
decreased GM-CSF and IFN-γ in the HPC (Ezeomah et al., improve our understanding of how neuroimmune mechanisms
2020).Whilethisstudydidnotdirectlymanipulateanyofthese maycontributetoopioidrelapse.
neuroimmunesubstrates,expressionofIL-1βandIL-6withinthe
NAc,aswellasIFN-βandvariousinterleukinswithintheHPC,
NEUROIMMUNE MECHANISMS AND
correlate positively and negatively (respectively) with fentanyl
SUBSTANCE USE DISORDER
intake. Similarly, another study using single-cell qRT-PCR
analyses demonstrated that morphine withdrawal is associated COMORBIDITIES
with increased expression of neuroinflammatory genes, such
as Tnf, as well as increased TNFα protein expression within Many individuals who are diagnosed with a SUD often suffer
neurons, microglia, and astrocytes from the central amygdala. fromotherphysicalorpsychiatriccomorbiditiesthatcanhinder
Amongthesecelltypes,astrocytesexhibitedthelargestchanges successful treatment outcomes. According to the United States
in neuroimmune gene expression (O’Sullivan et al., 2019). Substance Abuse and Mental Health Services Administration
Such findings implicate opioid-induced neuroinflammatory (SAMHSA), over 9.2 million American adults had both a SUD
interactionswithneuralrewardsystemsthatareknowntodrive and a comorbid mental illness such as anxiety or depression
drug-seeking behavior (Koob and Volkow, 2016). Rodent self- as of 2018 (Substance Abuse and Mental Health Services
administration models with the prescription opioid oxycodone Administration,2019).Furthermore,physicalcomorbiditiessuch
have shown upregulation within both the dorsal and ventral aschronicpainandHIVaremoredifficulttotreatamongthose
striatumofnumerousimmune-relatedgenesusingRNAseqand with SUDs (National Institute on Drug Abuse [NIDA], 2020a).
qPCRtechniques[e.g.,Ccr5,Icam1,Cybb(ZhangY.etal.,2017)], Convergent findings from numerous clinical and preclinical
as well as changes within the NAc and CPu in the expression studieshaveimplicatedimmunedysfunctionasapossibleshared
of various integrin, semaphorin, and ephrin genes that play a mechanism linking these comorbidities to the pathophysiology
role in neurodevelopment, cell migration, structural regulation ofSUDs.Here,webrieflyhighlightrecentstudiesdemonstrating
ofsynapses,andimmunesignaling(Yuferovetal.,2018). immune system dysfunction in disorders that are commonly
Several studies examining the efficacy of various comorbid with SUDs, focusing primarily on major depressive
immunomodulatorytreatmentshavealsoprovidedevidencefor disorder(MDD),posttraumaticstressdisorder(PTSD),chronic
immunesignalingasanimportantmechanismunderlyingopioid pain, and HIV. The studies discussed here may provide useful
addiction-related behaviors. For example, N-acetylcysteine insights into commonly shared mechanisms that facilitate
effectivelyinhibitsheroin-seekingbehaviorakintootherdrugsof the pathogenesis of these comorbidities as well as increase
abuse(ZhouandKalivas,2008;Hodebourgetal.,2019).Similarly, SUDvulnerability.
IL-10 overexpression within the NAc reduces remifentanil self-
Depression
administration in rats (Lacagnina et al., 2017) and intra-NAc
treatmentwiththeantibioticandmicrogliainhibitorminocycline The idea that depression (also referred to as Major Depressive
inhibits drug-primed reinstatement of morphine CPP in rats Disorder, or MDD) may be influenced by immune system
(Arezoomandan and Haghparast, 2016). Clinical studies also dysfunction dates back to the early 1990’s, when Ronald
supporttheuseofanti-inflammatorymedicationstotreatOUDs. Smith published his seminal paper on the “macrophage
Forinstance,theanti-inflammatoryphosphodiesteraseinhibitor theory of depression” (Smith, 1991). Among the evidence
ibudilast reduces heroin cravings and self-reported pain ratings describedbySmithincludedtheobservationsthatexperimental
amongopioid-dependentindividuals(Metzetal.,2017).Another volunteers who were administered monocyte/macrophage-
study suggests beneficial effects of ibudilast on withdrawal derived cytokines developed many of the symptoms of MDD
symptoms in opioid-dependent individuals undergoing and that individuals with chronic inflammatory diseases such
detoxification (Cooper et al., 2016). The cyclooxygenase-2 as rheumatoid arthritis are more likely to have depression.
(COX-2) inhibitor celecoxib may also reduce opioid cravings Ahead of his time, Smith also postulated that the “food-gut-
amongindividualsundergoingdetoxification(Jafarietal.,2017). allergy” axis may be involved in the pathogenesis of MDD.
Overall,thestudiesdescribedhereprovideevidencesupporting While outside the scope of this review, recent studies have
theconclusionthatneuroimmunemechanismsmaybeinvolved elucidated key mechanisms of the gut microbiome in human
inthepathophysiologyofOUDs,particularlyregardingtolerance healthanddisease,includingitsroleintheetiologyofpsychiatric
to both the rewarding and analgesic properties of opioids, as illnesses (Singh et al., 2017; Cryan and de Wit, 2019). Both
wellaswithdrawalfromchronicopioiduse.Nevertheless,there systemic inflammation induced by xenobiotic substances and
is still a significant gap in the literature regarding the efficacy inflammatory disease states, such as in multiple sclerosis and
of novel immunomodulatory medications, and particularly spinal cord injury, are associated with depressive symptoms in
anti-inflammatoryagents,inreducingopioidcravingandrelapse humans(AllisonandDitor,2015;Engleretal.,2017;Morrisetal.,
aswellastolerancetotheanalgesiceffectsofopioids.Specifically, 2018). Other inflammatory conditions such as irritable bowel
thechangesinneuroimmunefunctioninacuteversusprotracted syndrome and psoriasis are associated with higher prevalence
FrontiersinNeuroscience|www.frontiersin.org 11 April2021|Volume15|Article650785

## Page 12

fnins-15-650785 April13,2021 Time:14:5 #12
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
ratesofdepression,anxiety,andsubstanceabuse,suggestingthat SERT−/− rats exhibit greater cocaine self-administration, and
inflammatorymechanismsmayresideattheintersectionbetween cocaineself-administeringSERT+/+ratsshowedreducedmRNA
thesedisorders(HayesandKoo,2010;Fondetal.,2014;Knight levels of genes encoding for GLT-1 and GluN1 to the levels
et al., 2015). MDD is often comorbid with AUDs in particular, of SERT−/− rats (Caffino et al., 2019). Another recent study
and many studies implicate neuroimmune dysfunction as a utilizing the bilateral olfactory bulbectomy (OBX) model of
significant pathophysiological feature of this comorbidity (for depression in combination with cocaine self-administration
review, see Neupane, 2016). Individuals with MDD also show showed that treatment with escitalopram dose-dependently
elevated serum levels of various immune factors such as IL-6 reducescue-inducedcocaine-seekingbehaviorinbothOBXand
(Engleretal.,2017;Yeetal.,2018)andTNFα(Fanetal.,2017;
sham control rats as well as burst responding on day 1 of
Zou et al., 2018), and IL-6 in particular has been implicated in extinction training (Jastrzêbska et al., 2017). As illustrated in
depression across a number of clinical and preclinical studies Figure1, glutamatergic signaling interfaces with neuroimmune
(for review, see Hodes et al., 2016). A recent example is that function in glial cells, and serotonergic dysfunction in MDD
stress-susceptiblemicetreatedsystemicallywithanIL-6antibody (e.g., altered SERT function) could lead to dysregulated
show significant reductions in depressive-like behaviors in the glutamatergicsignalingand,subsequently,alteredneuroimmune
chronicsocialdefeatstressmodelofdepression,whichgenerally function.Nevertheless,thisremainslargelyspeculative,andmore
upregulates systemic levels of IL-6 (Hodes et al., 2014; Stewart studies are needed to fully investigate whether serotonergic
et al., 2015; Zhang J.C. et al., 2017). As well, social stress substrates directly or indirectly alter neuroimmune function
and drugs of abuse can downregulate the expression of cell within animal models of MDD and SUDs and if such
adhesion and tight junction proteins such as collagen-IV and neuroimmune mechanisms are relevant to the pathophysiology
claudin-5, leading to infiltration of immune factors like IL-6 ofthiscomorbidity.
fromtheperiphery(Menardetal.,2017;Rodríguez-Ariasetal., Although it is unclear whether specific cytokine inhibitors
2017). In a recent preclinical study, mice exposed to chronic alone would be broadly effective treatments for MDD (Raison
unpredictablestressexhibitedelevatedlevelsofTNFαwithinthe
etal.,2013;Smolenetal.,2014),thesestudiessupportthenotion
HPCandincreaseddepressive-andanxiety-likebehaviors,which that immunopharmacology may be an efficacious adjunctive
were attenuated by minocycline treatment (Zhang et al., 2019). treatmentstrategyincombinationwithexistinganti-depressants
Interestingly, minocycline has also been shown to reduce both for treating co-morbid MDD and SUDs. Ketamine, which has
METH- and alcohol-seeking behavior in rodents (Fujita et al., demonstrated efficacy in cases of chronic, treatment-resistant
2012;Attarzadeh-Yazdietal.,2014;Gajbhiyeetal.,2017). depression, exhibits a broad spectrum of anti-inflammatory
Serum levels of TNFα are also elevated in individuals effects (e.g., TNFα and IL-6 inhibition) in both clinical and
with MDD (Tuglu et al., 2003), and elevated levels of TNFα preclinicalstudies(Murroughetal.,2013;Tanetal.,2017;Chen
may be associated with treatment-resistance, particularly with et al., 2018). Indeed, broad-spectrum immunomodulators, as
selective serotonin reuptake inhibitors (SSRIs) (Tuglu et al., opposedtocytokine-specificantibodiesforexample,mayprove
2003; O’Brien et al., 2007; Eller et al., 2008). Interestingly, tobeeffectivetreatmentstrategiesforMDD.Forinstance,drugs
TNFα levels are positively correlated with midbrain serotonin that confer a wide range of antioxidant and anti-inflammatory
transporter (SERT) availability in humans (Krishnadas et al., effects, such as the cysteine prodrug N-acetylcysteine, show
2016), suggesting a possible immunomodulatory mechanism clinical promise as adjunctive treatments for MDD, bipolar
that underlies dysregulated serotonin neurotransmission in depression, and for SUDs (Berk et al., 2011, 2014; Magalhães
depression. The SSRIs fluoxetine and escitalopram inhibit M1 et al., 2011; Carvalho et al., 2013; Tomko et al., 2018).
proinflammatoryactivationandpromoteM2anti-inflammatory Nevertheless, more studies are needed to further examine
activation of microglia in vitro (Su et al., 2015). As well, rats whether such treatment strategies are effective in cases of
experiencingchronicmildstressexhibitelevatedplasmalevelsof comorbidMDDandSUDs.
proinflammatorycytokines(IL-1β,IL-17,andTNFα),whichare
preventedbychronicfluoxetinetreatment(Luetal.,2017).This
Posttraumatic Stress Disorder
ismirroredbyarecentmeta-analysisdemonstratingthatpatients
with MDD who respond to antidepressant treatment show Akin to MDD, posttraumatic stress disorder (PTSD) is a
significantlydecreasedperipheralTNFαlevels(Liuetal.,2020). comorbidityexperiencedbymanyindividualswithSUDs.PTSD
The studies above highlight that antidepressant SERT is associated with systemic elevation of inflammatory markers
inhibitors exert immunomodulatory effects, and these effects thatmayunderlythepathophysiologyofthedisorder(forreview,
may be related to their therapeutic efficacy. As well, several seeHoriandKim,2019).Arecentmeta-analysisbyPassosetal.
recentpreclinicalstudiessuggestthatchangesinSERTexpression (2015) revealed that serum IL-6, IL-1β, and interferon gamma
and/or activity alters glutamatergic plasticity and addiction- (IFN-γ) are all elevated in individuals with PTSD compared to
related behaviors. For example, SERT knockout
(SERT−/−)
healthy controls. IL-6 is also positively correlated with disease
rats, which exhibit depression- and anxiety-like behaviors severity and IL-1β with disease duration. Furthermore, when
(Kalueff et al., 2010), show decreased mRNA expression of key MDD comorbidity is controlled for, individuals with PTSD
glutamatergic substrates within the habenula, including GLT-1, show elevated TNFα, IL-6, and IL-1β (Passos et al., 2015).
NMDA subunits (GluN1, GluN2A, and GluN2B), and AMPA Genetic studies in humans also provide converging evidence
subunits (GluA1 and GluA2) (Caffinoetal.,2019). Moreover, in support of immune dysregulation in PTSD. For example, a
FrontiersinNeuroscience|www.frontiersin.org 12 April2021|Volume15|Article650785

## Page 13

fnins-15-650785 April13,2021 Time:14:5 #13
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
recentgenome-wideassociationstudyidentifiedsignificantgene reduced by mGlu5 PAM treatment and that the mechanism of
loci (e.g., ANKRD55) associated with immune disorders such actioninvolvesAkt/GSK-3β/CREBsignaling(Bhatetal.,2021).
as rheumatoid arthritis and psoriasis in individuals with PTSD This corroborates previous evidence showing that stimulation
(Steinetal.,2016). of mGlu5 reduces LPS-induced microglial activation and
Preclinicalstudiesalsoimplicatebothcentralandperipheral proinflammatory signaling (Byrnes et al., 2009). A recent study
immuneactivationinthepathophysiologyofPTSD.Forinstance, by Schwendt et al. (2018) showed that rats resilient to stress
fear memory retrieval in mice is associated with increased induced by predator odor exposure exhibit increased mGlu5
circulating IL-6 and inhibition of IL-6 signaling can improve geneexpressionwithintheamygdalaandmPFC.Aswell,stress-
extinction learning (Young et al., 2018). In addition, many susceptible animals show enhanced cue-induced reinstatement
inflammatoryandinnateimmunepathwayssuchasinterferons, of cocaine seeking that is not attenuated by the β-lactam
interleukins,andTNFαremainactivatedlongaftersocialstress antibioticceftriaxone,whichisadrugknowntoreliablysuppress
exposure in mice, while anti-inflammatory mediators such as this behavior (Knackstedt et al., 2010; LaCrosse et al., 2016;
TGFβ are inhibited (Muhie et al., 2017). Interestingly, predator Schwendt et al., 2018). Importantly, treating stress-susceptible
stress exposure in mice induces a state of immunosuppression animals with a mGlu5 positive allosteric modulator (PAM)
within the brain, but acute “priming” of the immune system alongwithceftriaxoneandfearextinctionsuccessfullyprevented
with LPS prior to this form of stress exposure has no effect on cue-induced reinstatement of cocaine seeking (Schwendt et al.,
lateravoidancebehavior(Deslauriersetal.,2017).Thissuggests 2018). Another recent study parallels these findings, showing
thatchronicstressexperiencedwithPTSD,asopposedtoacute that early life stress in rats causes these animals to spend less
trauma exposure itself, may underly the persistence of immune time in the light area of a light-dark box and to exhibit lower
dysregulationseeninindividualswithPTSD. mGlu5 gene expression within the amygdala. This study also
Other studies utilizing predator-based psychosocial stress showed that time spent in the light area is positively correlated
models also highlight the significance of prior drug experience with mGlu5 gene expression within the amygdala (Buonaguro
in modulating the effects of stress on drug taking later in life. et al., 2020). One question that remains is whether such
For example, a recent study demonstrated that rats exposed mGlu5-mediated neuroimmune mechanisms are therapeutic in
to chronic predator stress showed enhanced ethanol preference cases of comorbid PTSD and SUDs. Given the putative role of
(oversucrose)comparedtounstressedcontrolsonlywhenthey glutamatergicsubstratessuchasmGlu5inbothPTSDandSUDs,
had ethanol experience with two-bottle choice prior to stress furtherinvestigationintotheneuroimmunemechanismsofthis
exposure (Zoladz et al., 2018). A question that remains is receptor system within animal models of comorbid PTSD and
whetherpriorstressanddrugexperienceinteracttodysregulate SUDsiswarranted.
immune signaling in a way that promotes stress susceptibility Novel drugs that modulate immune signaling have shown
and/orsubsequentincreasesinaddiction-relatedbehaviors.One stress-reducing effects in preclinical models. For example, a
recentstudyshedssomelightonthistopic,demonstratingthat recentstudyshowedthatintranasaloxytocintreatmentfollowing
early life stress in the form of maternal separation increases single prolonged stress (SPS) exposure is sufficient to reverse
PFC and NAc TNFα levels in males, but not females, and physiological and behavioral deficits such as increased central
enhances cocaine CPP in maternally stressed males. As well, and peripheral proinflammatory cytokine expression, reduced
this study showed that systemic inhibition of TNFα restores plasma corticosterone levels, and impaired extinction learning
cocaineCPPtocontrollevels(Gangulyetal.,2019).Thissupports (WangS.C.etal.,2018).Additionally,SPSinratstreatedwitha
anotherrecentstudyshowingthatearlylifesocialstressinmice cyclooxygenase-2(COX-2)inhibitorexhibitdecreasedapoptosis
can sensitize both central and peripheral immune responses in the HPC, reduced levels of proinflammatory cytokines
to cocaine within the VTA and that humans with CUDs that in the HPC, and decreased anxiety-like behavior (Wang M.
experiencedchildhoodsocialstressshowelevatedexpressionof et al., 2018). Other preclinical studies have also shown similar
inflammatory markers (e.g., TLR4, TNFα, IL-1β, and IL-6) (Lo effects on anxiety-like behavior and proinflammatory cytokine
Iaconoetal.,2018).Indeed,thesefindingshighlightthatahistory expression within the brain using COX-2 inhibitors (Gamble-
of chronic stress or trauma, especially during adolescence, may Georgeetal.,2016;Leeetal.,2016),andhumanstudiessuggest
causeaberrantchangesinimmunefunctionthatcouldincrease that anti-inflammatory treatments such as COX-2 inhibitors
SUDsusceptibilitylaterinlife. may be effective in reducing depression symptoms (Köhler
As highlighted throughout this review and illustrated et al., 2014). Interestingly, the antioxidant N-acetylcysteine
in Figure 1, glutamate dysfunction is a consistent feature (NAC)wasrecentlyshowntoinhibitconditionedstress-induced
observed across drugs of abuse and recent evidence cocaine and alcohol seeking when administered during or
implicates metabotropic glutamate receptor 5 (mGlu5) in immediately following restraint stress (Garcia-Keller et al.,
the pathophysiology of PTSD and neuroimmune function. 2020), which raises the question as to whether suppression
Indeed,dysfunctionofglutamatergicplasticityisalsothoughtto of oxidative stress and inflammation via NAC treatment is
beinvolvedinpathophysiologyofPTSD(forreview,seeAverill therapeuticinthiscontext.Importantly,NACiscurrentlybeing
etal.,2017).Microglia,astrocytes,andperipheralimmunecells investigated clinically for its use in treating comorbid AUDs
express mGlu5, which promotes anti-inflammatory responses and PTSD (Back et al., 2020). Drugs with immunomodulatory
(Fazio et al., 2018). Interestingly, a recent study showed that activity, such as monoclonal antibodies, glucocorticoids, and
neuroinflammationinducedbytraumaticbraininjuryinmiceis cannabinoids, are also being investigated for their use in
FrontiersinNeuroscience|www.frontiersin.org 13 April2021|Volume15|Article650785

## Page 14

fnins-15-650785 April13,2021 Time:14:5 #14
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
the treatment of PTSD (HoriandKim,2019). Overall, these chronic pain management may have the added benefit of
studies provide a firm rationale for future investigations into reducingtheriskofaddictiontoopioidpainmedications.
immunomodulatory medications to treat symptoms of PTSD. Chronic pain and antinociceptive opioid drugs are subject
However, it remains largely unknown whether such treatment to important sex differences that may have underlying
strategies are efficacious in treating cases of comorbid PTSD neuroimmunemechanisms.Indeed,someofthemostcommon
and SUDs. Indeed, use of psychotropic substances can explain chronic pain conditions such as migraine, low back pain, and
a significant degree of heterogeneity across studies examining neck pain, are vastly overexpressed in women (Mogil, 2012).
proinflammatorycytokineexpressioninindividualswithPTSD In fact, women are overall more likely to use prescription
(Passosetal.,2015).Thus,futureinvestigationsshouldconsider opioids than men (Serdarevic et al., 2017) and women may
the neuroimmune intersections of comorbid PTSD and SUDs also experience greater levels of pain than men in a manner
thatmayimpactthetherapeuticefficacyoftreatments. that may be dependent on opioid withdrawal (Huhn et al.,
2019). Preclinical studies have identified sexual dimorphism of
Chronic Pain
cellular responses to opioids that may explain some of the sex
Substance abuse and misuse, particularly with opioids, is more differences in pain observed in humans. For example, a recent
common among individuals with chronic pain. For example, studydemonstratedthatfemaleratsexhibitincreasedbasaland
an estimated 10% of individuals living with chronic pain LPS-induced microglial activation within the PAG, and that
also misuse prescription opioids, and chronic pain interacts basal activation of microglia is a significant predictor of the
with mesocorticolimbic reward circuits and stress pathways to ED of morphine’s antinociceptive effects (Doyle et al., 2017).
50
increaseSUDvulnerability(forreview,seeElmanandBorsook, Moreover, this study showed that naloxone inhibition of TLR4
2016;Garlandetal.,2013).Chronicpain,definedaspainlasting withinthePAGsignificantlyimprovestheantinociceptiveeffects
longer than 3 months or beyond the period of normal tissue of morphine. T cells may also underly observed sex differences
healing,affectsasmuchas43%ofadultswithintheUnitedStates in opioid analgesia, with one recent study demonstrating
(Dowell et al., 2016). While the prescribing of opioids has that T-cell-deficient mice exhibit impaired opioid-induced
declined since 2012 (Zhu et al., 2019), these medications are analgesia that is more pronounced in females (Rosen et al.,
still commonly used to treat chronic pain and opioid-related 2019). Other non-opioidergic, sex-specific neuroimmune
overdoses and deaths still remain high (Scholl et al., 2018). mechanisms underlying chronic pain have been identified,
Inflammation and immune system dysfunction are defining which could have significant implications for clinical treatment
features of many forms of chronic pain (Marchand et al., of pain and SUDs in human populations. For instance, ATP
2005; Totsch and Sorge, 2017) and several recent studies have signaling via P2X4 receptors on microglia has been shown to
identifiedimmunomodulatorypainmechanismsthatmayextend be essential for nerve injury-induced allodynia in males but
ourunderstandingofthepathophysiologyofSUDs(particularly not in females (Mapplebeck et al., 2018). However, human
OUDs). For example, a recent preclinical study using the studies have shown that the serotonin and norepinephrine
completeFreund’sadjuvant(CFA)modelofinflammationfound reuptake inhibitor duloxetine, which also inhibits P2X4
thatratsexperiencingchronicinflammationrequirehigherdoses signaling (Yamashita et al., 2016), reduces pain in women with
ofheroin(150µg/kg)toachievesignificantincreasesinNAccore fibromyalgia (Arnold et al., 2007; Bidari et al., 2019). This
dopaminerelease.Aswell,thisstudyshowedthatinflammatory highlightsthecomplexityofsexdifferencesintheneuroimmune
pain impairs MOR-mediated inhibition of GABA transmission regulation of pain and suggests that perhaps dynamic immune
within the VTA and enhances heroin self-administration at interactions with monoamine neurotransmitter systems play
higher doses without impacting sucrose self-administration a significant modulatory role in chronic pain between males
(Hipólito et al., 2015). This is consistent with another study and females (Lei et al., 2011; Packiasabapathy and Sadhasivam,
demonstrating that chronic neuropathic pain decreases MOR1 2018).
availabilityandexpressionwithintheratCPuandmotorcortex, Neuromodulatory systems such as the endocannabinoid
which correlates positively with sucrose preference in nerve- system (ECS) have also garnered significant attention for their
injured animals (Thompson et al., 2018). Converging evidence role in chronic pain. Conflicting clinical and preclinical studies
suggests that chronic inflammatory pain may also impair the exist regarding sex differences in the efficacy of cannabinoids
analgesiceffectsofopioids(Steeleetal.,2002;DeLeoetal.,2004; as chronic pain treatments (for review, see Cooper and Craft,
Zhangetal.,2004).StudiesalsoshowthattheMORantagonist 2018). The efficacy of such treatments likely depend upon
naltrexone may reduce chronic inflammatory pain through the route of administration, type of pain, and locus of pain
inhibition of T and B cell proliferation and TLR4 signaling (Romero-Sandoval et al., 2017). Nevertheless, the ECS is well
(Tawfiketal.,2016;Pattenetal.,2018),suggestingapotentially regarded for its role in regulating neuroimmune signaling and
promising role for adjunctive immunomodulatory therapies pain. For example, cannabinoid receptors such as CB1 and
in chronic pain management. Taken together, inflammatory CB2 are expressed in CNS regions involved in nociception
mechanisms can lead to dysregulations in endogenous opioid (e.g., PAG, amygdala, dorsal root ganglion, thalamus, etc.)
receptor signaling that can facilitate chronic pain and lead to and these receptors exert primarily anti-inflammatory effects
escalateddrugintakeovertimeand,subsequently,increasedrisk (Burstein and Zurier, 2009; Barrie and Manolios, 2017).
for drug dependence and substance abuse. Thus, use of anti- Cannabis has been proposed as a potential adjunctive or
inflammatory medications as adjunctive therapies to improve alternative therapeutic for OUDs, particularly in cases of
FrontiersinNeuroscience|www.frontiersin.org 14 April2021|Volume15|Article650785

## Page 15

fnins-15-650785 April13,2021 Time:14:5 #15
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
comorbidchronicpain(WieseandWilson-Poe,2018),although prime the NLRP3 inflammasome in macrophages (Nolan et al.,
this has been disputed (Olfsonetal.,2018; Wilsonetal.,2018; 2020)(however,seeZhuetal.,2018).Thiscouldbeexacerbated
McBrien et al., 2019). Nevertheless, cannabidiol (CBD), which by drugs of abuse that promote dopamine transmission within
is a specific chemical constituent of cannabis that has no areas of the brain that are particularly vulnerable to HIV,
intoxicating psychoactive properties, exerts anti-inflammatory such as the striatum (Nolan and Gaskill, 2019). Clinically,
activity (Nichols and Kaplan, 2020) that has shown significant the mitochondrial protein translocator protein (TSPO), which
promise as a potential therapeutic for OUDs (Hurd et al., has garnered interest as a biomarker of neuroinflammation in
2015). Altogether, these studies underscore the need for future human imaging studies (Werry et al., 2019), is upregulated in
investigations into the use of immunomodulatory therapeutics people living with HIV (PLWH) and increased TSPO within
in the treatment of chronic pain, either alone or as adjunctive the hippocampus, amygdala, and thalamus is associated with
therapies. Importantly, these medications may be useful in impaired cognition (Vera et al., 2016). Other studies suggest
the treatment of comorbid chronic pain and SUDs, where that impaired cognitive function is associated with enhanced
commonimmunemechanismsmayunderlythepathophysiology TSPO binding in frontal and temporal regions of the brain
ofbothconditions. in PLWH (Garveya et al., 2014; Rubin et al., 2018). It
remains unclear whether combined HIV and active drug use,
Human Immunodeficiency Virus (HIV) compared to drug abstinence, produces differential profiles of
HIV is another physical comorbidity that can significantly neuroinflammation and immune activation to confer increased
impedetreatmentoutcomesforSUDsandviceversa.According vulnerability to HAND and drug relapse. Nevertheless, many
totheUnitedStatesCentersforDiseaseControlandPrevention preclinical studies suggest that HIV and its protein products
(CDC),over1millionpeopleintheUnitedStatesarecurrently mayexacerbatedrugrewardandreinforcementaswellasdrug-
living with HIV and 1 in 7 of those affected are unaware of induced neuroadaptations that may impede successful SUD
their HIV status (Centers for Disease Control and Prevention, treatmentoutcomes.
2019).Globally,nearly40millionpeoplearecurrentlylivingwith GrowingevidencesuggeststhatHIVanditsproteinproducts
HIV, and individuals who inject drugs are at a 22 times greater interactwithbrainrewardcircuitrytocontributetodysregulated
risk for acquiring HIV (UNAIDS, 2019). Importantly, HIV still reward-seeking behavior and cognition. For example, HIV-1
remainsasignificantpublichealthconcernamongminorityand transgenicrats,whichconstitutivelyexpressHIV-1viralproteins
socioeconomicallydisadvantagedpopulations(NationalInstitute and model many HIV-associated neurological abnormalities
on Drug Abuse [NIDA], 2012; Durvasula and Miller, 2014). observed in humans (Moran et al., 2014; Vigorito et al.,
As well, drug abuse (particularly psychostimulant abuse) is 2015; McLaurin et al., 2018), exhibit increased dopamine
associated with higher rates of risky behaviors such as unsafe affinity at striatal dopamine transporters and a leftward shift
sexualpracticesthatcanincreaseHIVrisk(CentersforDisease in the ascending limb of the cocaine dose response function,
ControlandPrevention,2018). suggesting enhanced sensitivity to the reinforcing properties
Modern antiretroviral therapy (ART) has proven successful of cocaine (McIntosh et al., 2015). Another study using this
at suppressing viral load and mitigating the transition to transgenicratmodelshowedthattheseanimalsexhibitenhanced
acquired immunodeficiency syndrome (AIDS), allowing many hyperexcitabilityofpyramidalneuronswithinthePFCfollowing
individuals living with HIV to live relatively normal lives. abstinencefromcocaine(Waymanetal.,2016).Aswell,inducible
However, ART does not readily cross the BBB, rendering the Tatexpressionwithinthebrainoftransgenicmiceisassociated
brain vulnerable to chronic HIV infection (Atluri et al., 2015). with enhanced METH-induced microglia activation as well as
Specifically, drugs of abuse such as cocaine can increase BBB METH-induced locomotor sensitization (Kesby et al., 2017).
permeability (Zhang et al., 1998) and facilitate invasion (An Other studies using the inducible Tat mouse model have
and Scaravilli, 1997) and viral replication (Sahu et al., 2015) of shown that induced Tat expression within the brain increases
HIV in the brain even during the early asymptomatic stages the magnitude of cocaine CPP and is sufficient to reinstate
of HIV infection. This process can happen rapidly and lead to extinguished cocaine CPP (Paris et al., 2014a). Similar effects
chronic CNS infection that results in neuroimmune activation havebeenobservedinfemales,albeitinanestrouscyclephase-
and, in many cases, HIV-associated neurocognitive disorders dependent manner (Paris et al., 2014b). Similarly, inducible
(HAND) (Hong and Banks, 2015; Zayyad and Spudich, 2015). gp120 expression within the mouse brain is associated with
CocainefacilitatesHIVreplicationthroughaNF-κB-dependent the formation of METH conditioned place preference at lower
mechanism(Fiumeetal.,2012;Sahuetal.,2015)andimpairsthe METHdosescomparedtonon-transgeniccontrols(Kesbyetal.,
innateimmuneresponseofastrocytestoinfiltratingvirusessuch 2014). Many other preclinical studies have also demonstrated
as HIV through increased oxidative stress when tested in vitro impairedcognitivefunctioninanimalsexposedtoHIVproteins
(Cisnerosetal.,2018).Drugsofabusealsoexacerbatetheeffects and drugs of abuse, mimicking the cognitive dysfunction
of the HIV proteins trans-activator of transcription (Tat) and observed in humans with HAND (Moran et al., 2014; Kesby
gp120ininducingoxidativestress,microgliosis,andastrogliosis et al., 2015a,b, 2016; Paydary et al., 2016). Taken together, such
(Aksenov et al., 2001, 2003; Shah et al., 2013; Samikkannu studies suggest that HIV and its protein products may increase
et al., 2015; Zeng et al., 2018). Moreover, HIV Tat primes one’s sensitivity to the rewarding and reinforcing properties of
and activates proinflammatory responses in microglia via the psychostimulantsandimpaircognitivefunction.
NLRfamilypyrindomaincontaining3(NLRP3)inflammasome In contrast to the studies above, a recent study using the
(Chiveroetal.,2017), and dopamine can activate NF-κB and HIV transgenic rat model suggests that HIV many promote a
FrontiersinNeuroscience|www.frontiersin.org 15 April2021|Volume15|Article650785

## Page 16

fnins-15-650785 April13,2021 Time:14:5 #16
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
motivationalstateofapathy(Bertrandetal.,2018).However,one function during periods of active drug taking versus periods of
significant limitation to this study and studies like it is that the protractedabstinence.Abstinencerepresentsacriticalperiodof
HIVtransgenicratmodelconstitutivelyexpressesHIVproteins vulnerability within the addiction cycle, and the neuroimmune
throughout the CNS prior to the establishment of stable drug sequelae of chronic drug use and abstinence remains poorly
self-administration, which may produce profoundly different understood. Investigation of these processes could improve
effectsonmesocorticolimbiccircuitfunctionandneuroimmune our understanding of how motivation for drug increases (or
signalingcomparedtotheinductionofviralproteinexpression “incubates”) over time throughout a protracted period of
within the CNS after drug self-administration is established or abstinencetoincreaserelapsevulnerability(Pickensetal.,2011).
during a period of abstinence. Indeed, some individuals with Asmentionednumeroustimesthroughoutthisreview,therole
preexistingSUDscontractHIVcollaterallythroughdruguseand of sex differences in the neuroimmune mechanisms of SUDs
risky behaviors associated with drug use (Centers for Disease andassociatedcomorbiditiesremainspoorlyunderstood.Indeed,
Control and Prevention, 2018). Regardless, it is possible that there are significant sex differences in the prevalence rates of
HIV-inducedperturbationstoneuroimmunesignalingdescribed individualconditionssuchasSUDs,MDD,PTSD,chronicpain,
abovemayunderlytheseneurobehavioralintersectionsbetween etc. As thoroughly reviewed by others (Rosen et al., 2017;
HIVandSUDs.Thus,immunopharmacologymaybeapromising BekhbatandNeigh,2018;Osborneetal.,2018;McCarthy,2019),
avenue of future research into medications that inhibit the there are sex-specific neuroimmune mechanisms involved in
long-term neurocognitive deficits observed with chronic HIV the pathophysiology of these conditions that may be suitable
infection as well as drug craving and relapse in cases of targetsformedicationsdevelopment.Nevertheless,whetherthese
comorbid SUDs (Roederer et al., 1992; Ambrosius et al., 2019; sex-specificneuroimmunemechanismsdrivethecomorbidityof
Tripathi et al., 2020). Interestingly, ART itself possess anti- these disorders and diseases and contribute to their disparate
inflammatory properties (Hileman and Funderburg, 2017), but prevalence rates is largely unknown and future research is
drugs of abuse may interact pharmacologically with ART to neededtoaddressthisgap.Manyofthestudiesdiscussedherein
reduce its effectiveness in both suppressing viral load and are largely observational in nature and few have attempted
minimizing cognitive deficits associated with HAND (Kumar to experimentally manipulate neuroimmune mechanisms using
et al., 2015). Future studies should examine the efficacy of drug self-administration animal models, which is another
anti-inflammatory adjunctive therapeutics in reducing HIV- remaining gap in the field. For example, there are significant
associated neurocognitive deficits and promoting long-term differences in the neurobiological mechanisms underlying cue-
abstinencefromdruguse. induceddrug-seekingbehaviorbetweenanimalmodelsinvolving
experimenter-delivered drug versus self-administration of drug
(Nambaetal.,2018),andthesemechanismsmaybedifferentially
CONCLUSION regulated by distinct neuroimmune mechanisms. Overall, we
suggestthatfutureresearchneedstoaddressthegapsmentioned
Throughout this review, we have highlighted recent studies abovetobetterassesswhetherputativeneuroimmunetargetsare
that demonstrate functionally significant immunomodulatory suitable candidates for medications development to treat SUDs
mechanismsthatmayunderliethepathophysiologyofSUDsand andassociatedcomorbidities.
associatedcomorbidities.Whileimmunomodulationoflearning,
memory, and synaptic plasticity is not a new concept per se,
AUTHOR CONTRIBUTIONS
recent research has greatly expounded the role of immune
signaling in neuropsychiatric disorders and diseases, providing
MNconceptualizedthisreview.MNandJL-Jwrotethefirstdraft.
afirmfoundationforfutureinvestigationsintonoveltreatment
EN,MO,andJNsubsequentlycontributedtothecontent,ideas,
targets. The literature presented herein suggests that central
and editing of the manuscript. All authors contributed to the
and peripheral immune mechanisms may represent a common
articleandapprovedthesubmittedversion.
threadunderlyingtheinteractionsbetweenSUDsandassociated
comorbidities. Indeed, the clinical and preclinical findings
discussed here underscore the need for future investigations
FUNDING
into the efficacy of adjunctive immunomodulatory medications
thatmaybetherapeuticallyefficaciousinthetreatmentofSUDs
ThisworkwassupportedbyNationalInstitutesofHealthgrants
and associated comorbidities such as MDD, PTSD, chronic
F31DA047072(MN),R21DA048651(JN),R01DA043172and
pain, and HIV. Despite these advances, one major gap in the
R01 AA025590 (MO), F32 AA027962 (JL-J), Sigma Xi grant
literaturethatdemandsfutureinvestigationishowneuroimmune
G2019100191831450(MN),ArizonaStateUniversityInstitutefor
signalingwithinmesocorticolimbiccircuitsis alteredacrossthe
SocialScienceResearchseedgrant(JN),andARCSFoundation
entire addiction cycle. For example, very few studies to date
ScholarAward(MN).
have examined how neuroimmune signaling is altered across a
protracted period of abstinence compared to acute and chronic
drug exposure, and if such changes are causally linked to ACKNOWLEDGMENTS
drug-seeking behavior. Moreover, very few studies to date have
thoroughly examined how comorbidities impact neuroimmune Figure1wascreatedwithBioRender.com.
FrontiersinNeuroscience|www.frontiersin.org 16 April2021|Volume15|Article650785

## Page 17

fnins-15-650785 April13,2021 Time:14:5 #17
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
REFERENCES Asyyed,A.,Storm,D.,andDiamond,I.(2006).EthanolactivatescAMPresponse
element-mediatedgeneexpressioninselectregionsofthemousebrain.Brain
Adeluyi,A.,Guerin,L.,Fisher,M.L.,Galloway,A.,Cole,R.D.,Chan,S.S.L.,etal. Res.1106,63–71.doi:10.1016/j.brainres.2006.05.107
(2019).Microgliamorphologyandproinflammatorysignalinginthenucleus Atluri,V.S.R.,Hidalgo,M.,Samikkannu,T.,Kurapati,K.R.V.,Jayant,R.D.,
accumbens during nicotine withdrawal. Sci. Adv. 5:eaax7031. doi: 10.1126/ Sagar,V.,etal.(2015).Effectofhumanimmunodeficiencyvirusonblood-
sciadv.aax7031 brain barrier integrity and function: an update. Front. Cell. Neurosci 9:212.
Aksenov,M.Y.,Hasselrot,U.,Bansal,A.K.,Wu,G.,Nath,A.,Anderson,C.,etal. doi:10.3389/fncel.2015.00212
(2001).OxidativedamageinducedbytheinjectionofHIV-1Tatproteininthe Attarzadeh-Yazdi,G.,Arezoomandan,R.,andHaghparast,A.(2014).Minocycline,
ratstriatum.Neurosci.Lett.305,5–8.doi:10.1016/s0304-3940(01)01786-4 an antibiotic with inhibitory effect on microglial activation, attenuates the
Aksenov,M.Y.,Hasselrot,U.,Wu,G.,Nath,A.,Anderson,C.,Mactutus,C.F., maintenanceandreinstatementofmethamphetamine-seekingbehaviorinrat.
et al. (2003). Temporal relationships between HIV-1 Tat-induced neuronal Prog. Neuro Psychopharmacol. Biol. Psychiatry 53, 142–148. doi: 10.1016/j.
degeneration, OX-42 immunoreactivity, reactive astrocytosis, and protein pnpbp.2014.04.008
oxidationintheratstriatum.BrainRes.987,1–9.doi:10.1016/s0006-8993(03) Averill,L.A.,Purohit,P.,Averill,C.L.,Boesl,M.A.,Krystal,J.H.,andAbdallah,
03194-9 C. G. (2017). Glutamate dysregulation and glutamatergic therapeutics for
Alasmari, F., Crotty Alexander, L. E., Nelson, J. A., Schiefer, I. T., Breen, E., PTSD:evidencefromhumanstudies.Neurosci.Lett.649,147–155.doi:10.1016/
Drummond, C. A., et al. (2017). Effects of chronic inhalation of electronic j.neulet.2016.11.064
cigarettescontainingnicotineonglialglutamatetransportersandα-7nicotinic Avila,D.V.,Myers,S.A.,Zhang,J.W.,Kharebava,G.,McClain,C.J.,Kim,H.Y.,
acetylcholinereceptorinfemaleCD-1mice.Prog.NeuroPsychopharmacol.Biol. etal.(2017).Phosphodiesterase4bexpressionplaysamajorroleinalcohol-
Psychiatry77,1–8.doi:10.1016/j.pnpbp.2017.03.017 inducedneuro-inflammation.Neuropharmacology125,376–385.doi:10.1016/
Alfonso-Loeches, S., Pascual-Lucas, M., Blanco, A. M., Sanchez-Vera, I., and j.neuropharm.2017.08.011
Guerri, C. (2010). Pivotal role of TLR4 receptors in alcohol-induced Avital, A., Goshen, I., Kamsler, A., Segal, M., Iverfeldt, K., Richter-Levin, G.,
neuroinflammationandbraindamage.J.Neurosci.30,8285–8295.doi:10.1523/ et al. (2003). Impaired interleukin-1 signaling is associated with deficits in
jneurosci.0976-10.2010 hippocampalmemoryprocessesandneuralplasticity.Hippocampus13,826–
Alfonso-Loeches, S., Ureña-Peralta, J., Morillo-Bargues, M. J., Gómez-Pinedo, 834.doi:10.1002/hipo.10135
U.,andGuerri,C.(2016).Ethanol-inducedTLR4/NLRP3neuroinflammatory Bachtell,R.,Hutchinson,M.R.,Wang,X.,Rice,K.C.,Maier,S.F.,andWatkins,
response in microglial cells promotes leukocyte infiltration across the BBB. L.R.(2015).Targetingthetollofdrugabuse:thetranslationalpotentialoftoll-
Neurochem.Res.41,193–209.doi:10.1007/s11064-015-1760-5 likereceptor4.CNSNeurol.Disord.DrugTargets14,692–699.doi:10.2174/
Alhaddad,H.,Das,S.C.,andSari,Y.(2014).Effectsofceftriaxoneonethanol 1871527314666150529132503
intake:apossibleroleforxCTandGLT-1isoformsmodulationofglutamate Back,S.E.,Gray,K.,SantaAna,E.,Jones,J.L.,Jarnecke,A.M.,Joseph,J.E.,etal.
levelsinPrats.Psychopharmacology231,4049–4057.doi:10.1007/s00213-014- (2020).acetylcysteineforthetreatmentofcomorbidalcoholusedisorderand
3545-y posttraumaticstressdisorder:designandmethodologyofarandomizedclinical
Allison,D.J.,andDitor,D.S.(2015).Targetinginflammationtoinfluencemood trial.Contemp.Clin.Trials91:105961.doi:10.1016/j.cct.2020.105961
following spinal cord injury: a randomized clinical trial. J. Neuroinflamm. Back,S.E.,McCauley,J.L.,Korte,K.J.,Gros,D.F.,Leavitt,V.,Gray,K.M.,etal.
12:204. (2016).double-blind,randomized,controlledpilottrialofN-acetylcysteinein
Ambrosius,B.,Gold,R.,Chan,A.,andFaissner,S.(2019).Antineuroinflammatory veteranswithposttraumaticstressdisorderandsubstanceusedisorders.J.Clin.
drugsinHIV-associatedneurocognitivedisordersaspotentialtherapy.Neurol. Psychiatry77,e1439–e1446.
Neuroimmunol.Neuroinflamm.6:e551.doi:10.1212/nxi.0000000000000551 Baker, D. A., McFarland, K., Lake, R. W., Shen, H., Tang, X.-C., Toda, S.,
Amin, F. U., Shah, S. A., and Kim, M. O. (2016). Glycine inhibits ethanol- etal.(2003).Neuroadaptationsincystine-glutamateexchangeunderliecocaine
inducedoxidativestress,neuroinflammationandapoptoticneurodegeneration relapse.Nat.Neurosci.6,743–749.doi:10.1038/nn1069
inpostnatalratbrain.Neurochem.Int.96,1–12.doi:10.1016/j.neuint.2016.04. Balschun,D.,Randolf,A.,Pitossi,F.,Schneider,H.,DelRey,A.,andBesedovsky,
001 H.O.(2003).Hippocampalinterleukin-1βgeneexpressionduringlong-term
An,S.F.,andScaravilli,F.(1997).EarlyHIV-1infectionofthecentralnervous potentiationdecayswithage.Ann.N.Y.Acad.Sci.992,1–8.doi:10.1111/j.1749-
system.Arch.Anat.Cytol.Pathol.45,94–105. 6632.2003.tb03132.x
Antón,M.,Alén,F.,GómezdeHeras,R.,Serrano,A.,Pavón,F.J.,Leza,J.C., Balschun,D.,Wetzel,W.,delRey,A.,Pitossi,F.,Schneider,H.,Zuschratter,W.,
etal.(2017).OleoylethanolamidepreventsneuroimmuneHMGB1/TLR4/NF- etal.(2004).Interleukin-6:acytokinetoforget.FASEBJ.18,1788–1790.doi:
kBdangersignalinginratfrontalcortexanddepressive-likebehaviorinduced 10.1096/fj.04-1625fje
byethanolbingeadministration.Addict.Biol.22,724–741.doi:10.1111/adb. Barrie,N.,andManolios,N.(2017).Theendocannabinoidsysteminpainand
12365 inflammation:itsrelevancetorheumaticdisease.Eur.J.Rheumatol.4,210–218.
Araos,P.,Pedraz,M.,Serrano,A.,Lucena,M.,Barrios,V.,García-Marchena,N., doi:10.5152/eurjrheum.2017.17025
etal.(2015).Plasmaprofileofpro-inflammatorycytokinesandchemokines Barson,J.R.,Karatayev,O.,Chang,G.Q.,Johnson,D.F.,Bocarsly,M.E.,Hoebel,
in cocaine users under outpatient treatment: influence of cocaine symptom B.G.,etal.(2009).Positiverelationshipbetweendietaryfat,ethanolintake,
severityandpsychiatricco-morbidity.Addict.Biol.20,756–772.doi:10.1111/ triglycerides, and hypothalamic peptides: counteraction by lipid-lowering
adb.12156 drugs.Alcohol43,433–441.doi:10.1016/j.alcohol.2009.07.003
Arezoomandan,R.,andHaghparast,A.(2016).Administrationoftheglialcell Beattie, E. C., Stellwagen, D., Morishita, W., Bresnahan, J. C., Ha, B. K., Von
modulator,minocycline,inthenucleusaccumbensattenuatedthemaintenance Zastrow, M., et al. (2002). Control of synaptic strength by glial TNFalpha.
andreinstatementofmorphine-seekingbehavior.Can.J.Physiol.Pharmacol. Science295,2282–2285.doi:10.1126/science.1067859
94,257–264.doi:10.1139/cjpp-2015-0209 Bekhbat, M., and Neigh, G. N. (2018). Sex differences in the neuro-immune
Arnold, L. M., Pritchett, Y. L., D’Souza, D. N., Kajdasz, D. K., Iyengar, S., consequencesofstress:focusondepressionandanxiety.BrainBehav.Immun.
andWernicke,J.F.(2007).Duloxetineforthetreatmentoffibromyalgiain 67,1–12.doi:10.1016/j.bbi.2017.02.006
women:pooledresultsfromtworandomized,placebo-controlledclinicaltrials. Bell,R.L.,Lopez,M.F.,Cui,C.,Egli,M.,Johnson,K.W.,Franklin,K.M.,etal.
J.WomenHeal.16,1145–1156.doi:10.1089/jwh.2006.0213 (2015).Ibudilastreducesalcoholdrinkinginmultipleanimalmodelsofalcohol
Asher,O.,Cunningham,T.D.,Yao,L.,Gordon,A.S.,andDiamond,I.(2002). dependence.Addict.Biol.20,38–42.doi:10.1111/adb.12106
Ethanol stimulates cAMP-responsive element (CRE)-mediated transcription Bellinger,F.P.,Madamba,S.G.,Campbell,I.L.,andSiggins,G.R.(1995).Reduced
viaCRE-bindingproteinandcAMP-dependentproteinkinase.J.Pharmacol. long-termpotentiationinthedentategyrusoftransgenicmicewithcerebral
Exp.Ther.301,66–70.doi:10.1124/jpet.301.1.66 overexpressionofinterleukin-6.Neurosci.Lett.198,95–98.doi:10.1016/0304-
Ashoor,A.,Nordman,J.C.,Veltri,D.,Yang,K.H.S.,AlKury,L.,Shuba,Y.,etal. 3940(95)11976-4
(2013).Mentholbindingandinhibitionofα7-nicotinicacetylcholinereceptors. BenAchour,S.,andPascual,O.(2010).Glia:themanywaystomodulatesynaptic
PLoSOne8:e67674.doi:10.1371/journal.pone.0067674 plasticity.Neurochem.Int.57,440–445.doi:10.1016/j.neuint.2010.02.013
FrontiersinNeuroscience|www.frontiersin.org 17 April2021|Volume15|Article650785

## Page 18

fnins-15-650785 April13,2021 Time:14:5 #18
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
Berk,M.,Dean,O.M.,Cotton,S.M.,Jeavons,S.,Tanious,M.,Kohlmann,K.,etal. Burstein,S.H.,andZurier,R.B.(2009).Cannabinoids,endocannabinoids,and
(2014).TheefficacyofadjunctiveN-acetylcysteineinmajordepressivedisorder: relatedanalogsininflammation.AAPSJ.11,109–119.
a double-blind, randomized, placebo-controlled trial. J. Clin. Psychiatry 75, Byrnes,K.R.,Stoica,B.,Loane,D.J.,Riccio,A.,Davis,M.I.,andFaden,A.I.(2009).
628–636. Metabotropic glutamate receptor 5 activation inhibits microglial associated
Berk,M.,Dean,O.,Cotton,S.M.,Gama,C.S.,Kapczinski,F.,Fernandes,B.S., inflammationandneurotoxicity.Glia57,550–560.doi:10.1002/glia.20783
et al. (2011). The efficacy of N-acetylcysteine as an adjunctive treatment in Caffino,L.,Verheij,M.M.M.,Que,L.,Guo,C.,Homberg,J.R.,andFumagalli,
bipolar depression: an open label trial. J. Affect. Disord. 135, 389–394. doi: F.(2019).Increasedcocaineself-administrationinratslackingtheserotonin
10.1016/j.jad.2011.06.005 transporter:aroleforglutamatergicsignalinginthehabenula.Addict.Biol.24,
Bertrand,S.J.,Mactutus,C.F.,Harrod,S.B.,Moran,L.M.,andBooze,R.M. 1167–1178.doi:10.1111/adb.12673
(2018). HIV-1 proteins dysregulate motivational processes and dopamine Calipari, E. S., Godino, A., Peck, E. G., Salery, M., Mervosh, N. L., Landry,
circuitry.Sci.Rep.8,1–17. J.A.,etal.(2018).Granulocyte-colonystimulatingfactorcontrolsneuraland
Besson,M.,David,V.,Baudonnat,M.,Cazala,P.,Guilloux,J.-P.,Reperant,C.,etal. behavioralplasticityinresponsetococaine.Nat.Commun.9,1–14.
(2012).Alpha7-nicotinicreceptorsmodulatenicotine-inducedreinforcement Carvalho, A. F., Macêdo, D. S., Goulia, P., and Hyphantis, T. N. N. -
and extracellular dopamine outflow in the mesolimbic system in mice. (2013).Acetylcysteineaugmentationtotranylcypromineintreatment-resistant
Psychopharmacology220,1–14.doi:10.1007/s00213-011-2422-1 major depression. J. Clin. Psychopharmacol. 33, 719–720. doi: 10.1097/jcp.
Bhat,S.A.,Henry,R.J.,Blanchard,A.C.,Stoica,B.A.,Loane,D.J.,andFaden,A.I. 0b013e31829839c6
(2021).EnhancedAkt/GSK-3β/CREBsignalingmediatestheanti-inflammatory Cekanaviciute, E., and Buckwalter, M. S. (2016). Astrocytes: integrative
actionsofmGluR5positiveallostericmodulatorsinmicrogliaandfollowing regulators of neuroinflammation in stroke and other neurological diseases.
traumaticbraininjuryinmalemice.J.Neurochem.156,225–248.doi:10.1111/ Neurotherapeutics13,685–701.doi:10.1007/s13311-016-0477-8
jnc.14954 CentersforDiseaseControlandPrevention(2018).HIVandSubstanceUseinthe
Bidari,A.,Moazen-Zadeh,E.,Ghavidel-Parsa,B.,Rahmani,S.,Hosseini,S.,and UnitedStates.Availableonlineat:https://www.cdc.gov/hiv/risk/substanceuse.
Hassankhani,A.(2019).Comparingduloxetineandpregabalinfortreatment html(accessedAugust16,2019).
ofpainanddepressioninwomenwithfibromyalgia:anopen-labelrandomized CentersforDiseaseControlandPrevention(2019).EstimatedHIVIncidenceand
clinicaltrial.DARUJ.Pharm.Sci.27,149–158.doi:10.1007/s40199-019-00257- Prevalence in the United States, 2010-2016. HIV Surveillance Supplemental
4 Report24.Atlanta,GA:CentersforDiseaseControlandPrevention.
Bilbao,A.,Serrano,A.,Cippitelli,A.,Pavón,F.J.,Giuffrida,A.,Suárez,J.,etal. Chandrasekar,V.,andDreyer,J.L.(2009).microRNAsmiR-124,let-7dandmiR-
(2016).Roleofthesatietyfactoroleoylethanolamideinalcoholism.Addict.Biol. 181aregulatecocaine-inducedplasticity.Mol.Cell.Neurosci.42,350–362.doi:
21,859–872.doi:10.1111/adb.12276 10.1016/j.mcn.2009.08.009
Biswas, L., Harrison, E., Gong, Y., Avusula, R., Lee, J., Zhang, M., et al. Chen,J.X.,Huang,K.M.,Liu,M.,Jiang,J.X.,Liu,J.P.,Zhang,Y.X.,etal.(2017).
(2016).Enhancingeffectofmentholonnicotineself-administrationinrats. ActivationofTLR4/STAT3signalinginVTAcontributestotheacquisitionand
Psychopharmacology233,3417–3427.doi:10.1007/s00213-016-4391-x maintenanceofmorphine-inducedconditionedplacepreference.Behav.Brain
Blednov,Y.A.,Benavidez,J.M.,Black,M.,andHarris,R.A.(2014).Inhibitionof Res.335,151–157.doi:10.1016/j.bbr.2017.08.022
phosphodiesterase4reducesethanolintakeandpreferenceinC57BL/6Jmice. Chen,M.H.,Li,C.T.,Lin,W.C.,Hong,C.J.,Tu,P.C.,Bai,Y.M.,etal.(2018).
Front.Neurosci.8:129.doi:10.3389/fnins.2014.00129 Rapid inflammation modulation and antidepressant efficacy of a low-dose
Blednov,Y.A.,Black,M.,Benavidez,J.M.,Stamatakis,E.E.,andHarris,R.A. ketamine infusion in treatment-resistant depression: a randomized, double-
(2016).PPARagonists:II.FenofibrateandTesaglitazaralterbehaviorsrelated blindcontrolstudy.PsychiatryRes.269,207–211.doi:10.1016/j.psychres.2018.
tovoluntaryalcoholconsumption.Alcohol.Clin.Exp.Res.40,563–571.doi: 08.078
10.1111/acer.12972 Chivero, E. T., Guo, M.-L., Periyasamy, P., Liao, K., Callen, S. E., and Buch,
Blednov, Y. A., Ponomarev, I., Geil, C., Bergeson, S., Koob, G. F., and Harris, S.(2017).HIV-1TatprimesandactivatesMicroglialNLRP3inflammasome-
R. A. (2012). Neuroimmune regulation of alcohol consumption: behavioral Mediated neuroinflammation. J. Neurosci. 37, 3599–3609. doi: 10.1523/
validationofgenesobtainedfromgenomicstudies.Addict.Biol.17,108–120. JNEUROSCI.3045-16.2017
doi:10.1111/j.1369-1600.2010.00284.x Choi,S.S.,Lee,H.J.,Lim,I.,Satoh,J.I.,andKim,S.U.(2014).Humanastrocytes:
Borgmann,K.,andGhorpade,A.(2015).HIV-1,methamphetamineandastrocytes secretomeprofilesofcytokinesandChemokines.PLoSOne9:e92325.doi:10.
atneuroinflammatorycrossroads.Front.Microbiol.6:1143.doi:10.3389/fmicb. 1371/journal.pone.0092325
2015.01143 Cisneros,I.E.,Erdenizmenli,M.,Cunningham,K.A.,Paessler,S.,andDineley,
Brady, L. J., Hofford, R. S., Tat, J., Calipari, E. S., and Kiraly, D. D. (2019). K.T.(2018).Cocaineevokesaprofileofoxidativestressandimpactsinnate
Granulocyte-colonystimulatingfactoraltersthePharmacodynamicproperties antiviralresponsepathwaysinastrocytes.Neuropharmacology135,431–443.
ofcocaineinfemalemice.ACSChem.Neurosci.10,4213–4220.doi:10.1021/ doi:10.1016/j.neuropharm.2018.03.019
acschemneuro.9b00309 Clark,K.H.,Wiley,C.A.,andBradberry,C.W.(2013).Psychostimulantabuseand
Braida,D.,Sacerdote,P.,Panerai,A.E.,Bianchi,M.,Aloisi,A.M.,Iosuè,S.,etal. neuroinflammation:emergingevidenceoftheirinterconnection.Neurotox.Res.
(2004).CognitivefunctioninyoungandadultIL(interleukin)-6deficientmice. 23,174–188.doi:10.1007/s12640-012-9334-7
Behav.BrainRes.153,423–429.doi:10.1016/j.bbr.2003.12.018 ClinicalTrials.gov (2021a). Development of Ibudilast for Alcohol Use Disorder
Brenhouse, H. C., Danese, A., and Grassi-Oliveira, R. (2019). Neuroimmune - Full Text View. Available online at: https://clinicaltrials.gov/ct2/show/
impactsofearly-lifestressondevelopmentandpsychopathology.Curr.Top. NCT02025998?term=Ibudilast&cond=alcohol&draw=1&rank=1 (accessed
Behav.Neurosci.43,423–447.doi:10.1007/7854_2018_53 March12,2021).
Brown,K.T.,Levis,S.C.,O’Neill,C.E.,Northcutt,A.L.,Fabisiak,T.J.,Watkins, ClinicalTrials.gov (2021b). Medication Development in Alcoholism: Apremilast
L. R., et al. (2018). Innate immune signaling in the ventral tegmental area VersusPlacebo-FullTextView.Availableonlineat:https://clinicaltrials.gov/
contributes to drug-primed reinstatement of cocaine seeking. Brain. Behav. ct2/show/NCT03175549?term=apremilast&cond=alcohol&draw=2&rank=1
Immun.67,130–138.doi:10.1016/j.bbi.2017.08.012 (accessedMarch12,2021).
Brunzell, D. H., and McIntosh, J. M. (2012). Alpha7 nicotinic acetylcholine Cooper,Z.D.,andCraft,R.M.(2018).Sex-dependenteffectsofcannabisand
receptors modulate motivation to self-administer nicotine: implications for cannabinoids:atranslationalperspective.Neuropsychopharmacology43,34–51.
smokingandschizophrenia.Neuropsychopharmacology37,1134–1143.doi:10. doi:10.1038/npp.2017.140
1038/npp.2011.299 Cooper,Z.D.,Johnson,K.W.,Pavlicova,M.,Glass,A.,Vosburg,S.K.,Sullivan,
Buonaguro, E. F., Morley-Fletcher, S., Avagliano, C., Vellucci, L., Iasevoli, F., M. A., et al. (2016). The effects of ibudilast, a glial activation inhibitor, on
Bouwalerh,H.,etal.(2020).Glutamatergicpostsynapticdensityinearlylife opioidwithdrawalsymptomsinopioid-dependentvolunteers.Addict.Biol.21,
stress programming: topographic gene expression of mGlu5 receptors and 895–903.doi:10.1111/adb.12261
Homerproteins.Prog.NeuroPsychopharmacol.Biol.Psychiatry96:109725.doi: Crews,F.T.,andVetreno,R.P.(2011).Addiction,adolescence,andinnateimmune
10.1016/j.pnpbp.2019.109725 geneinduction.Front.Psychiatry2:19.doi:10.3389/fpsyt.2011.00019
FrontiersinNeuroscience|www.frontiersin.org 18 April2021|Volume15|Article650785

## Page 19

fnins-15-650785 April13,2021 Time:14:5 #19
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
Crews, F. T., Lawrimore, C. J., Walter, T. J., and Coleman, L. G. (2017). The Ezeomah,C.,Cunningham,K.A.,Stutz,S.J.,Fox,R.G.,Bukreyeva,N.,Dineley,
roleofneuroimmunesignalinginalcoholism.Neuropharmacology122,56–73. K. T., et al. (2020). Fentanyl self-administration impacts brain immune
doi:10.1016/j.neuropharm.2017.01.031 responsesinmaleSprague-Dawleyrats.Brain. Behav.Immun.87,725–738.
Crews,F.T.,Zou,J.,andQin,L.(2011).Inductionofinnateimmunegenesinbrain doi:10.1016/j.bbi.2020.03.003
createtheneurobiologyofaddiction.Brain.Behav.Immun.25,S4–S12. Fan,N.,Luo,Y.,Ou,Y.,andHe,H.(2017).AlteredserumlevelsofTNF-α,IL-6,
Cryan,J.F.,anddeWit,H.(2019).Thegutmicrobiomeinpsychopharmacology andIL-18indepressivedisorderpatients.Hum.Psychopharmacol.32:2588.
andpsychiatry.Psychopharmacology236,1407–1409.doi:10.1007/s00213-019- Fazio,F.,Ulivieri,M.,Volpi,C.,Gargaro,M.,andFallarino,F.(2018).Targeting
05288-y metabotropic glutamate receptors for the treatment of neuroinflammation.
Cui, C., Shurtleff, D., and Harris, R. A. (2014). Neuroimmune mechanisms of Curr.Opin.Pharmacol.38,16–23.doi:10.1016/j.coph.2018.01.010
alcoholanddrugaddiction.Int.Rev.Neurobiol.118,1–12.doi:10.1016/b978- Fiume,G.,Vecchio,E.,DeLaurentiis,A.,Trimboli,F.,Palmieri,C.,Pisano,A.,
0-12-801284-0.00001-4 etal.(2012).Humanimmunodeficiencyvirus-1TatactivatesNF-κBviaphysical
Deepmala,Slattery,J.,Kumar,N.,Delhey,L.,Berk,M.,Dean,O.,etal.(2015). interactionwithIκB-αandp65.NucleicAcidsRes.40,3548–3562.doi:10.1093/
Clinical trials of N-acetylcysteine in psychiatry and neurology: a systematic nar/gkr1224
review.Neurosci.Biobehav.Rev.55,294–321.doi:10.1016/j.neubiorev.2015.04. Fond, G., Loundou, A., Hamdani, N., Boukouaci, W., Dargel, A., Oliveira, J.,
015 etal.(2014).Anxietyanddepressioncomorbiditiesinirritablebowelsyndrome
delRey,A.,Balschun,D.,Wetzel,W.,Randolf,A.,andBesedovsky,H.O.(2013). (IBS): a systematic review and meta-analysis. Eur. Arch. Psychiatry Clin.
Acytokinenetworkinvolvingbrain-borneIL-1β,IL-1ra,IL-18,IL-6,andTNFα Neurosci.264,651–660.doi:10.1007/s00406-014-0502-z
operatesduringlong-termpotentiationandlearning.Brain.Behav.Immun.33, Foucault-Fruchard,L.,andAntier,D.(2017).Therapeuticpotentialofα7nicotinic
15–23.doi:10.1016/j.bbi.2013.05.011 receptoragoniststoregulateneuroinflammationinneurodegenerativediseases.
DeLeo, J. A., Tanga, F. Y., and Tawfik, V. L. (2004). Neuroimmune activation NeuralRegen.Res.12,1418–1421.doi:10.4103/1673-5374.215244
and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia. Foucault-Fruchard,L.,Doméné,A.,Page,G.,Windsor,M.,Emond,P.,Rodrigues,
Neuroscientist10,40–52.doi:10.1177/1073858403259950 N.,etal.(2017).Neuroprotectiveeffectofthealpha7nicotinicreceptoragonist
Deslauriers,J.,vanWijngaarde,M.,Geyer,M.A.,Powell,S.,andRisbrough,V.B. PHA543613inaninvivoexcitotoxicadultratmodel.Neuroscience356,52–63.
(2017).EffectsofLPS-inducedimmuneactivationpriortotraumaexposureon doi:10.1016/j.neuroscience.2017.05.019
PTSD-likesymptomsinmice.Behav.BrainRes.323,117–123.doi:10.1016/j. Fujii,T.,Mashimo,M.,Moriwaki,Y.,Misawa,H.,Ono,S.,Horiguchi,K.,etal.
bbr.2017.01.048 (2017).Expressionandfunctionofthecholinergicsysteminimmunecells.
Dinarello,C.A.(2018).OverviewoftheIL-1familyininnateinflammationand Front.Immunol.8:1085.doi:10.3389/fimmu.2017.01085
acquiredimmunity.Immunol.Rev.281,8–27.doi:10.1111/imr.12621 Fujita, Y., Kunitachi, S., Iyo, M., and Hashimoto, K. (2012). The antibiotic
Dong,Y.,andBenveniste,E.N.(2001).Immunefunctionofastrocytes.Glia36, minocyclineprevents methamphetamine-induced rewardingeffectsin mice.
180–190.doi:10.1002/glia.1107 Pharmacol.Biochem.Behav.101,303–306.doi:10.1016/j.pbb.2012.01.005
Dowell, D., Haegerich, T. M., and Chou, R. C. D. C. (2016). Guideline for Gajbhiye,S.V.,Tripathi,R.K.,Petare,A.,Potey,A.V.,andShankar,A.(2018).
prescribingopioidsforchronicpain-UnitedStates,2016.MMWRRecomm. Minocyclineinalcoholwithdrawalinducedanxietyandalcoholrelapseinrats.
Rep.65,1–49.doi:10.15585/mmwr.rr6501e1er Curr.Clin.Pharmacol.13,65–72.doi:10.2174/1574884713666180228110310
Doyle,H.H.,Eidson,L.N.,Sinkiewicz,D.M.,andMurphy,A.Z.(2017).Sex Gajbhiye, S. V., Tripathi, R. K., Salve, B., Petare, A., and Potey, A. V. (2017).
differencesinmicrogliaactivitywithintheperiaqueductalgrayoftherat:a Evaluationofeffectofminocyclineonrewardingpotentialandalcoholrelapse
potentialmechanismdrivingthedimorphiceffectsofmorphine.J.Neurosci. inplacepreferencemodelinmice.Neurosci.Lett.649,28–33.doi:10.1016/j.
37,3202–3214.doi:10.1523/jneurosci.2906-16.2017 neulet.2017.04.007
Duan,S.,Anderson,C.M.,Stein,B.A.,andSwanson,R.A.(1999).Glutamate Gamble-George,J.C.,Baldi,R.,Halladay,L.,Kocharian,A.,Hartley,N.,Silva,
inducesrapidupregulationofastrocyteglutamatetransportandcell-surface C.,etal.(2016).Cyclooxygenase-2inhibitionreducesstress-inducedaffective
expressionofGLAST.J.Neurosci.19,10193–10200.doi:10.1523/jneurosci.19- pathology.eLife5:e14137.
23-10193.1999 Ganguly,P.,Honeycutt,J.A.,Rowe,J.R.,Demaestri,C.,andBrenhouse,H.C.
Durvasula,R.,andMiller,T.R.(2014).Substanceabusetreatmentinpersonswith (2019).EffectsofearlylifestressoncocaineconditioningandAMPAreceptor
HIV/AIDS:challengesinmanagingtriplediagnosis.Behav.Med.40,43–52. composition are sex-specific and driven by TNF. Brain. Behav. Immun. 78,
doi:10.1080/08964289.2013.866540 41–51.doi:10.1016/j.bbi.2019.01.006
Eidson, L. N., and Murphy, A. Z. (2019). Inflammatory mediators of opioid Garcia-Keller, C., Smiley, C., Monforton, C., Melton, S., Kalivas, P. W., and
tolerance: implications for dependency and addiction. Peptides 115, 51–58. Gass, J. N. (2020). -Acetylcysteine treatment during acute stress prevents
doi:10.1016/j.peptides.2019.01.003 stress-inducedaugmentationofaddictivedruguseandrelapse.Addict.Biol.
Eidson,L.N.,Inoue,K.,Young,L.J.,Tansey,M.G.,andMurphy,A.Z.(2017).Toll- 25:e12798.
likereceptor4mediatesmorphine-inducedneuroinflammationandtolerance Garland, E. L., Froeliger, B., Zeidan, F., Partin, K., and Howard, M. O.
viasolubletumornecrosisfactorsignaling.Neuropsychopharmacology42,661– (2013). The downward spiral of chronic pain, prescription opioid misuse,
670.doi:10.1038/npp.2016.131 andaddiction:cognitive,affective,andneuropsychopharmacologicpathways.
Eipper-Mains,J.E.,Kiraly,D.D.,Palakodeti,D.,Mains,R.E.,Eipper,B.A.,and Neurosci.Biobehav.Rev.37,2597–2607.doi:10.1016/j.neubiorev.2013.08.006
Graveley,B.R.(2011).microRNA-Seqrevealscocaine-regulatedexpressionof Garveya,L.J.,Pavese,N.,Politis,M.,Ramlackhansingh,A.,Brooks,D.J.,Taylor-
striatalmicroRNAs.RNA17,1529–1543.doi:10.1261/rna.2775511 Robinson,S.D.,etal.(2014).Increasedmicrogliaactivationinneurologically
ElbiniDhouib,I.,Jallouli,M.,Annabi,A.,Gharbi,N.,Elfazaa,S.,andLasram,M.M. asymptomaticHIV-infectedpatientsreceivingeffectiveART.AIDS28,67–72.
(2016).AminireviewonN-acetylcysteine:anolddrugwithnewapproaches. doi:10.1097/01.aids.0000432467.54003.f7
LifeSci.151,359–363.doi:10.1016/j.lfs.2016.03.003 Gobejishvili, L., Barve, S., Joshi-Barve, S., and McClain, C. (2008). Enhanced
Eller,T.,Vasar,V.,Shlik,J.,andMaron,E.(2008).Pro-inflammatorycytokinesand PDE4BexpressionaugmentsLPS-inducibleTNFexpressioninethanol-primed
treatmentresponsetoescitaloprsaminmajordepressivedisorder.Prog.Neuro monocytes: relevance to alcoholic liver disease. Am. J. Physiol. Gastrointest.
Psychopharmacol.Biol.Psychiatry32,445–450.doi:10.1016/j.pnpbp.2007.09. LiverPhysiol.295:G718.
015 Gonçalves, J., Leitão, R. A., Higuera-Matas, A., Assis, M. A., Coria, S. M.,
Elman,I.,andBorsook,D.(2016).Commonbrainmechanismsofchronicpainand Fontes-Ribeiro, C., et al. (2017). Extended-access methamphetamine self-
addiction.Neuron89,11–36.doi:10.1016/j.neuron.2015.11.027 administration elicits neuroinflammatory response along with blood-brain
Engler,H.,Brendt,P.,Wischermann,J.,Wegner,A.,Röhling,R.,Schoemberg,T., barrierbreakdown.Brain.Behav.Immun.62,306–317.doi:10.1016/j.bbi.2017.
etal.(2017).SelectiveincreaseofcerebrospinalfluidIL-6duringexperimental 02.017
systemicinflammationinhumans:associationwithdepressivesymptoms.Mol. Gonzalez, P. V., Schiöth, H. B., Lasaga, M., and Scimonelli, T. N. (2009).
Psychiatry22,1448–1454.doi:10.1038/mp.2016.264 MemoryimpairmentinducedbyIL-1βisreversedbyα-MSHthroughcentral
FrontiersinNeuroscience|www.frontiersin.org 19 April2021|Volume15|Article650785

## Page 20

fnins-15-650785 April13,2021 Time:14:5 #20
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
melanocortin-4receptors.Brain.Behav.Immun.23,817–822.doi:10.1016/j. Hoefer, M. M., Sanchez, A. B., Maung, R., de Rozieres, C. M., Catalan, I. C.,
bbi.2009.03.001 Dowling,C.C.,etal.(2015).CombinationofmethamphetamineandHIV-1
González-Reimers, E., Santolaria-Fernández, F., Martín-González, M. C., gp120causesdistinctlong-termalterationsofbehavior,geneexpression,and
Fernández-Rodríguez, C. M., and Quintero-Platt, G. (2014). Alcoholism: a injuryinthecentralnervoussystem.Exp.Neurol.263,221–234.doi:10.1016/j.
systemicproinflammatorycondition.WorldJ.Gastroenterol.20,14660–14671. expneurol.2014.09.010
doi:10.3748/wjg.v20.i40.14660 Hofford,R.S.,Russo,S.J.,andKiraly,D.D.(2019).Neuroimmunemechanisms
Goshen,I.,andYirmiya,R.(2007).“Theroleofpro-inflammatorycytokinesin ofpsychostimulantandopioidusedisorders.Eur.J.Neurosci.50,2562–2573.
memoryprocessesandneuralplasticity,”inPsychoneuroimmunology,Vol.1, doi:10.1111/ejn.14143
ed.R.Ader(Amsterdam:Elsevier),337–377.doi:10.1016/b978-012088576-3/ Hong,S.,andBanks,W.A.(2015).RoleoftheimmunesysteminHIV-associated
50021-6 neuroinflammationandneurocognitiveimplications.BrainBehav.Immun.45,
Goshen,I.,Kreisel,T.,Ounallah-Saad,H.,Renbaum,P.,Zalzstein,Y.,Ben-Hur,T., 1–12.doi:10.1016/j.bbi.2014.10.008
etal.(2007).Adualroleforinterleukin-1inhippocampal-dependentmemory Hori,H.,andKim,Y.(2019).Inflammationandpost-traumaticstressdisorder.
processes.Psychoneuroendocrinology32,1106–1115.doi:10.1016/j.psyneuen. PsychiatryClinicalNeurosci.73,143–153.
2007.09.004 Hu, W., Lu, T., Chen, A., Huang, Y., Hansen, R., Chandler, L. J., et al.
Gotti,C.,Clementi,F.,Fornari,A.,Gaimarri,A.,Guiducci,S.,Manfredi,I.,etal. (2011). Inhibition of phosphodiesterase-4 decreases ethanol intake in mice.
(2009).Structuralandfunctionaldiversityofnativebrainneuronalnicotinic Psychopharmacology218,331–339.doi:10.1007/s00213-011-2290-8
receptors.Biochem.Pharmacol.78,703–711.doi:10.1016/j.bcp.2009.05.024 Huhn,A.S.,Tompkins,D.A.,Campbell,C.M.,andDunn,K.E.(2019).Individuals
Gozen, O., Nesil, T., Kanit, L., Koylu, E. O., and Pogun, S. (2016). Nicotinic withchronicpainwhomisuseprescriptionopioidsreportsex-baseddifferences
cholinergicanddopaminergicreceptormRNAexpressioninmaleandfemale inpainandopioidwithdrawal.PainMed.20,1942–1947.doi:10.1093/pm/
ratswithhighorlowpreferencefornicotine.Am.J.DrugAlcoholAbuse42, pny295
556–566.doi:10.1080/00952990.2016.1198799 Hurd,Y.L.,Yoon,M.,Manini,A.F.,Hernandez,S.,Olmedo,R.,Ostman,M.,
Hagino,Y.,Kariura,Y.,Manago,Y.,Amano,T.,Wang,B.,Sekiguchi,M.,etal. etal.(2015).EarlyphaseinthedevelopmentofCannabidiolasatreatment
(2004).HeterogeneityandpotentiationofAMPAtypeofglutamatereceptorsin foraddiction:opioidrelapsetakesinitialcenterstage.Neurotherapeutics12,
ratculturedmicroglia.Glia47,68–77.doi:10.1002/glia.20034 807–815.doi:10.1007/s13311-015-0373-7
Hajhashemi, V., and Khanjani, P. (2014). Analgesic and anti-inflammatory Hutchinson,M.R.,Northcutt,A.L.,Hiranita,T.,Wang,X.,Lewis,S.S.,Thomas,
activitiesofbupropioninanimalmodels.Res.Pharm.Sci.9,251–257. J.,etal.(2012).Opioidactivationoftoll-likereceptor4contributestodrug
Hall,B.J.,Slade,S.,Wells,C.,Rose,J.E.,andLevin,E.D.(2015).Bupropion- reinforcement.J.Neurosci.32,11187–11200.
varenicline interactions and nicotine self-administration behavior in rats. Ibáñez,F.,Montesinos,J.,Ureña-Peralta,J.R.,Guerri,C.,andPascual,M.(2019).
Pharmacol.Biochem.Behav.130,84–89.doi:10.1016/j.pbb.2015.01.009 TLR4participatesinthetransmissionofethanol-inducedneuroinflammation
Harada, K., Kamiya, T., and Tsuboi, T. (2016). Gliotransmitter release from via astrocyte-derived extracellular vesicles. J. Neuroinflamm.
astrocytes: functional, developmental, and pathological implications in the 16:136.
brain.Front.Neurosci.9:499.doi:10.3389/fnins.2015.00499 Inoue,K.,Shinohara,H.,Behar,M.,Yumoto,N.,Tanaka,G.,Hoffmann,A.,etal.
Hartmann, P., and Tacke, F. (2016). Tiny RNA with great effects: MiR-155 in (2016).OscillationdynamicsunderliefunctionalswitchingofNF-κBforB-cell
alcoholicliverdisease.J.Hepatol.64,1214–1216.doi:10.1016/j.jhep.2016.02. activation.NPJSyst.Biol.Appl.2,1–9.
039 Israel, Y., Quintanilla, M. E., Ezquer, F., Morales, P., Santapau, D., Berríos-
Hayes,J.,andKoo,J.(2010).Psoriasis:depression,anxiety,smoking,anddrinking Cárcamo, P., et al. (2019). Aspirin and N-acetylcysteine co-administration
habits.Dermatol.Ther.23,174–180.doi:10.1111/j.1529-8019.2010.01312.x markedly inhibit chronic ethanol intake and block relapse binge drinking:
He, J., and Crews, F. T. (2008). Increased MCP-1 and microglia in various role of neuroinflammation-oxidative stress self-perpetuation. Addict. Biol
regionsofthehumanalcoholicbrain.Exp.Neurol.210,349–358.doi:10.1016/ 26:e12853.doi:10.1111/adb.12853
j.expneurol.2007.11.017 Jacobsen, J. H. W., Hutchinson, M. R., and Mustafa, S. (2016). Drug
Hein, A. M., Stasko, M. R., Matousek, S. B., Scott-McKean, J. J., Maier, S. F., addiction:targetingdynamicneuroimmunereceptorinteractionsasapotential
Olschowka,J.A.,etal.(2010).SustainedhippocampalIL-1βoverexpression therapeuticstrategy.Curr.Opin.Pharmacol.26,131–137.doi:10.1016/j.coph.
impairs contextual and spatial memory in transgenic mice. Brain. Behav. 2015.10.010
Immun.24,243–253.doi:10.1016/j.bbi.2009.10.002 Jafari,S.,Khajehpour,S.,Razzaghi,E.M.,Heidari,K.,Soleimani,M.,andGhaeli,
Hernández,J.A.,López-Sánchez,R.C.,andRendón-Ramírez,A.(2016).Lipids P.(2017).Cravinganddrugreward:acomparisonofCelecoxibandibuprofen
and oxidative stress associated with ethanol-induced neurological damage. indetoxifyingopiateaddicts.Iran.J.Psychiatry12,229–235.
Oxid.Med.Cell.Longev.2016:1543809. Jankowsky,J.L.,Derrick,B.E.,andPatterson,P.H.(2000).Cytokineresponses
Hileman,C.O.,andFunderburg,N.T.(2017).Inflammation,immuneactivation, toLTPinductionintherathippocampus:acomparisonofinvitroandinvivo
andantiretroviraltherapyinHIV.Curr.HIV/AIDSRep.14,93–100.doi:10. techniques.Learn.Mem.7,400–412.doi:10.1101/lm.32600
1007/s11904-017-0356-x Jastrzêbska,J.,Frankowska,M.,Suder,A.,Wydra,K.,Nowak,E.,Filip,M.,etal.
Hipólito,L.,Wilson-Poe,A.,Campos-Jurado,Y.,Zhong,E.,Gonzalez-Romero, (2017).Effectsofescitalopramandimipramineoncocainereinforcementand
J.,Virag,L.,etal.(2015).Inflammatorypainpromotesincreasedopioidself- drug-seekingbehaviorsinaratmodelofdepression.BrainRes.1673,30–41.
administration:roleofdysregulatedventraltegmentalareaµopioidreceptors. doi:10.1016/j.brainres.2017.07.016
J.Neurosci.35:12217.doi:10.1523/jneurosci.1053-15.2015 Kalra,R.,Singh,S.P.,Pena-Philippides,J.C.,Langley,R.J.,Razani-Boroujerdi,S.,
Hodebourg,R.,Murray,J.E.,Fouyssac,M.,Puaud,M.,Everitt,B.J.,andBelin, andSopori,M.L.(2004).Immunosuppressiveandanti-inflammatoryeffectsof
D.(2019).Heroinseekingbecomesdependentondorsalstriataldopaminergic nicotineadministeredbypatchinananimalmodel.Clin.Diagn.Lab.Immunol.
mechanismsandcanbedecreasedbyN-acetylcysteine.Eur.J.Neurosci.50, 11,563–568.doi:10.1128/cdli.11.3.563-568.2004
2036–2044.doi:10.1111/ejn.13894 Kalueff, A. V., Olivier, J. D. A., Nonkes, L. J. P., and Homberg, J. R.
Hodes, G. E., Kana, V., Menard, C., Merad, M., and Russo, S. J. (2015). (2010).Conservedrolefortheserotonintransportergeneinratandmouse
Neuroimmunemechanismsofdepression.Nat.Neurosci.18,1386–1393.doi: neurobehavioralendophenotypes.Neurosci.Biobehav.Rev.34,373–386.doi:
10.1038/nn.4113 10.1016/j.neubiorev.2009.08.003
Hodes,G.E.,Ménard,C.,andRusso,S.J.(2016).Integratinginterleukin-6into Karahanian,E.,Quintanilla,M.E.,Fernandez,K.,andIsrael,Y.(2014).Fenofibrate
depressiondiagnosisandtreatment.Neurobiol.Stress4,15–22.doi:10.1016/j. -Alipid-loweringdrug-reducesvoluntaryalcoholdrinkinginrats.Alcohol48,
ynstr.2016.03.003 665–670.doi:10.1016/j.alcohol.2014.08.004
Hodes,G.E.,Pfau,M.L.,Leboeuf,M.,Golden,S.A.,Christoffel,D.J.,Bregman,D., Karimi-Haghighi,S.,andHaghparast,A.(2018).Cannabidiolinhibitspriming-
etal.(2014).Individualdifferencesintheperipheralimmunesystempromote inducedreinstatementofmethamphetamineinREMsleepdeprivedrats.Prog.
resilienceversussusceptibilitytosocialstress.Proc.Natl.Acad.Sci.U.S.A.111, Neuro Psychopharmacol. Biol. Psychiatry 82, 307–313. doi: 10.1016/j.pnpbp.
16136–16141.doi:10.1073/pnas.1415191111 2017.08.022
FrontiersinNeuroscience|www.frontiersin.org 20 April2021|Volume15|Article650785

## Page 21

fnins-15-650785 April13,2021 Time:14:5 #21
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
Karimi-Haghighi, S., Dargahi, L., and Haghparast, A. (2020). Cannabidiol Kutlu,M.G.,Brady,L.J.,Peck,E.G.,Hofford,R.S.,Yorgason,J.T.,Siciliano,C.A.,
modulatestheexpressionofneuroinflammatoryfactorsinstress-anddrug- etal.(2018).Granulocytecolonystimulatingfactorenhancesrewardlearning
inducedreinstatementofmethamphetamineinextinguishedrats.Addict.Biol. throughpotentiationofmesolimbicdopaminesystemfunction.J.Neurosci.38,
25:e12740. 8845–8859.doi:10.1523/jneurosci.1116-18.2018
Karlsson, C., Schank, J. R., Rehman, F., Stojakovic, A., Björk, K., Barbier, E., Lacagnina,M.J.,Kopec,A.M.,Cox,S.S.,Hanamsagar,R.,Wells,C.,Slade,S.,
et al. (2017). Proinflammatory signaling regulates voluntary alcohol intake etal.(2017).OpioidSelf-administrationisattenuatedbyearly-lifeexperience
andstress-inducedconsumptionafterexposuretosocialdefeatstressinmice. and gene therapy for anti-inflammatory IL-10 in the nucleus Accumbens
Addict.Biol.22,1279–1288.doi:10.1111/adb.12416 of male rats. Neuropsychopharmacology 42, 2128–2140. doi: 10.1038/npp.
Kashima,D.T.,andGrueter,B.A.(2017).Toll-likereceptor4deficiencyalters 2017.82
nucleusaccumbenssynapticphysiologyanddrugrewardbehavior.Proc.Natl. LaCrosse, A. L., Hill, K., and Knackstedt, L. A. (2016). Ceftriaxone attenuates
Acad.Sci.U.S.A.114,8865–8870.doi:10.1073/pnas.1705974114 cocaine relapse after abstinence through modulation of nucleus accumbens
Kaur, B., and Prakash, A. (2017). Ceftriaxone attenuates glutamate-mediated AMPAsubunitexpression.Eur.Neuropsychopharmacol.26,186–194.doi:10.
neuro-inflammationandrestoresBDNFinMPTPmodelofParkinson’sdisease 1016/j.euroneuro.2015.12.022
inrats.Pathophysiology24,71–79.doi:10.1016/j.pathophys.2017.02.001 Lainiola,M.,andLinden,A.-M.(2017).Alcoholintakeintwodifferentmouse
Kesby,J.P.,Heaton,R.K.,Young,J.W.,Umlauf,A.,Woods,S.P.,Letendre,S.L., drinkingmodelsafterrecoveryfromthelipopolysaccharide-inducedsickness
etal.(2015a).MethamphetamineexposurecombinedwithHIV-1diseaseor reaction.Alcohol65,1–10.doi:10.1016/j.alcohol.2017.06.002
gp120expression:comparisonoflearningandexecutivefunctionsinhumans Lebourgeois,S.,González-Marín,M.C.,Jeanblanc,J.,Naassila,M.,andVilpoux,C.
andmice.Neuropsychopharmacology40,1899–1909.doi:10.1038/npp.2015.39 (2018).EffectofN-acetylcysteineonmotivation,seekingandrelapsetoethanol
Kesby,J.P.,Hubbard,D.T.,Markou,A.,andSemenova,S.(2014).Expression self-administration.Addict.Biol.23,643–652.doi:10.1111/adb.12521
of HIV gp120 protein increases sensitivity to the rewarding properties of Lee, B., Sur, B., Yeom, M., Shim, I., Lee, H., and Hahm, D. H. (2016). Effects
methamphetamineinmice.Addict.Biol.19,593–605.doi:10.1111/adb.12023 of systemic administration of ibuprofen on stress response in a rat model
Kesby,J.P.,Markou,A.,andSemenova,S.(2015b).Cognitivedeficitsassociated ofpost-traumaticstressdisorder.KoreanJ.Physiol.Pharmacol.20,357–366.
withcombinedHIVgp120expressionandchronicmethamphetamineexposure doi:10.4196/kjpp.2016.20.4.357
inmice.Eur.Neuropsychopharmacol.25,141–150.doi:10.1016/j.euroneuro. Lei,J.,Jin,L.,Zhao,Y.,Sui,M.Y.,Huang,L.,Tan,Y.X.,etal.(2011).Sex-related
2014.07.014 differences in descending norepinephrine and serotonin controls of spinal
Kesby,J.P.,Markou,A.,andSemenova,S.(2016).TheeffectsofHIV-1regulatory withdrawalreflexduringintramuscularsalineinducedmusclenociceptionin
TATproteinexpressiononbrainrewardfunction,responsetopsychostimulants rats.Exp.Neurol.228,206–214.doi:10.1016/j.expneurol.2011.01.004
anddelay-dependentmemoryinmice.Neuropharmacology109,205–215.doi: Levin,E.D.,Petro,A.,Rezvani,A.H.,Pollard,N.,Christopher,N.C.,Strauss,
10.1016/j.neuropharm.2016.06.011 M.,etal.(2009).Nicotinicα7-orβ2-containingreceptorknockout:effectson
Kesby,J.P.,Najera,J.A.,Romoli,B.,Fang,Y.,Basova,L.,Birmingham,A.,etal. radial-armmazelearningandlong-termnicotineconsumptioninmice.Behav.
(2017). HIV-1 TAT protein enhances sensitization to methamphetamine by BrainRes.196,207–213.doi:10.1016/j.bbr.2008.08.048
affectingdopaminergicfunction.Brain.Behav.Immun.65,210–221.doi:10. Levin, S. G., and Godukhin, O. V. (2017). Modulating effect of cytokines on
1016/j.bbi.2017.05.004 mechanismsofsynapticplasticityinthebrain.Biochemistry82,264–274.doi:
Kim,J.,Connelly,K.L.,Unterwald,E.M.,andRawls,S.M.(2017).Chemokines 10.1134/s000629791703004x
andcocaine:CXCR4receptorantagonistAMD3100attenuatescocaineplace Lewitus,G.M.,Konefal,S.C.,Greenhalgh,A.D.,Pribiag,H.,Augereau,K.,and
preferenceandlocomotorstimulationinrats.Brain.Behav.Immun.62,30–34. Stellwagen,D.(2016).MicroglialTNF-αSuppressesCocaine-InducedPlasticity
doi:10.1016/j.bbi.2016.08.015 andBehavioralSensitization.Neuron90,483–491.doi:10.1016/j.neuron.2016.
Knackstedt,L.A.,Melendez,R.I.,andKalivas,P.W.(2010).Ceftriaxonerestores 03.030
glutamatehomeostasisandpreventsrelapsetococaineseeking.Biol.Psychiatry Lewitus,G.M.,Pribiag,H.,Duseja,R.,St-Hilaire,M.,andStellwagen,D.(2014).
67,81–84.doi:10.1016/j.biopsych.2009.07.018 AnadaptiveroleofTNFαintheregulationofstriatalsynapses.J.Neurosci.34,
Knapska, E., and Kaczmarek, L. (2015). “Matrix metalloproteinase 9 (MMP-9) 6146–6155.doi:10.1523/jneurosci.3481-13.2014
inlearningandmemory,”inNovelMechanismsofMemory,edsK.P.Giese, Li,A.J.,Katafuchi,T.,Oda,S.,Hori,T.,andOomura,Y.(1997).Interleukin-6
andK.Radwanska(Cham:SpringerInternationalPublishing),161–181.doi: inhibitslong-termpotentiationinrathippocampalslices.BrainRes.748,30–38.
10.1007/978-3-319-24364-1_9 doi:10.1016/s0006-8993(96)01283-8
Knight,J.R.,Locke,G.R.,Zinsmeister,A.R.,Schleck,C.D.,andTalley,N.J. Li, Z.,You, Y., Griffin,N., Feng, J., and Shan, F. (2018).Low-dose naltrexone
(2015).Familyhistoryofmentalillnessoralcoholabuseandtheirritablebowel (LDN): a promising treatment in immune-related diseases and cancer
syndrome.J.Psychosom.Res.78,237–241.doi:10.1016/j.jpsychores.2014.11.021 therapy. Int. Immunopharmacol. 61, 178–184. doi: 10.1016/j.intimp.2018.
Köhler, O., Benros, E. M., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., 05.020
Mors,O.,etal.(2014).Effectofanti-inflammatorytreatmentondepression, Lippai,D.,Bala,S.,Csak,T.,Kurt-Jones,E.A.,andSzabo,G.(2013).Chronic
depressivesymptoms,andadverseeffectsasystematicreviewandmeta-analysis alcohol-inducedmicroRNA-155contributestoneuroinflammationinaTLR4-
ofrandomizedclinicaltrials.JAMAPsychiatry 71,1381–1391.doi:10.1001/ dependent manner in mice. PLoS One 8:e70945. doi: 10.1371/journal.pone.
jamapsychiatry.2014.1611 0070945
Koo,J.W.,andDuman,R.S.(2009).Interleukin-1receptornullmutantmiceshow Liston, A., Papadopoulou, A. S., Danso-Abeam, D., and Dooley, J. (2012).
decreasedanxiety-likebehaviorandenhancedfearmemory.Neurosci.Lett.456, MicroRNA-29intheadaptiveimmunesystem:settingthethreshold.Cell.Mol.
39–43.doi:10.1016/j.neulet.2009.03.068 LifeSci.69,3533–3541.doi:10.1007/s00018-012-1124-0
Koob, G. F., and Volkow, N. D. (2010). Neurocircuitry of addiction. Liu,H.,Leak,R.K.,andHu,X.(2016).Neurotransmitterreceptorsonmicroglia.
Neuropsychopharmacology35,217–238.doi:10.1038/npp.2009.110 StrokeVasc.Neurol.1,52–58.doi:10.1136/svn-2016-000012
Koob,G.F.,andVolkow,N.D.(2016).Neurobiologyofaddiction:aneurocircuitry Liu, J. J., Bin, W. Y., Strawbridge, R., Bao, Y., Chang, S., Shi, L., et al.
analysis.LancetPsychiatry3,760–773.doi:10.1016/s2215-0366(16)00104-8 (2020).Peripheralcytokinelevelsandresponsetoantidepressanttreatmentin
Krishnadas,R.,Nicol,A.,Sassarini,J.,Puri,N.,Burden,A.D.,Leman,J.,etal. depression:asystematicreviewandmeta-analysis.Mol.Psychiatry25,339–350.
(2016).Circulatingtumournecrosisfactorishighlycorrelatedwithbrainstem doi:10.1038/s41380-019-0474-5
serotonintransporteravailabilityinhumans.Brain.Behav.Immun.51,29–38. Liu, Q. F., Li, L., Guo, Y. Q., Li, X., Mou, Z. D., Wang, X., et al. (2016).
doi:10.1016/j.bbi.2015.08.005 InjectionofToll-likereceptor4siRNAintotheventrolateralperiaqueductal
Kuhn,B.N.,Kalivas,P.W.,andBobadilla,A.C.(2019).Understandingaddiction grayattenuateswithdrawalsyndromeinmorphine-dependentrats.Arch.Ital.
usinganimalmodels.Front.Behav.Neurosci.13:262.doi:10.3389/fnbeh.2019. Biol.154,133–142.doi:10.12871/00039829201644
00262 Liu, X., Chang, L., Vigorito, M., Kass, M., Li, H., and Chang, S. L. (2009).
Kumar,S.,Rao,P.S.S.,Earla,R.,andKumar,A.(2015).Drug-druginteractions Methamphetamine-inducedbehavioralsensitizationisenhancedintheHIV-
betweenanti-retroviraltherapiesanddrugsofabuseinHIVsystems.Expert 1transgenicrat.J.Neuroimmun.Pharmacol.4,309–316.doi:10.1007/s11481-
Opin.DrugMetab.Toxicol.11,343–355.doi:10.1517/17425255.2015.996546 009-9160-8
FrontiersinNeuroscience|www.frontiersin.org 21 April2021|Volume15|Article650785

## Page 22

fnins-15-650785 April13,2021 Time:14:5 #22
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
Liu, Y., Zhou, L.-J., Wang, J., Li, D., Ren, W.-J., Peng, J., et al. (2017). TNF- byasubsequentmethamphetamineexposure.J.Pharmacol.Exp.Ther.340,
differentiallyregulatessynapticplasticityinthehippocampusandspinalcord 295–303.doi:10.1124/jpet.111.188433
bymicroglia-dependentmechanismsafterperipheralnerveinjury.J.Neurosci. McIntosh, S., Sexton, T., Pattison, L. P., Childers, S. R., and Hemby, S. E.
37,871–881.doi:10.1523/jneurosci.2235-16.2016 (2015).Increasedsensitivitytococaineself-administrationinHIV-1transgenic
LoIacono,L.,Catale,C.,Martini,A.,Valzania,A.,Viscomi,M.T.,Chiurchiù,V., rats is associated with changes in striatal dopamine transporter binding.
etal.(2018).Fromtraumaticchildhoodtococaineabuse:thecriticalfunctionof J.Neuroimmun.Pharmacol.10,493–505.doi:10.1007/s11481-015-9594-0
theimmunesystem.Biol.Psychiatry84,905–916.doi:10.1016/j.biopsych.2018. McLaurin, K. A., Booze, R. M., and Mactutus, C. F. (2018). Evolution of the
05.022 HIV-1transgenicrat:utilityinassessingtheprogressionofHIV-1-associated
Logrip,M.L.(2015).Phosphodiesteraseregulationofalcoholdrinkinginrodents. neurocognitivedisorders.J.Neurovirol.24,229–245.doi:10.1007/s13365-017-
Alcohol49,795–802.doi:10.1016/j.alcohol.2015.03.007 0544-x
Loscher,C.E.,Mills,K.H.G.,andLynch,M.A.(2003).Interleukin-1receptor Menard,C.,Pfau,M.L.,Hodes,G.E.,Kana,V.,Wang,V.X.,Bouchard,S.,etal.
antagonist exerts agonist activity in the hippocampus independent of the (2017).Socialstressinducesneurovascularpathologypromotingdepression.
interleukin-1typeIreceptor.J.Neuroimmunol.137,117–124.doi:10.1016/ Nat.Neurosci.20,1752–1760.doi:10.1038/s41593-017-0010-3
s0165-5728(03)00072-9 Metz, V. E., Jones, J. D., Manubay, J., Sullivan, M. A., Mogali, S., Segoshi, A.,
Lu,Y.,Ho,C.S.,Liu,X.,Chua,A.N.,Wang,W.,McIntyre,R.S.,etal.(2017). etal.(2017).Effectsofibudilastonthesubjective,reinforcing,andanalgesic
Chronicadministrationoffluoxetineandpro-inflammatorycytokinechangein effects of oxycodone in recently detoxified adults with opioid dependence.
aratmodelofdepression.PLoSOne12:e0186700.doi:10.1371/journal.pone. Neuropsychopharmacology42,1825–1832.doi:10.1038/npp.2017.70
0186700 Miguel-Hidalgo,J.J.(2009).Theroleofglialcellsindrugabuse.Curr.DrugAbuse
Lykhmus,O.,Voytenko,L.,Koval,L.,Mykhalskiy,S.,Kholin,V.,Peschana,K., Rev.2,76–82.doi:10.2174/1874473710902010076
et al. (2015). α7 nicotinic acetylcholine receptor-specific antibody induces Mihalak,K.B.,Carroll,F.I.,andLuetje,C.W.(2006).Vareniclineisapartial
inflammationandamyloidβ42accumulationinthemousebrainto impair agonist at α4β2 and a full agonist at α7 neuronal nicotinic receptors. Mol.
memory.PLoSOne10:e0122706.doi:10.1371/journal.pone.0122706 Pharmacol.70,801–805.doi:10.1124/mol.106.025130
Lynch,W.J.,Nicholson,K.L.,Dance,M.E.,Morgan,R.W.,andFoley,P.L.(2010). Mizoguchi, H., Yamada, K., Mouri, A., Niwa, M., Mizuno, T., Noda, Y., et al.
Animal models of substance abuse and addiction: implications for science, (2007). Role of matrix metalloproteinase and tissue inhibitor of MMP in
animalwelfare,andsociety.Compar.Med.60,177–188. methamphetamine-inducedbehavioralsensitizationandreward:implications
MacHado, I., González, P., Schiöth, H. B., Lasaga, M., and Scimonelli, T. N. fordopaminereceptordown-regulationanddopaminerelease.J.Neurochem.
(2010).α-Melanocyte-stimulatinghormone(α-MSH)reversesimpairmentof 102,1548–1560.
memoryreconsolidationinducedbyinterleukin-1beta(IL-1beta)hippocampal Mogil, J. S. (2012). Sex differences in pain and pain inhibition: multiple
infusions.Peptides31,2141–2144.doi:10.1016/j.peptides.2010.07.018 explanationsofacontroversialphenomenon.Nat.Rev.Neurosci.13,859–866.
Macnamara,C.L.,Holmes,N.M.,Westbrook,R.F.,andClemens,K.J.(2016). doi:10.1038/nrn3360
Varenicline impairs extinction and enhances reinstatement across repeated Monnig,M.A.(2017).Immuneactivationandneuroinflammationinalcoholuse
cyclesofnicotineself-administrationinrats.Neuropharmacology105,463–470. andHIVinfection:evidenceforsharedmechanisms.Am.J.DrugAlcoholAbuse
doi:10.1016/j.neuropharm.2016.02.023 43,7–23.doi:10.1080/00952990.2016.1211667
Magalhães, P. V., Dean, O. M., Bush, A. I., Copolov, D. L., Malhi, G. S., Montesinos,J.,Gil,A.,andGuerri,C.(2017).Nalmefenepreventsalcohol-induced
Kohlmann,K.K.,etal.(2011).acetylcysteineformajordepressiveepisodes neuroinflammationandalcoholdrinkingpreferenceinadolescentfemalemice:
in bipolar disorder. Rev. Bras. Psiquiatr. 33, 374–378. doi: 10.1590/s1516- roleofTLR4.Alcohol.Clin.Exp.Res.41,1257–1270.doi:10.1111/acer.13416
44462011000400011 Montesinos, J., Pascual, M., Millán-Esteban, D., and Guerri, C. (2018). Binge-
Mapplebeck, J. C. S., Dalgarno, R., Tu, Y., Moriarty, O., Beggs, S., Kwok, likeethanoltreatmentinadolescenceimpairsautophagyandhinderssynaptic
C.H.T.,etal.(2018).MicroglialP2X4R-evokedpainhypersensitivityissexually maturation:roleofTLR4.Neurosci.Lett.682,85–91.doi:10.1016/j.neulet.2018.
dimorphicinrats.Pain159,1752–1763.doi:10.1097/j.pain.0000000000001265 05.049
Marchand,F.,Perretti,M.,andMcMahon,S.B.(2005).Roleoftheimmunesystem Montesinos,J.,Pascual,M.,Pla,A.,Maldonado,C.,Rodríguez-Arias,M.,Miñarro,
inchronicpain.Nat.Rev.Neurosci.6,521–532.doi:10.1038/nrn1700 J.,etal.(2015).TLR4eliminationpreventssynapticandmyelinalterationsand
Markoutsa,E.,andXu,P.(2017).RedoxPotential-SensitiveN-Acetylcysteine- long-termcognitivedysfunctionsinadolescentmicewithintermittentethanol
prodrugnanoparticlesinhibittheactivationofmicrogliaandimproveneuronal treatment.Brain.Behav.Immun.45,233–244.doi:10.1016/j.bbi.2014.11.015
survival. Mol. Pharm. 14, 1591–1600. doi: 10.1021/acs.molpharmaceut.6b0 Montesinos, J., Pascual, M., Rodríguez-Arias, M., Miñarro, J., and Guerri, C.
1028 (2016).InvolvementofTLR4inthelong-termepigeneticchanges,rewarding
Marshall,S.A.,Casachahua,J.D.,Rinker,J.A.,Blose,A.K.,Lysle,D.T.,andThiele, andanxietyeffectsinducedbyintermittentethanoltreatmentinadolescence.
T. E. (2016). IL-1 receptor signaling in the basolateral amygdala modulates Brain.Behav.Immun.53,159–171.doi:10.1016/j.bbi.2015.12.006
binge-likeethanolconsumptioninmaleC57BL/6Jmice.Brain.Behav.Immun. Moore,A.H.,Wu,M.,Shaftel,S.S.,Graham,K.A.,andO’Banion,M.K.(2009).
51,258–267.doi:10.1016/j.bbi.2015.09.006 Sustainedexpressionofinterleukin-1βinmousehippocampusimpairsspatial
Mattson,C.L.,Tanz,L.J.,Quinn,K.,Kariisa,M.,Patel,P.,andDavis,N.L.(2021). memory. Neuroscience 164, 1484–1495. doi: 10.1016/j.neuroscience.2009.08.
Trendsandgeographicpatternsindrugandsyntheticopioidoverdosedeaths— 073
UnitedStates,2013-2019.MMWRMorb.Mortal.Wkly.Rep.70,202–207.doi: Moran, L. M., Booze, R. M., and Mactutus, C. F. (2014). Modeling deficits in
10.15585/mmwr.mm7006a4 attention,inhibition,andflexibilityinHAND.J.NeuroimmunePharmacol.9,
Maza-Quiroga,R.,García-Marchena,N.,Romero-Sanchiz,P.,Barrios,V.,Pedraz, 508–521.doi:10.1007/s11481-014-9539-z
M.,Serrano,A.,etal.(2017).Evaluationofplasmacytokinesinpatientswith Moran,M.M.,McFarland,K.,Melendez,R.I.,Kalivas,P.W.,andSeamans,J.K.
cocaineusedisordersinabstinenceidentifiestransforminggrowthfactoralpha (2005).Cystine/glutamateexchangeregulatesmetabotropicglutamatereceptor
(tgfα) as a potential biomarker of consumption and dual diagnosis. PeerJ presynapticinhibitionofexcitatorytransmissionandvulnerabilitytococaine
5:e3926.doi:10.7717/peerj.3926 seeking.J.Neurosci.25,6389–6393.doi:10.1523/jneurosci.1007-05.2005
McBrien, H., Luo, C., Sanger, N., Zielinski, L., Bhatt, M., Zhu, X. M., et al. Moreira,F.P.,Medeiros,J.R.C.,Lhullier,A.C.,Souza,L.D.,de,M.,Jansen,K.,
(2019).Cannabisuseduringmethadonemaintenancetreatmentforopioiduse etal.(2016).CocaineabuseandeffectsintheserumlevelsofcytokinesIL-6and
disorder:asystematicreviewandmeta-analysis.C.Open7,E665–E673. IL-10.DrugAlcoholDepend.158,181–185.doi:10.1016/j.drugalcdep.2015.11.
McCarthy,M.M.(2019).Sexdifferencesinneuroimmunityasaninherentrisk 024
factor.Neuropsychopharmacology44,38–44.doi:10.1038/s41386-018-0138-1 Morris,G.,Reiche,E.M.V.,Murru,A.,Carvalho,A.F.,Maes,M.,Berk,M.,etal.
McFadden, L. M., Hadlock, G. C., Allen, S. C., Vieira-Brock, P. L., Stout, (2018). Multiple immune-inflammatory and oxidative and nitrosative stress
K.A.,Ellis,J.D.,etal.(2012).Methamphetamineself-administrationcauses pathwaysexplainthefrequentpresenceofdepressioninmultiplesclerosis.Mol.
persistentstriataldopaminergicalterationsandmitigatesthedeficitscaused Neurobiol.55,6282–6306.doi:10.1007/s12035-017-0843-5
FrontiersinNeuroscience|www.frontiersin.org 22 April2021|Volume15|Article650785

## Page 23

fnins-15-650785 April13,2021 Time:14:5 #23
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
Moussawi, K., Pacchioni, A., Moran, M., Olive, M. F., Gass, J. T., Lavin, A., Nolan, R., and Gaskill, P. J. (2019). The role of catecholamines in HIV
et al. (2009). N-Acetylcysteine reverses cocaine-induced metaplasticity. Nat. neuropathogenesis.BrainRes.1702,54–73.doi:10.1016/j.brainres.2018.04.030
Neurosci.12,182–189.doi:10.1038/nn.2250 Northcutt, A. L., Hutchinson, M. R., Wang, X., Baratta, M. V., Hiranita,
Muhie,S.,Gautam,A.,Chakraborty,N.,Hoke,A.,Meyerhoff,J.,Hammamieh, T., Cochran, T. A., et al. (2015). DAT isn’t all that: cocaine reward and
R.,etal.(2017).Molecularindicatorsofstress-inducedneuroinflammationin reinforcementrequireToll-likereceptor4signaling.Mol.Psychiatry20,1525–
amousemodelsimulatingfeaturesofpost-traumaticstressdisorder.Transl. 1537.doi:10.1038/mp.2014.177
Psychiatry7:e1135.doi:10.1038/tp.2017.91 Northrop,N.A.,andYamamoto,B.K.(2015).Methamphetamineeffectsonblood-
Mulligan, M. K., Ponomarev, I., Hitzemann, R. J., Belknap, J. K., Tabakoff, B., brainbarrierstructureandfunction.Front.Neurosci.9:69.doi:10.3389/fnins.
Harris, R. A., et al. (2006). Toward understanding the genetics of alcohol 2015.00069
drinkingthroughtranscriptomemeta-analysis.Proc.Natl.Acad.Sci.U.S.A.103, O’Brien,S.M.,Scully,P.,Fitzgerald,P.,Scott,L.V.,andDinan,T.G.(2007).
6368–6373.doi:10.1073/pnas.0510188103 Plasmacytokineprofilesindepressedpatientswhofailtorespondtoselective
Murray, C. L., Obiang, P., Bannerman, D., and Cunningham, C. (2013). serotoninreuptakeinhibitortherapy.J.Psychiatr.Res.41,326–331.doi:10.
EndogenousIL-1incognitivefunctionandanxiety:astudyinIL-1RI-/-mice. 1016/j.jpsychires.2006.05.013
PLoSOne8:e78385.doi:10.1371/journal.pone.0078385 O’Sullivan,S.J.,Malahias,E.,Park,J.,Srivastava,A.,Reyes,B.A.S.,Gorky,J.,etal.
Murrough,J.W.,Iosifescu,D.V.,Chang,L.C.,AlJurdi,R.K.,Green,C.E.,Perez, (2019).Single-Cellgliaandneurongeneexpressioninthecentralamygdalain
A.M.,etal.(2013).Antidepressantefficacyofketamineintreatment-resistant opioidwithdrawalsuggestsinflammationwithcorrelatedgutDysbiosis.Front.
majordepression:atwo-siterandomizedcontrolledtrial.Am.J.Psychiatry170, Neurosci.13:665.doi:10.3389/fnins.2019.00665
1134–1142.doi:10.1176/appi.ajp.2013.13030392 Ochoa-Aguilar,A.,Ventura-Martinez,R.,Sotomayor-Sobrino,M.A.,Jaimez,R.,
Murugan,M.,Sivakumar,V.,Lu,J.,Ling,E.A.,andKaur,C.(2011).Expression Coffeen, U., Jiménez-González, A., et al. (2018). Ceftriaxone and clavulanic
ofN-methylD-aspartatereceptorsubunitsinamoeboid microgliamediates acid induce antiallodynia and anti-inflammatory effects in rats using the
productionofnitricoxideviaNF-κBsignalingpathwayandoligodendrocyte carrageenanmodel.J.PainRes.11,977–985.doi:10.2147/jpr.s154661
celldeathinhypoxicpostnatalrats.Glia59,521–539.doi:10.1002/glia.21121 Olfson,M.,Wall,M.M.,Liu,S.-M.,andBlanco,C.(2018).Cannabisuseandrisk
Namba, M. D., Kupchik, Y. M., Spencer, S. M., Garcia Keller, C., Goenaga, ofprescriptionopioidusedisorderintheUnitedStates.Am.J.Psychiatry175,
J. G., Powell, G. L., et al. (2019). Accumbens neuroimmune signaling and 47–53.doi:10.1176/appi.ajp.2017.17040413
dysregulationofastrocyticglutamatetransportunderlieconditionednicotine Oliver,C.F.,Simmons,S.J.,Nayak,S.U.,Smith,G.R.,Reitz,A.B.,andRawls,
seeking.Addict.Biol.25:e12797. S.M.(2018).Chemokinesand‘bathsalts’:CXCR4receptorantagonistreduces
Namba,M.D.,Tomek,S.E.,Olive,M.F.,Beckmann,J.S.,andGipson,C.D.(2018). rewardingandlocomotor-stimulanteffectsofthedesignercathinoneMDPVin
The winding road to relapse: forging a new understanding of cue-induced rats.DrugAlcoholDepend.186,75–79.doi:10.1016/j.drugalcdep.2018.01.013
reinstatementmodelsandtheirassociatedneuralmechanisms.Front.Behav. Orio, L. (2020). The multifaceted potential of the lipid transmitter
Neurosci.12:17.doi:10.3389/fnbeh.2018.00017 oleoylethanolamidetotreatalcohol-inducedneuroinflammationandalcohol
National Institute on Drug Abuse [NIDA] (2012). Who Is at Risk for HIV usedisorders.NeuralRegen.Res.15,71–72.doi:10.4103/1673-5374.264457
Infection and Which Populations Are Most Affected?. Available online at: Orio, L., Alen, F., Pavón, F. J., Serrano, A., and García-Bueno, B. (2019).
https://www.drugabuse.gov/publications/research-reports/hivaids/who-risk- Oleoylethanolamide, neuroinflammation, and alcohol abuse. Front. Mol.
hiv-infection-which-populations-are-most-affected(accessedJune28,2019). Neurosci.11:490.doi:10.3389/fnmol.2018.00490
National Institute on Drug Abuse [NIDA] (2020a). Common Comorbidities Osborne, B. F., Turano, A., and Schwarz, J. M. (2018). Sex differences in the
with Substance Use Disorders. Available online at: https://www.drugabuse. neuroimmune system. Curr. Opin. Behav. Sci. 23, 118–123. doi: 10.1016/j.
gov/publications/research-reports/common-comorbidities-substance- cobeha.2018.05.007
use-disorders/part-2-co-occurring-substance-use-disorder-physical- Packiasabapathy,S.,andSadhasivam,S.(2018).Gender,genetics,andanalgesia:
comorbidities(accessedApril2,2020). understandingthedifferencesinresponsetopainrelief.J.PainRes.11,2729–
NationalInstituteonDrugAbuse[NIDA](2020b).HowEffectiveisDrugAddiction 2739.doi:10.2147/jpr.s94650
Treatment?. Available online at: https://www.drugabuse.gov/publications/ Pandey,S.C.(2004).ThegenetranscriptionfactorcyclicAMP-responsiveelement
principles-drug-addiction-treatment-research-based-guide-third-edition/ binding protein: role in positive and negative affective states of alcohol
frequently-asked-questions/how-effective-drug-addiction-treatment addiction.Pharmacol.Therap.104,47–58.doi:10.1016/j.pharmthera.2004.08.
(accessedMay7,2020). 002
National Institute on Drug Abuse [NIDA] (2020c). Opioid Overdose Crisis. Paris,J.J.,Carey,A.N.,Shay,C.F.,Gomes,S.M.,He,J.J.,andMcLaughlin,
Available online at: https://www.drugabuse.gov/drugs-abuse/opioids/opioid- J.P.(2014).EffectsofconditionalcentralexpressionofHIV-1tatproteinto
overdose-crisis#six(accessedApril19,2020). potentiatecocaine-mediatedpsychostimulationandrewardamongmalemice.
NationalInstituteonDrugAbuse[NIDA](2020d).Trends&Statistics.Available Neuropsychopharmacology39,380–388.doi:10.1038/npp.2013.201
onlineat:https://www.drugabuse.gov/related-topics/trends-statistics(accessed Paris, J. J., Fenwick, J., and McLaughlin, J. P. (2014). Estrous cycle and HIV-
May7,2020). 1 Tat protein influence cocaine-conditioned place preference and induced
NationalInstituteonDrugAbuse[NIDA](2021).OverdoseDeathRates.Available locomotion of female mice. Curr. HIV Res. 12, 388–396. doi: 10.2174/
online at: https://www.drugabuse.gov/drug-topics/trends-statistics/overdose- 1570162x13666150121105221
death-rates(accessedMarch15,2021). Passos, I. C., Vasconcelos-Moreno, M. P., Costa, L. G., Kunz, M., Brietzke, E.,
Nayak, S. U., Cicalese, S., Tallarida, C., Oliver, C. F., and Rawls, S. M. (2020). Quevedo, J., et al. (2015). Inflammatory markers in post-traumatic stress
Chemokine CCR5 and cocaine interactions in the brain: cocaine enhances disorder: A systematic review, meta-analysis, and meta-regression. Lancet
mesolimbicCCR5mRNAlevelsandproducesplacepreferenceandlocomotor Psychiatry2,1002–1012.doi:10.1016/s2215-0366(15)00309-0
activationthatarereducedbyaCCR5antagonist.Brain.Behav.Immun.83, Patel, H., McIntire, J., Ryan, S., Dunah, A., and Loring, R. (2017). Anti-
288–292.doi:10.1016/j.bbi.2019.09.017 inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are
Neupane,S.P.(2016).Neuroimmuneinterfaceinthecomorbiditybetweenalcohol mediated by inhibition of the NF-κB pathway and activation of the Nrf2
usedisorderandmajordepression.Front.Immunol.7:655.doi:10.3389/fimmu. pathway.J.Neuroinflamm.14,192.
2016.00655 Patten,D.K.,Schultz,B.G.,andBerlau,D.J.(2018).Thesafetyandefficacyof
Nichols, J. M., and Kaplan, B. L. F. (2020). Immune responses regulated by low-dose naltrexone in the management of chronic pain and inflammation
Cannabidiol.CannabisCannabinoidRes.5,12–31.doi:10.1089/can.2018.0073 in multiple sclerosis, fibromyalgia, crohn’s disease, and other chronic pain
Nolan, R. A., Reeb, K. L., Rong, Y., Matt, S. M., Johnson, H. S., Runner, K., disorders. Pharmacother. J. Hum. Pharmacol. Drug Ther. 38, 382–389. doi:
etal.(2020).DopamineactivatesNF-κBandprimestheNLRP3inflammasome 10.1002/phar.2086
inprimaryhumanmacrophages.Brain,Behav.Immun.Heal.2:100030.doi: Paydary,K.,MahinTorabi,S.,SeyedAlinaghi,S.,Noori,M.,Noroozi,A.,Ameri,S.,
10.1016/j.bbih.2019.100030 etal.(2016).Impulsivity,sensationseeking,andrisk-takingbehaviorsamong
FrontiersinNeuroscience|www.frontiersin.org 23 April2021|Volume15|Article650785

## Page 24

fnins-15-650785 April13,2021 Time:14:5 #24
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
hiv-positive and HIV-negative heroin dependent persons. AIDS Res. Treat. Romero-Sandoval, E. A., Kolano, A. L., and Alvarado-Vázquez, P. A. (2017).
2016,1–8.doi:10.1155/2016/5323256 Cannabisandcannabinoidsforchronicpain.Curr.Rheumatol.Rep.19,1–10.
Pedraz, M., Araos, P., García-Marchena, N., Serrano, A., Romero-Sanchiz, P., doi:10.1159/000489029
Suárez,J.,etal.(2015).Sexdifferencesinpsychiatriccomorbidityandplasma Rosen,S.F.,Ham,B.,Haichin,M.,Walters,I.C.,Tohyama,S.,Sotocinal,S.G.,
biomarkers for cocaine addiction in abstinent cocaine-addicted subjects in etal.(2019).IncreasedpainsensitivityanddecreasedopioidanalgesiainT-cell-
outpatientsettings.Front.Psychiatry6:17.doi:10.3389/fpsyt.2015.00017 deficient mice and implications for sex differences. Pain 160, 358–366. doi:
Perea,G.,Sur,M.,andAraque,A.(2014).Neuron-glianetworks:integralgearof 10.1097/j.pain.0000000000001420
brainfunction.Front.Cell.Neurosci.8:378.doi:10.3389/fncel.2014.00378 Rosen,S.,Ham,B.,andMogil,J.S.(2017).Sexdifferencesinneuroimmunityand
Pianca, T. G., Rosa, R. L., Ceresér, K. M. M., de Aguiar, B. W., de Abrahão, pain.J.Neurosci.Res.95,500–508.doi:10.1002/jnr.23831
R.C.,Lazzari,P.M.,etal.(2017).Differencesinbiomarkersofcrack-cocaine Ross,F.M.,Allan,S.M.,Rothwell,N.J.,andVerkhratsky,A.(2003).Adualrole
adolescentusersbefore/afterabstinence.DrugAlcoholDepend.177,207–213. forinterleukin-1inLTPinmousehippocampalslices.J.Neuroimmunol.144,
doi:10.1016/j.drugalcdep.2017.03.043 61–67.doi:10.1016/j.jneuroim.2003.08.030
Pickens,C.L.,Airavaara,M.,Theberge,F.,Fanous,S.,Hope,B.T.,andShaham, Rubin, L. H., Sacktor, N., Creighton, J., Du, Y., Endres, C. J., Pomper, M. G.,
Y.(2011).Neurobiologyoftheincubationofdrugcraving.TrendsNeurosci.34, et al. (2018). Microglial activation is inversely associated with cognition in
411–420.doi:10.1016/j.tins.2011.06.001 individualslivingwithHIVoneffectiveantiretroviraltherapy.AIDS32,1661–
Plein,L.M.,andRittner,H.L.(2018).Opioidsandtheimmunesystem-friendor 1667.doi:10.1097/qad.0000000000001858
foe.Br.J.Pharmacol.175,2717–2725.doi:10.1111/bph.13750 Sahu,G.,Farley,K.,El-Hage,N.,Aiamkitsumrit,B.,Fassnacht,R.,Kashanchi,F.,
Porasuphatana, S., Weaver, J., and Rosen, G. M. (2006). Inducible nitric etal.(2015).CocainepromotesbothinitiationandelongationphaseofHIV-1
oxide synthase catalyzes ethanol oxidation to α-hydroxyethyl radical and transcriptionbyactivatingNF-κBandMSK1andinducingselectiveepigenetic
acetaldehyde.Toxicology223,167–174.doi:10.1016/j.tox.2006.02.022 modificationsatHIV-1LTR.Virology483,185–202.doi:10.1016/j.virol.2015.
Posillico,C.K.,Terasaki,L.S.,Bilbo,S.D.,andSchwarz,J.M.(2015).Examination 03.036
ofsexandminocyclinetreatmentonacutemorphine-inducedanalgesiaand Saito,T.,Lee,J.M.,Hoffman,P.L.,andTabakoff,B.(1987).Effectsofchronic
inflammatorygeneexpressionalongthepainpathwayinSprague-Dawleyrats. ethanol treatment on the β-adrenergic receptor-coupled adenylate cyclase
Biol.SexDiffer.6,1–12. systemofmousecerebralcortex.J.Neurochem.48,1817–1822.doi:10.1111/
Powell,G.L.,Leyrer-Jackson,J.M.,Goenaga,J.,Namba,M.D.,Piña,J.,Spencer, j.1471-4159.1987.tb05741.x
S.,etal.(2019).ChronictreatmentwithN-acetylcysteinedecreasesextinction Samikkannu,T.,Ranjith,D.,Rao,K.V.K.,Atluri,V.S.R.,Pimentel,E.,El-Hage,
respondingandreducescue-inducednicotine-seeking.Physiol.Rep.7:e13958. N.,etal.(2015).HIV-1gp120andmorphineinducedoxidativestress:rolein
doi:10.14814/phy2.13958 cellcycleregulation.Front.Microbiol.6:614.doi:10.3389/fmicb.2015.00614
Prakash,M.D.,Tangalakis,K.,Antonipillai,J.,Stojanovska,L.,Nurgali,K.,and Sanchez-Alavez, M., Nguyen, W., Mori, S., Wills, D. N., Otero, D., Ehlers,
Apostolopoulos,V.(2017).Methamphetamine:effectsonthebrain,gutand C. L., et al. (2019). Time course of microglia activation and brain and
immunesystem.Pharmacol.Res.120,60–67.doi:10.1016/j.phrs.2017.03.009 blood cytokine/chemokine levels following chronic ethanol exposure and
Qin,L.,andCrews,F.T.(2012).NADPHoxidaseandreactiveoxygenspecies protractedwithdrawalinrats.Alcohol76,37–45.doi:10.1016/j.alcohol.2018.
contribute to alcohol-induced microglial activation and neurodegeneration. 07.005
J.Neuroinflamm.9:5. Saravia,R.,Ten-Blanco,M.,Grande,M.T.,Maldonado,R.,andBerrendero,F.
Qin,L.,He,J.,Hanes,R.N.,Pluzarev,O.,Hong,J.S.,andCrews,F.T.(2008). (2019).Anti-inflammatoryagentsforsmokingcessation?Focusoncognitive
Increasedsystemicandbraincytokineproductionandneuroinflammationby deficitsassociatedwithnicotinewithdrawalinmalemice.Brain.Behav.Immun.
endotoxinfollowingethanoltreatment.J.Neuroinflamm.5:10.doi:10.1186/ 75,228–239.doi:10.1016/j.bbi.2018.11.003
1742-2094-5-10 Schneider,H.,Pitossi,F.,Balschun,D.,Wagner,A.,DelRey,A.,andBesedovsky,
Qin,Z.,Wang,P.Y.,Su,D.F.,andLiu,X.(2016).miRNA-124inimmunesystem H.O.(1998).Aneuromodulatoryroleofinterleukin-1βinthehippocampus.
andimmunedisorders.Front.Immunol.7:406.doi:10.3389/fimmu.2016.00406 Proc.Natl.Acad.Sci.U.S.A.95,7778–7783.doi:10.1073/pnas.95.13.7778
Qrunfleh, A. M., Alazizi, A., and Sari, Y. (2013). Ceftriaxone, a beta- Schneider,R.,Bandiera,S.,Souza,D.G.,Bellaver,B.,Caletti,G.,Quincozes-Santos,
lactam antibiotic, attenuates relapse-like ethanol-drinking behavior A.,etal.(2017).acetylcysteinepreventsalcoholrelatedneuroinflammationin
in alcohol-preferring rats. J. Psychopharmacol. 27, 541–549. doi: rats.Neurochem.Res.42,2135–2141.doi:10.1007/s11064-017-2218-8
10.1177/0269881113482529 Scholl,L.,Seth,P.,Kariisa,M.,Wilson,N.,andBaldwin,G.(2018).Drugand
Quintanilla,M.E.,Morales,P.,Ezquer,F.,Ezquer,M.,Herrera-Marschitz,M.,and opioid-involvedoverdosedeaths-UnitedStates,2013-2017.MMWRMorb.
Israel,Y.(2021).AdministrationofN-acetylcysteinePlusacetylsalicylicacid Mortal.Wkly.Rep.67,1419–1427.
markedlyinhibitsnicotinereinstatementfollowingchronicoralnicotineintake Schwendt,M.,Shallcross,J.,Hadad,N.A.,Namba,M.D.,Hiller,H.,Wu,L.,etal.
infemalerats.Front.Behav.Neurosci.14:617418. (2018).novelratmodelofcomorbidPTSDandaddictionrevealsintersections
Raison,C.L.,Rutherford,R.E.,Woolwine,B.J.,Shuo,C.,Schettler,P.,Drake,D.F., between stress susceptibility and enhanced cocaine seeking with a role for
etal.(2013).randomizedcontrolledtrialofthetumornecrosisfactorantagonist mGlu5receptors.Transl.Psychiatry8:209.
infliximabfortreatment-resistantdepression:theroleofbaselineinflammatory Scofield,M.D.,Li,H.,Siemsen,B.M.,Healey,K.L.,Tran,P.K.,Woronoff,N.,
biomarkers. Arch. Gen. Psychiatry 70, 31–41. doi: 10.1001/2013.jamapsychia etal.(2016).CocaineSelf-administrationandextinctionleadstoreducedglial
try.4 fibrillary acidic protein expression and morphometric features of astrocytes
Reissner,K.J.,Gipson,C.D.,Tran,P.K.,Knackstedt,L.A.,Scofield,M.D.,and inthenucleusaccumbenscore.Biol.Psychiatry80,207–215.doi:10.1016/j.
Kalivas,P.W.(2015).GlutamatetransporterGLT-1mediatesN-acetylcysteine biopsych.2015.12.022
inhibitionofcocainereinstatement.Addict.Biol.20,316–323.doi:10.1111/adb. Sekine,Y.,Minabe,Y.,Ouchi,Y.,Takei,N.,Iyo,M.,Nakamura,K.,etal.(2003).
12127 Associationofdopaminetransporterlossintheorbitofrontalanddorsolateral
Rivera, P. D., Hanamsagar, R., Kan, M. J., Tran, P. K., Stewart, D., Jo, Y. C., prefrontalcorticeswithmethamphetamine-relatedpsychiatricsymptoms.Am.
etal.(2019).Removalofmicroglial-specificMyD88signalingaltersdentate J.Psychiatry160,1699–1701.doi:10.1176/appi.ajp.160.9.1699
gyrusdoublecortinandenhancesopioidaddiction-likebehaviors.Brain.Behav. Serdarevic, M., Striley, C. W., and Cottler, L. B. (2017). Sex differences in
Immun.76,104–115.doi:10.1016/j.bbi.2018.11.010 prescriptionopioiduse.Curr.Opin.Psychiatry30,238–246.doi:10.1097/yco.
Rodríguez-Arias, M., Montagud-Romero, S., Rubio-Araiz, A., Aguilar, M. A., 0000000000000337
Martín-García,E.,Cabrera,R.,etal.(2017).Effectsofrepeatedsocialdefeaton Shah,A.,Kumar,S.,Simon,S.D.,Singh,D.P.,andKumar,A.(2013).HIVgp120-
adolescentmiceoncocaine-inducedCPPandself-administrationinadulthood: andmethamphetamine-mediatedoxidativestressinducesastrocyteapoptosis
integrityoftheblood-brainbarrier.Addict.Biol.22,129–141.doi:10.1111/adb. viacytochromeP4502E1.CellDeathDis.4,e850–e850.
12301 Shytle,R.D.,Mori,T.,Townsend,K.,Vendrame,M.,Sun,N.,Zeng,J.,etal.(2004).
Roederer,M.,Ela,S.W.,Staal,F.J.T.,Herzenberg,L.A.,andHerzenberg,L.A. Cholinergic modulation of microglial activation by α7 nicotinic receptors.
(1992)..AIDSRes.Hum.Retroviruses8,209–217. J.Neurochem.89,337–343.doi:10.1046/j.1471-4159.2004.02347.x
FrontiersinNeuroscience|www.frontiersin.org 24 April2021|Volume15|Article650785

## Page 25

fnins-15-650785 April13,2021 Time:14:5 #25
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
Siemsen,B.M.,Landin,J.D.,McFaddin,J.A.,Hooker,K.N.,Chandler,L.J.,and Tancredi,V.,D’Antuono,M.,Cafè,C.,Giovedì,S.,Buè,M.C.,D’Arcangelo,G.,
Scofield,M.D.(2020).Chronicintermittentethanolandlipopolysaccharide etal.(2002).Theinhibitoryeffectsofinterleukin-6onsynapticplasticityin
exposure differentially alter Iba1-derived microglia morphology in the therathippocampusareassociatedwithaninhibitionofmitogen-activated
prelimbic cortex and nucleus accumbens core of male Long-Evans rats. proteinkinaseERK.J.Neurochem.75,634–643.doi:10.1046/j.1471-4159.2000.
J.Neurosci.Res.doi:10.1002/jnr.24683[Epubaheadofprint]. 0750634.x
Singh,R.K.,Chang,H.W.,Yan,D.,Lee,K.M.,Ucmak,D.,Wong,K.,etal.(2017). Tawfik,D.I.,Osman,A.S.,Tolba,H.M.,Khattab,A.,Abdel-Salam,L.O.,and
Influenceofdietonthegutmicrobiomeandimplicationsforhumanhealth. Kamel,M.M.(2016).Evaluationoftherapeuticeffectoflowdosenaltrexone
J.Transla.Med.15,1–17.doi:10.1016/b978-0-12-811440-7.00001-6 in experimentally-induced Crohn’s disease in rats. Neuropeptides 59, 39–45.
Smith,A.C.W.,Scofield,M.D.,andKalivas,P.W.(2015).Thetetrapartitesynapse: doi:10.1016/j.npep.2016.06.003
extracellular matrix remodeling contributes to corticoaccumbens plasticity Temburni,M.K.,andJacob,M.H.(2001).Newfunctionsforgliainthebrain.Proc.
underlyingdrugaddiction.BrainRes.1628,29–39.doi:10.1016/j.brainres.2015. Natl.Acad.Sci.U.S.A.98,3631–3632.doi:10.1073/pnas.081073198
03.027 Thompson, S. J., Pitcher, M. H., Stone, L. S., Tarum, F., Niu, G., Chen, X.,
Smith,R.S.(1991).Themacrophagetheoryofdepression.Med.Hypotheses35, et al. (2018). Chronic neuropathic pain reduces opioid receptor availability
298–306.doi:10.1016/0306-9877(91)90272-z with associated anhedonia in rat. Pain 159, 1856–1866. doi: 10.1097/j.pain.
Smolen, J. S., Weinblatt, M. E., Sheng, S., Zhuang, Y., and Hsu, B. (2014). 0000000000001282
Sirukumab,ahumananti-interleukin-6monoclonalantibody:arandomised, Thomsen, M. S., and Mikkelsen, J. D. (2012). The α7 nicotinic acetylcholine
2-part (proof-of-concept and dose-finding), phase II study in patients with receptor ligands methyllycaconitine, NS6740 and GTS-21 reduce
activerheumatoidarthritisdespitemethotrexatetherapy.Ann.Rheum.Dis.73, lipopolysaccharide-inducedTNF-αreleasefrommicroglia.J.Neuroimmunol.
1616–1625.doi:10.1136/annrheumdis-2013-205137 251,65–72.doi:10.1016/j.jneuroim.2012.07.006
Squeglia,L.M.,Baker,N.L.,McClure,E.A.,Tomko,R.L.,Adisetiyo,V.,and Tomko,R.L.,Jones,J.L.,Gilmore,A.K.,Brady,K.T.,Back,S.E.,andGray,K.M.
Gray,K.M.(2016).AlcoholuseduringatrialofN-acetylcysteineforadolescent (2018). N-acetylcysteine: a potential treatment for substance use disorders.
marijuanacessation.Addict.Behav.63,172–177.doi:10.1016/j.addbeh.2016.08. Curr.Psychiatr.17,30–55.
001 Totsch,S.K.,andSorge,R.E.(2017).Immunesysteminvolvementinspecificpain
Squeglia,L.M.,Tomko,R.L.,Baker,N.L.,McClure,E.A.,Book,G.A.,andGray, conditions.Mol.Pain13:1744806917724559.
K.M.(2018).TheeffectofN-acetylcysteineonalcoholuseduringacannabis Tripathi, A., Thangaraj, A., Chivero, E. T., Periyasamy, P., Burkovetskaya,
cessation trial. Drug Alcohol Depend. 185, 17–22. doi: 10.1016/j.drugalcdep. M.E.,Niu,F.,etal.(2020).N-Acetylcysteinereversesantiretroviral-mediated
2017.12.005 microglialactivationbyattenuatingautophagy-lysosomaldysfunction.Front.
Steele,A.D.,Szabo,I.,Bednar,F.,andRogers,T.J.(2002).Interactionsbetween Neurol.11:840.doi:10.3389/fneur.2020.00840
opioid and chemokine receptors: heterologous desensitization. Cytokine Tuglu,C.,Kara,S.H.,Caliyurt,O.,Vardar,E.,andAbay,E.(2003).Increasedserum
GrowthFact.Rev.13,209–222.doi:10.1016/s1359-6101(02)00007-2 tumornecrosisfactor-alphalevelsandtreatmentresponseinmajordepressive
Stein, M. B., Chen, C. Y., Ursano, R. J., Cai, T., Gelernter, J., Heeringa, S. G., disorder.Psychopharmacology170,429–433.doi:10.1007/s00213-003-1566-z
etal.(2016).Genome-wideassociationstudiesofposttraumaticstressdisorder Tyagi,M.,Weber,J.,Bukrinsky,M.,andSimon,G.L.(2016).Theeffectsofcocaine
in2cohortsofUSarmysoldiers.JAMAPsychiatry73,695–704.doi:10.1001/ on HIV transcription. J. Neurovirol. 22, 261–274. doi: 10.1007/s13365-015-
jamapsychiatry.2016.0350 0398-z
Stellwagen,D.,Beattie,E.C.,Seo,J.Y.,andMalenka,R.C.(2005).Differential UNAIDS(2019).GlobalHIV&AIDSStatistics—2019FactSheet.Availableonline
regulationofAMPAreceptorandGABAreceptortraffickingbytumornecrosis at:https://www.unaids.org/en/resources/fact-sheet(accessedApril8,2020).
factor-α.J.Neurosci.25,3219–3228.doi:10.1523/jneurosci.4486-04.2005 Vallés,S.L.,Blanco,A.M.,Pascual,M.,andGuerri,C.(2006).Chronicethanol
Stewart,A.M.,Roy,S.,Wong,K.,Gaikwad,S.,Chung,K.M.,andKalueff,A.V. treatmentenhancesinflammatorymediatorsandcelldeathinthebrainandin
(2015). Cytokine and endocrine parameters in mouse chronic social defeat: astrocytes.BrainPathol.14,365–371.doi:10.1111/j.1750-3639.2004.tb00079.x
implicationsfortranslational‘cross-domain’modelingofstress-relatedbrain Vera,J.H.,Guo,Q.,Cole,J.H.,Boasso,A.,Greathead,L.,Kelleher,P.,etal.(2016).
disorders.Behav.BrainRes.276,84–91.doi:10.1016/j.bbr.2014.08.037 NeuroinflammationintreatedHIV-positiveindividuals:aTSPOPETSTUDY.
Su,F.,Yi,H.,Xu,L.,andZhang,Z.(2015).FluoxetineandS-citalopraminhibitM1 Neurology86,1425–1432.doi:10.1212/wnl.0000000000002485
activationandpromoteM2activationofmicrogliainvitro.Neuroscience294, Vereker, E., O’Donnell, E., and Lynch, M. A. (2000). The inhibitory effect of
60–68.doi:10.1016/j.neuroscience.2015.02.028 interleukin-1β on long-term potentiation is coupled with increased activity
Substance Abuse and Mental Health Services Administration (2019). Key ofstress-activatedproteinkinases.J.Neurosci.20,6811–6819.doi:10.1523/
substanceuseandmentalhealthindicatorsintheUnitedStates:Resultsfrom jneurosci.20-18-06811.2000
the 2018 National Survey on Drug Use and Health (HHS Publication No. Vigorito,M.,Connaghan,K.P.,andChang,S.L.(2015).TheHIV-1transgenicrat
PEP19-5068, NSDUH Series H-54). Rockville, MD: Center for Behavioral modelofneuroHIV.Brain.Behav.Immun.48,336–349.doi:10.1016/j.bbi.2015.
Health Statistics and Quality, Substance Abuse and Mental Health Services 02.020
Administration.Availableonlineat:https://www.samhsa.gov/data/ Volkow,N.D.,Chang,L.,Wang,G.J.,Fowler,J.S.,Franceschi,D.,Sedler,M.,etal.
Sun,A.Y.,andSun,G.Y.(2001).Ethanolandoxidativemechanismsinthebrain. (2001a).Lossofdopaminetransportersinmethamphetamineabusersrecovers
J.Biomed.Sci.8,37–43.doi:10.1007/bf02255969 withprotractedabstinence.J.Neurosci.21,9414–9418.doi:10.1523/jneurosci.
Swan,G.E.,andLessov-Schlaggar,C.N.(2007).Theeffectsoftobaccosmoke 21-23-09414.2001
andnicotineoncognitionandthebrain.Neuropsychol.Rev.17,259–273.doi: Volkow,N.D.,Chang,L.,Wang,G.J.,Fowler,J.S.,Leonido-Yee,M.,Franceschi,
10.1007/s11065-007-9035-9 D., et al. (2001b). Association of dopamine transporter reduction with
Swendsen,J.,Conway,K.P.,Degenhardt,L.,Glantz,M.,Jin,R.,Merikangas,K.R., psychomotorimpairmentinmethamphetamineabusers.Am.J.Psychiatry158,
et al. (2010). Mental disorders as risk factors for substance use, abuse and 377–382.doi:10.1176/appi.ajp.158.3.377
dependence:resultsfromthe10-yearfollow-upoftheNationalComorbidity Vowles,K.E.,McEntee,M.L.,Julnes,P.S.,Frohe,T.,Ney,J.P.,andVanDerGoes,
Survey. Addiction 105, 1117–1128. doi: 10.1111/j.1360-0443.2010.02 D.N.(2015).Ratesofopioidmisuse,abuse,andaddictioninchronicpain:a
902.x systematicreviewanddatasynthesis.Pain156,569–576.doi:10.1097/01.j.pain.
Tajuddin,N.,Moon,K.H.,Marshall,S.A.,Nixon,K.,Neafsey,E.J.,Kim,H.Y., 0000460357.01998.f1
et al. (2014). Neuroinflammation and neurodegeneration in adult rat brain Wang,B.,Chen,T.,Xue,L.,Wang,J.,Jia,Y.,Li,G.,etal.(2019).Methamphetamine
frombingeethanolexposure:abrogationbydocosahexaenoicacid.PLoSOne exacerbatesneuroinflammatoryresponsetolipopolysaccharidebyactivating
9:e101223.doi:10.1371/journal.pone.0101223 dopamineD1-likereceptors.Int.Immunopharmacol.73,1–9.doi:10.1016/j.
Tan, S., Wang, Y., Chen, K., Long, Z., and Zou, J. (2017). Ketamine alleviates intimp.2019.04.053
depressive-likebehaviorsviadown-regulatinginflammatorycytokinesinduced Wang,M.,Duan,F.,Wu,J.,Min,Q.,Huang,Q.,Luo,M.,etal.(2018).Effect
bychronicrestraintstressinmice.Biol.Pharm.Bull.40,1260–1267.doi:10. of cyclooxygenase-2 inhibition on the development of post-traumatic stress
1248/bpb.b17-00131 disorderinrats.Mol.Med.Rep.17,4925–4932.
FrontiersinNeuroscience|www.frontiersin.org 25 April2021|Volume15|Article650785

## Page 26

fnins-15-650785 April13,2021 Time:14:5 #26
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
Wang, S. C., Lin, C. C., Chen, C. C., Tzeng, N. S., and Liu, Y. P. (2018). Ye, S. M., and Johnson, R. W. (1999). Increased interleukin-6 expression by
Effects of oxytocin on fear memory and neuroinflammation in a rodent microgliafrombrainofagedmice.J.Neuroimmunol.93,139–148.doi:10.1016/
modelofposttraumaticstressdisorder.Int.J.Mol.Sci.19:3848.doi:10.3390/ s0165-5728(98)00217-3
ijms19123848 Young,M.B.,Howell,L.L.,Hopkins,L.,Moshfegh,C.,Yu,Z.,Clubb,L.,etal.
Wang, X., Loram, L. C., Ramos, K., De Jesus, A. J., Thomas, J., Cheng, K., (2018).peripheralimmuneresponsetorememberingtraumacontributestothe
etal.(2012).Morphineactivatesneuroinflammationinamannerparallelto maintenanceoffearmemoryinmice.Psychoneuroendocrinology94,143–151.
endotoxin. Proc. Natl. Acad. Sci. U.S.A. 109, 6325–6330. doi: 10.1073/pnas. doi:10.1016/j.psyneuen.2018.05.012
1200130109 Yue,K.,Tanda,G.,Katz,J.L.,andZanettini,C.A.(2020).furtherassessmentofa
Wang, X., Northcutt, A. L., Cochran, T. A., Zhang, X., Fabisiak, T. J., Haas, roleforToll-likereceptor4inthereinforcingandreinstatingeffectsofopioids.
M.E.,etal.(2019).Methamphetamineactivatestoll-likereceptor4toinduce Behav.Pharmacol.31,186–195.doi:10.1097/fbp.0000000000000474
centralimmunesignalingwithintheventraltegmentalareaandcontributes Yuferov,V.,Zhang,Y.,Liang,Y.,Zhao,C.,Randesi,M.,andKreek,M.J.(2018).
toextracellulardopamineincreaseinthenucleusaccumbensshell.ACSChem. Oxycodoneself-administrationinducesalterationsinexpressionofintegrin,
Neurosci.10,3622–3634.doi:10.1021/acschemneuro.9b00225 SemaphorinandEphringenesinthemousestriatum.Front.Psychiatry9:257.
Wayman,W.N.,Chen,L.,Hu,X.T.,andNapier,T.C.(2016).HIV-1transgenicrat doi:10.3389/fpsyt.2018.00257
prefrontalcortexhyper-excitabilityisenhancedbycocaineself-administration. Zambrano,S.,deToma,I.,Piffer,A.,Bianchi,M.E.,andAgresti,A.(2016).NF-κB
Neuropsychopharmacology41,1965–1973.doi:10.1038/npp.2015.366 oscillationstranslateintofunctionallyrelatedpatternsofgeneexpression.eLife
Wei, J., Pan, X., Pei, Z., Wang, W., Qiu, W., Shi, Z., et al. (2012). The beta- 5:e09100.
lactam antibiotic, ceftriaxone, provides neuroprotective potential via anti- Zaparte, A., Schuch, J. B., Viola, T. W., Baptista, T. A. S., Beidacki, A. S., do
excitotoxicity and anti-inflammation response in a rat model of traumatic Prado,C.H.,etal.(2019).Cocaineusedisorderisassociatedwithchangesin
brain injury. J. Trauma Acute Care Surg. 73, 654–660. doi: 10.1097/ta. Th1/Th2/Th17cytokinesandlymphocytessubsets.Front.Immunol.10:2435.
0b013e31825133c0 doi:10.3389/fimmu.2019.02435
Wei, P., Liu, Q., Li, D., Zheng, Q., Zhou, J., and Li, J. (2015). Acute nicotine Zayyad, Z., and Spudich, S. (2015). Neuropathogenesis of HIV: from initial
treatment attenuates lipopolysaccharide-induced cognitive dysfunction by neuroinvasion to HIV-associated neurocognitive disorder (HAND). Curr.
increasing BDNF expression and inhibiting neuroinflammation in the HIV/AIDSRep.12,16–24.doi:10.1007/s11904-014-0255-3
rat hippocampus. Neurosci. Lett. 604, 161–166. doi: 10.1016/j.neulet.2015. Zeng,X.F.,Li,Q.,Li,J.,Wong,N.,Li,Z.,Huang,J.,etal.(2018).HIV-1Tat
08.008 and methamphetamine co-induced oxidative cellular injury is mitigated by
Wen, R. T., Zhang, F. F., and Zhang, H. T. (2018). Cyclic nucleotide N-acetylcysteineamide(NACA)throughrectifyingmTORsignaling.Toxicol.
phosphodiesterases: potential therapeutic targets for alcohol use disorder. Lett.299,159–171.doi:10.1016/j.toxlet.2018.09.009
Psychopharmacology235,1793–1805.doi:10.1007/s00213-018-4895-7 Zhang,C.,Zhang,Y.P.,Li,Y.Y.,Liu,B.P.,Wang,H.Y.,Li,K.W.,etal.(2019).
Wen,R.T.,Zhang,M.,Qin,W.J.,Liu,Q.,Wang,W.P.,Lawrence,A.J.,etal. Minocyclineamelioratesdepressivebehaviorsandneuro-immunedysfunction
(2012).Thephosphodiesterase-4(PDE4)inhibitorrolipramdecreasesethanol inducedbychronicunpredictablemildstressintherat.Behav.BrainRes.356,
seeking and consumption in alcohol-preferring fawn-hooded rats. Alcohol. 348–357.doi:10.1016/j.bbr.2018.07.001
Clin.Exp.Res.36,2157–2167.doi:10.1111/j.1530-0277.2012.01845.x Zhang,H.,Largent-Milnes,T.M.,andVanderah,T.W.(2020).Glialneuroimmune
Werry,E.L.,Bright,F.M.,Piguet,O.,Ittner,L.M.,Halliday,G.M.,Hodges,J.R., signaling in opioid reward. Brain Res. Bull. 155, 102–111. doi: 10.1016/j.
etal.(2019).RecentdevelopmentsinTSPOPETimagingasabiomarkerof brainresbull.2019.11.012
neuroinflammationinneurodegenerativedisorders.Intern.J.Mol.Sci.20:3161. Zhang,J.C.,Yao,W.,Dong,C.,Yang,C.,Ren,Q.,Ma,M.,etal.(2017).Blockade
doi:10.3390/ijms20133161 of interleukin-6 receptor in the periphery promotes rapid and sustained
Wiese,B.,andWilson-Poe,A.R.(2018).EmergingevidenceforCannabis’.Rolein antidepressant actions: a possible role of gut-microbiota-brain axis. Transl.
OpioidUseDisorder.CannabisCannabinoidRes.3,179–189.doi:10.1089/can. Psychiatry7:e1138.doi:10.1038/tp.2017.112
2018.0022 Zhang,L.,Looney,D.,Taub,D.,Chang,S.L.,Way,D.,Witte,M.H.,etal.(1998).
Wilson,J.M.,Kalasinsky,K.S.,Levey,A.I.,Bergeron,C.,Reiber,G.,Anthony, Cocaine opens the blood-brain barrier to HIV-1 invasion. J. Neurovirol. 4,
R. M., et al. (1996). Striatal dopamine nerve terminal markers in human, 619–626.doi:10.3109/13550289809114228
chronicmethamphetamineusers.Nat.Med.2,699–703.doi:10.1038/nm0696- Zhang, N., Rogers, T. J., Caterina, M., and Oppenheim, J. J. (2004).
699 Proinflammatorychemokines,suchasC-CChemokineLigand3,desensitize
Wilson,M.,Gogulski,H.Y.,Cuttler,C.,Bigand,T.L.,Oluwoye,O.,Barbosa-Leiker, µ-Opioidreceptorsondorsalrootganglianeurons.J.Immunol.173,594–599.
C.,etal.(2018).Cannabisusemoderatestherelationshipbetweenpainand doi:10.4049/jimmunol.173.1.594
negativeaffectinadultswithopioidusedisorder.Addict.Behav.77,225–231. Zhang,Q.,Gupta,S.,Schipper,D.L.,Kowalczyk,G.J.,Mancini,A.E.,Faeder,J.R.,
doi:10.1016/j.addbeh.2017.10.012 etal.(2017).C.NF-κBdynamicsdiscriminatebetweenTNFdosesinsinglecells.
Wohleb, E. S., Franklin, T., Iwata, M., and Duman, R. S. (2016). Integrating CellSyst.5,638–645.e5.
neuroimmunesystemsintheneurobiologyofdepression.Nat.Rev.Neurosci. Zhang,Y.,Liang,Y.,Levran,O.,Randesi,M.,Yuferov,V.,Zhao,C.,etal.(2017).
17,497–511.doi:10.1038/nrn.2016.69 Alterationsofexpressionofinflammation/immune-relatedgenesinthedorsal
Yamashita, T., Yamamoto, S., Zhang, J., Kometani, M., Tomiyama, D., Kohno, andventralstriatumofadultC57BL/6Jmicefollowingchronicoxycodoneself-
K.,etal.(2016).DuloxetineinhibitsmicroglialP2X4receptorfunctionand administration:aRNAsequencingstudy.Psychopharmacology234,2259–2275.
alleviatesneuropathicpainafterperipheralnerveinjury.PLoSOne11:e0165189. doi:10.1007/s00213-017-4657-y
doi:10.1371/journal.pone.0165189 Zhou, W., and Kalivas, P. W. N. - (2008). Acetylcysteine reduces extinction
Yan,T.,Zhao,Y.,andZhang,X.(2016).AcetaldehydeinducesCytotoxicityofSH- responding and induces enduring reductions in cue- and heroin-induced
SY5YcellsviainhibitionofAktactivationandinductionofoxidativestress. drug-seeking. Biol. Psychiatry 63, 338–340. doi: 10.1016/j.biopsych.2007.
Oxid.Med.Cell.Longev.2016:4512309. 06.008
Yang, X., Diehl, A. M., and Wand, G. S. (1996). Ethanol exposure alters the Zhu,J.,Hu,Z.,Han,X.,Wang,D.,Jiang,Q.,Ding,J.,etal.(2018).Dopamine
phosphorylationofcyclicAMPresponsiveelementbindingproteinandcyclic D2receptorrestrictsastrocyticNLRP3inflammasomeactivationviaenhancing
AMPresponsiveelementbindingactivityinratcerebellum.J.Pharmacol.Exp. theinteractionofβ-arrestin2andNLRP3.CellDeathDiffer.25,2037–2049.
Ther.278,338–346. doi:10.1038/s41418-018-0127-2
Yang, X., Horn, K., Baraban, J. M., and Wand, G. S. (1998). Chronic ethanol Zhu,L.,Li,J.,Dong,N.,Guan,F.,Liu,Y.,Ma,D.,etal.(2016).MRNAchanges
administration decreases phosphorylation of cyclic AMP response element- innucleusaccumbensrelatedtomethamphetamineaddictioninmice.Sci.Rep.
bindingproteiningranulecellsofratcerebellum.J.Neurochem.70,224–232. 6:36993.
doi:10.1046/j.1471-4159.1998.70010224.x Zhu, L., Zhu, J., Liu, Y., Chen, Y., Li, Y., Chen, S., et al. (2015). Chronic
Ye,G.,Yin,G.Z.,Tang,Z.,Fu,J.L.,Chen,J.,Chen,S.S.,etal.(2018).Association methamphetamineregulatestheexpressionofMicroRNAsandputativetarget
betweenincreasedseruminterleukin-6levelsandsustainedattentiondeficitsin genesinthenucleusaccumbensofmice.J.Neurosci.Res.93,1600–1610.doi:
patientswithmajordepressivedisorder.Psychol.Med.48,2500–2507. 10.1002/jnr.23605
FrontiersinNeuroscience|www.frontiersin.org 26 April2021|Volume15|Article650785

## Page 27

fnins-15-650785 April13,2021 Time:14:5 #27
Nambaetal. NeuroimmuneMechanismsofSubstanceUseDisorders
Zhu,W.,Chernew,M.E.,Sherry,T.B.,andMaestas,N.(2019).InitialOpioid ConflictofInterest:Theauthorsdeclarethattheresearchwasconductedinthe
PrescriptionsamongU.S.CommerciallyInsuredPatients,2012-2017.N.Engl. absenceofanycommercialorfinancialrelationshipsthatcouldbeconstruedasa
J.Med.380,1043–1052.doi:10.1056/nejmsa1807069 potentialconflictofinterest.
Zoladz, P. R., Eisenmann, E. D., Rose, R. M., Kohls, B. A., Johnson, B. L.,
Robinson, K. L., et al. (2018). Predator-based psychosocial stress model of Copyright©2021Namba,Leyrer-Jackson,Nagy,OliveandNeisewander.Thisisan
PTSDdifferentiallyinfluencesvoluntaryethanolconsumptiondependingon open-accessarticledistributedunderthetermsoftheCreativeCommonsAttribution
methodology.Alcohol70,33–41. License(CCBY).Theuse,distributionorreproductioninotherforumsispermitted,
Zou, W., Feng, R., and Yang, Y. (2018). Changes in the serum levels providedtheoriginalauthor(s)andthecopyrightowner(s)arecreditedandthatthe
of inflammatory cytokines in antidepressant drug-naïve patients with originalpublicationinthisjournaliscited,inaccordancewithacceptedacademic
major depression. PLoS One 13:e0197267. doi: 10.1371/journal.pone.019 practice.Nouse,distributionorreproductionispermittedwhichdoesnotcomply
7267 withtheseterms.
FrontiersinNeuroscience|www.frontiersin.org 27 April2021|Volume15|Article650785

